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ABSTRACT 
Obesity has been identified epidemiologically as a risk factor for development of chronic 
venous disease. To examine whether abdominal adiposity obstructs venous outflow from the 
legs, 26 females aged 34-49 years with no clinical venous disease and body mass index (BMI) 
between 20.9 – 46.7 kg/m2 were studied. A novel measurement of the extent of abdominal fat 
along the legs when seated correlated well with BMI and other measures of central fat 
(sagittal-abdominal diameter, ultrasound fat thickness, % truncal fat by DEXA scan). On 
sitting, inguinal tissue pressure recorded by needle manometry increased more in obese (BMI 
> 30) than normal weight (BMI 20-25) subjects (8.2 vs 1.5 mmHg, p<0.01) as did the femoral 
vein cross-sectional area (129 vs 60%, p<0.05). Both measures correlated with increasing 
abdominal fat but were not associated with each other. In the lower leg, saphenous vein 
distensibility and compliance correlated positively with abdominal fat and BMI, but there was 
no such association for the popliteal vein. Female sex hormones, physical activity levels and 
insulin status did not affect venous haemodynamics. Thus, increased abdominal fat can 
potentially hinder venous return when sitting, leading to distension and changes in vein 
biomechanics, which could overtime contribute to venous disease. 
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CHAPTER 1:  
BACKGROUND AND LITERATURE REVIEW 
Obesity has been identified as a risk factor associated with the development of chronic venous 
disease. Epidemiological studies indicate a higher occurrence of varicose veins, chronic 
venous insufficiency or both in people who are overweight or obese as defined by their body 
mass index, especially women. The pathogenesis of venous disease involves valvular 
incompetence although it is not known if this is the primary defect or whether it occurs 
secondary to venous dilatation in response to venous hypertension. It has been suggested that 
obesity could be linked to venous disease by abdominal adiposity presenting a mechanical 
impeding pressure on peripheral venous return, promoting hypertension (Beebe-Dimmer et al. 
2005), or through raised levels of inflammatory mediators such as cytokines and adipokines 
(Allison et al. 2010).  
The majority of studies investigating the association between obesity and venous disease 
involve populations that already show clinical manifestations of the condition, and 
characterise obesity through body mass index, and venous dysfunction by visual examination 
and ultrasound assessment of reflux and/or obstruction. Once the veins have become diseased, 
they show increased distensibility because of the pathological changes in their wall 
composition (van Rij et al 2008). Such case-control studies of obesity and chronic venous 
disease are therefore limited in that this design does not establish a temporal sequence 
between exposure and disease. Moreover, while body mass index gives a ‘whole body’ view 
of obesity, it does not specifically define the abdominal obesity that might contribute to 
impairment of venous return. 
The work presented in this thesis aims to address these issues by examining the relationship 
of body composition and abdominal obesity to measures of leg vein function in a cohort of 
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individuals without clinical venous disease. By comparing venous capacity and compliance, 
as physiological parameters that can signify subtle pre-disease alterations in vein wall 
biomechanical properties, with abdominal fat across a range of otherwise healthy people, the 
potential for obesity-induced mechanical impediment to venous return may be determined. 
Furthermore, the relevance for venous function of confounding factors such as levels of 
physical activity and female hormone status will be controlled for and evaluated.  
 
1.1 PREVALENCE AND INCIDENCE OF CHRONIC VENOUS DISEASE 
Venous disease of the lower extremities is the commonest reported vascular condition and is a 
major source of the morbidity in the Western world. The spectrum of the disease ranges from 
uncomplicated varicose veins (VV) through to chronic venous insufficiency (CVI) which is 
characterised by oedema, venous eczema, haemosiderin deposits, lipodermatosclerosis and 
eventually ulceration. Several large population studies over the last decade report the 
incidence of chronic venous disease, reviewed by Beebe-Dimer et al. (2005). VV estimates 
range from 2 – 56% in males and <1 - 73.2% in females (Carpentier et al. 2004, Stanhope, 
1975, Lake et al. 1942) whilst CVI has been estimated at 9% in males and 7% in females in 
the Edinburgh Vein Study (Lee et al. 2003). The San Diego study (Criqui et al. 2003, Criqui 
et al. 2007) estimated that 27.9% of their target population had functional venous disease (i.e. 
VV and CVI). The incidence of venous disease given by the Framingham study was 1.9% in 
men and 2.6% in woman per annum (Brand et al. 1988). The variation in these figures is 
partly due to differences in definition of venous disease and since several studies only report 
the incidence based on symptomatic reporting by patients, it is possible that this excludes 
large numbers of sufferers. The numbers are thus likely to underestimate the true situation. 
Leg ulceration, of which the majority (~80%) is attributable to venous disease (Naik et al. 
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2000), affects 1% of the population in their lifetime (Callam et al. 1987) and this presents a 
huge burden to NHS resources since 2% of the present NHS budget goes on the treatment of 
venous ulceration (Laing, 1992).  
CVI itself can be a debilitating illness with loss of self-esteem and self-confidence. Sufferers 
can become dependent on medical care and lose independence, and loss of time at work, trips 
to the general practitioner, travel to and from medical appointments, can all be considered as a 
consequence of the illness. Sam et al. (2004, 2006) demonstrated clearly a marked 
improvement in the quality of life scores people recorded following treatment for VV yet 
there is very little health promotion carried out in this area where preventative measures may 
offer major functional, quality of life and financial benefits. It is thus clear that this is an area 
of major health concern which can be severely detrimental to people’s physical and 
psychological well being. 
Although venous disease prevalence increases with age in all the studies reported, it is not just 
a disease of the elderly. Callam et al. (1987) in their examination of 600 ulcerated legs found 
that 20% of ulcers had started before the age of 40, and the incidence of CVI in the EVS in 
the 35-44 year old age category was 2.53% in men and 3.76% in woman. This raises the 
question of what factors predispose and / or initiate venous disease in the population at a time 
when individuals may otherwise be relatively healthy. 
 
1.2 CLASSIFICATION OF CHRONIC VENOUS DISEASE 
In the literature, chronic venous disease is classically divided into two different categories, 
varicose veins and chronic venous insufficiency. VV are defined by the WHO (Prerovsky) as 
“saccular dilatations of the veins which are often tortuous”, while the Basle study (Widmer, 
1978) identifies three different components:- dilated saphenous veins (trunk veins), dilated 
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superficial tributaries (reticular veins) and dilated venules (hyphenwebs). The definition of 
CVI encompasses multiple presentations of similar pathologies characterised by the failure of 
the lower limbs to remove sufficient blood via the venous system leading to symptomatic 
presentation (Pappas et al. 2005). The condition ranges in presentation from symptoms of 
aching and swelling in the leg, through varicose veins to skin changes of venous eczema, 
haemosiderin deposits and lipodermatosclerosis, eventually leading to ulceration. Venous 
disease is now categorized using a universally accepted structure that recognizes that the two 
diseases are part of the same spectrum. The Clinical, Etiologic, Anatomic, Pathophysiologic 
(CEAP) classification system was devised by Moneta & Porter (1995) and endorsed by the 
American Venous Forum and the Joint Council of the Society for Vascular Surgery and the 
North American-International Society for Cardiovascular Surgery (Moneta et al 1995, 
Padberg 2005). The system has four areas of classification for labelling the disease listed in 
Table 1.1. The majority of clinicians categorise using the version in table 1.2  
 
Mark Definition 
C 
Clinical signs (grade0-6), supplemented by (s) for symptomatic and (a) for 
asymptomatic presentation 
E Etiologic Classification (Congenital, Primary, Secondary) 
A 
Anatomic Distribution (Superficial, Deep, or Perforator, alone or in 
combination) 
P 
Pathophysiologic Dysfunction (Reflux or Obstruction, alone or in 
combination) 
 
Table 1.1. CEAP Clinical classification of chronic lower extremity venous disease (Moneta & 
Porter 1995). 
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Class Clinical signs 
0 No visible or palpable signs of venous disease 
1 Teleangiectases, reticular veins, malleolar flare 
2 Varicose veins 
3 Edema without skin changes 
4 
Skin changes ascribed to venous disease (pigmentation, venous eczema, 
lipodermatosclerosis) 
5 Skin changes (as defined above) in conjunction with healed ulceration 
6 Skin changes (as defined above) in conjunction with active ulceration 
 
Table 1.2. Breakdown of  CEAP classification into the 7 categories of clinical signs used for 
practical purposes (Moneta & Porter 1995). 
 
1.3 LOWER LIMB VENOUS ANATOMY AND FUNCTION 
Before considering in detail the pathological changes associated with chronic venous disease, 
a brief description of the venous anatomy of the lower leg will be given (Figure 1.1). This is 
classified into the deep and superficial systems, the deep system comprising the venae 
commitantes of the crural vessels and their confluence into the popliteal vein and its 
continuation into the femoral vein (FV) and iliac veins draining into the inferior vena cava 
(IVC). The superficial system has two main vessels that drain the skin and subcutaneous 
tissue. The great saphenous vein (GSV) is a confluence of the veins on the medial side of the 
foot that passes anterior to the medial malleolus and runs on the antero-medial aspect of the 
whole limb draining into the FV at the sapheno-femoral junction (SFJ). It is enveloped along 
its entire length in a fascial sheath/compartment supplied by tributaries which lie outside this. 
This may explain why greater tortuosity is initially seen in primary VV in the tributaries and 
less in the main GSV trunk (Caggiati, 1999). The Short Saphenous Vein (SSV) commences at 
the outer border of the foot and runs posterior to the lateral malleolus. It pierces the fascia and 
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drain into the popliteal vein between the two head of the gastrocnemius muscle at the 
sapheno-popliteal junction (SPJ) (Browse et al 1999).  
The deep and superficial systems are connected together by perforator veins that drain the 
superficial system into the deep system at various variable points (Delis, 2005). The drainage 
of all the systems is kept flowing by the presence of multiple valve in the veins that prevent 
backflow. There is substantial variation in the course and tributaries of these systems with 
other named veins in existence (Delis et al 2004). 
The venous drainage leaves both legs under the inguinal ligament in the femoral canal and 
passes along the back of the abdominal cavity in the retro-peritoneum coming together to 
form the Inferior Vena Cava. It is joined by the circulation returning from the liver, kidneys 
and abdominal organs before piercing the diaphragm at the level of the tenth vertebra. Here it 
is subjected to the pressure variations that affect all structures in the abdominal cavity and 
retro-peritoneum (e.g. straining, lifting, coughing etc.) Once entering the chest the venous 
return is affected by the pressure in the right atrium and the intra-thoracic pressure variations. 
Venous disease is more common in the left than the right leg and this may reflect the fact that 
the left Common Iliac Vein must pass below the Right Common Iliac Artery to reach the 
inferior cava causing impedance to flow. If this becomes of clinical significance it is termed 
May-Turner Syndrome. 
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 Figure 1.1. The lower limb venous drainage and its passage through the 
 retroperitoneum of the abdominal cavity. 
 
With the body in a supine position, lower limb venous pressure is low (~ 5-10 mmHg) and 
venous return is achieved by the pressure gradient to the right atrium. In the upright position, 
hydrostatic load increases venous pressure in the foot to approximately 100 mmHg, and 
venous return is aided by the presence of valves to prevent backflow, the calf muscle pump, 
and the respiratory pump. The calf muscle pump involves the deep veins of the calf (supplied 
by blood from the superficial compartment through perforator veins) running through the 
muscle bellies of gastrocnemius and soleus (see Figure 1.2). When these muscles contract 
they exert a pressure of anywhere between 200 and 300 mmHg expelling more than 60% of 
the venous blood contained within them into the large popliteal vein, equating to 
approximately 30-40ml per contraction. This substantially lowers the pressure in the deep and 
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superficial venous systems until refill occurs by arterial inflow (Raju et al 1993). After 10 
contractions of muscle this takes approximately 25 seconds (Browse et al 1999; see Figure 
1.3).  Reflux in the deep system is prevented by valves in the tibial, popliteal and femoral 
veins and no reflux occurs into the superficial system as valves prevent flow outward in the 
perforator veins.  
 
Figure 1.2. The calf muscle pump showing the arrangement of veins in the calf interwoven 
between muscle layers that act to squeeze the veins on contraction (Gloviczki et al 2001176). 
 
The respiratory pump acts through decreased intra-thoracic pressure on inspiration which 
draws blood up from the IVC into the chest, driving it on expiration into the right atrium as 
pressure increases in expiration. The pressure gradient between limbs and heart is also aided 
by the increasing diameter of the veins approaching the heart, through La Place’s Law. Since 
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the equilibrium relationship between transmural pressure difference (dP), wall tension (T), 
and radius of curvature ® in a concave surface for a cylinder is defined as dP = T/R, this 
equates to blood moving from small caliber higher pressure chambers to larger lower pressure 
chambers (Daintree et al 1975).  
 
 
Figure 1.3. The effect of calf contraction on the blood volume of the lower limb as measured 
by photoplethysmography. The time it takes to return to normal should be greater than 25 
seconds (Browse et al. 1999). 
 
1.4 PATHOLOGY OF CHRONIC VENOUS DISEASE  
Failure of the structural integrity of the venous system in lower limbs leads to varicose veins 
(VV) and chronic venous insufficiency (CVI). The two key changes that occur leading to the 
formation of venous reflux and varicosities are 1) weakening and dilation of the vein wall and 
2) incompetence of the venous valves (Figure 1.4).  
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Figure 1.4. A) Normal healthy venous valves with the leaflets preventing back flow. B) 
Diseased venous valve with disruption of the vein wall and loss of integrity of the valve. 
Failure to control blood flow is seen with reflux through the separated leaflets. 
 
Compared to the normal GSV, varicose veins show thickening of the wall intima and media 
and a transverse greater diameter, changes in smooth muscle composition, endothelial 
disruption, and fibrosis. Studies have shown hypertrophic changes in the smooth muscle cells 
(SMC) in the media of vein walls with remodeling of the alignment and structure of the 
muscles cells (Sansilvestri-Morel et al. 2001, Elsharawya et al. 2007). Reports have described 
increased, decreased and no change in the volume of smooth muscle cells. Overall the 
literature tends to support a higher content of SMC, which suggests that the pathological 
abnormalities in varicose veins are not due to deficiency of smooth muscle but to the inability 
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of the SMC to produce the necessary venous tone (Elsharawya et al. 2007). There is 
generalized thickening of the wall and hypertrophy of the sub-endothelial tissues can cause 
protrusions of the wall into the vessel lumen. There is elongation of the intima, thrown into 
excessive folds and invagination with discontinuity of the endothelial sheet and desquamation 
in many places. Wrinkling and invagination of the endothelial layer, not seen in normal veins, 
is found. These invaginations were noted to fold over on themselves trapping blood cells and 
then blebbing off into the circulation leaving exposed areas of intima (Wali et al. 2002).  
The composition of the vein wall in terms of the connective tissue elements has been 
investigated and the relationship between elastin and collagen plays an important role in 
determining its distensibility properties and hence its ability to withstand pressure. Both are 
altered in venous disease. Elastin production has been shown to initially increase in the early 
stages (Naoum et al. 2007, Kirsch et al. 2000, Elsharawya et al. 2007) but with progression, 
the fibres become reduced in number and fragmented with the loss of the normal latticework 
in the intima and media. Venturi et al. (1996) found a strong association between the loss of 
elastin and the development of varicose veins. Evidence indicates that people with varicose 
veins have a higher turnover of elastin in tissue remodeling (Buján et al. 2003), and a study by 
Zsotér & Cronin (1966) showed that patients who had varicose veins in the lower limb also 
demonstrated increased distensibility of the forearm veins, implying a generalized defect. 
Reduction in elastin was noted in elderly populations, as expected, leading to reduced 
distensibility with time (Naoum et al. 2007). Measurement of collagen in the vein wall during 
venous disease has yielded conflicting results with reports of higher concentrations 
(Sansilvestri-Morel et al. 2001, Gandhi et al. 1993, Venturi et al. 1996), lower concentrations 
or no difference. However, more recent studies have accepted that the collagen contents is 
increased contributing to vein wall fibrosis and SMC separation (Venturi et al. 1996), but 
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have focused on the balance of the different types of collagen fibres. Within an overall 
increase in collagen production, Sansilvestri-Morel et al. (2001) noted a marked reduction in 
the production of collagen III fibres (involved in elasticity) compared to an increase in 
collagen I (structural strength). This imbalance of production occurred in the face of normal 
mRNA expression. Further studies by this group have found that not only is the saphenous 
vein affected by this imbalance but also the skin, suggesting that the connective tissue 
problem is at least part inherited (Sansilvestri-Morel et al. 2001, 2002, 2005, 2007).  
Valve deficiency in chronic venous disease is also evident as separation and shortening of the 
valve leaflets with depression of the valves commissures (Edwards et al. 1940, Rokitansansky 
1852). Valve cusp perforation, tearing and elongation have been described with disappearance 
of valves altogether (Takase et al. 2004, 2004). These changes are associated with 
inflammation as observed by Ono et al. (1998) who took histological samples of veins at 
human surgery and found monocyte infiltration. The San Diego group (Takase et al. 2004) 
speculated that the changes seen may be due to induced apoptosis of the cells in the valve 
leaflets but were not able to support this hypothesis biochemically. 
 
1.5 PATHOGENESIS OF CHRONIC VENOUS DISEASE AND LINK TO VENOUS 
HYPERTENSION 
A key question concerning the initiation of venous disease is which of these events – valve 
dysfunction or vein wall weakening - occurs first and how the two are related. On the one 
hand, it is considered that increased venous diameter due to structural wall changes and 
dilation could cause dysfunction of the valve leaflets. The disturbance in the wall ratio of 
elastin and collagen and the smooth muscle and endothelial changes described above alter the 
mechanical properties of the vein, resulting in reduced distensibility and dilatation, and 
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expose the valves to raised pressures that could precipitate their incompetence (Bergan et al. 
2008). This theory is based on three observations made by King(1950):- 1) that initial 
varicosities communicate with a normal venous system, as clearly seen on duplex in patients 
attending vascular clinic who have no saphenous reflux but varicose veins in the lower limb; 
2) that vein wall dilations occur distal to valves therefore making the backwash reflux of 
blood through the valves an unlikely theory (also suggested by Cotton in 1961) and 3) that 
histological examinations of the vein wall indicates that valves increase to a certain degree 
with venous dilation but then cease to operate beyond a maximal diameter. 
On the other hand, valve dysfunction as the primary defect would permit backflow and raised 
venous pressure, which could lead to dilation and weakening of the vein wall. The role of 
valves in the development of venous disease is shown in congenital valve aplasia where the 
total absence of valves, albeit a rare situation, leads to development of severe varicosities and 
secondary complications. It was previously suggested that the absence of valves in the ileo-
femoral vein segments (see Figure 1.1) increased hydrostatic pressure on the sapheno-femoral 
junction (SFJ) and that this led to descending valvular failure (Browse et al. 1999). Post-
mortem analysis has shown that up to 40% of the population may be affected.  A similar 
situation could also arise following disruption to, rather than absence of, valves in the ileo-
femoral segments.  However, no causative link has been proven and there is strong evidence 
that reflux in the GSV can be present without SFJ incompetence (Labropoulos et al. 1999, 
Abu-Own et al. 1994). The number of valves in the GSV has been noted to be significantly 
lower in varicosed veins although this is not necessarily related to junctional reflux. These 
points make a descending valvular incompetence theory less likely. 
Whatever the exact sequence of the events that result in chronic venous disease, it is evident 
that venous hypertension, either through vein wall dilation or because of valve dysfunction, is 
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a major contributing factor. The inflammatory changes in valve leaflets that are characteristic 
of the disease process can be mimicked by chronic pressure elevation in animal models 
(Bergan et al. 2008). In venous hypertension induced by arterio-venous fistulae, Takase et al. 
(2004) showed that the changes seen in diseased valves could be replicated after only short 
periods of hypertension with vein wall dilatation, reflux, and increases in inflammatory 
markers accompanied by leukocyte infiltration in the valve leaflets.  
There are a number of physical and haemodynamic characteristics of veins in humans that 
could predispose to venous hypertension and the sequelae that define chronic venous disease. 
These characteristics can be modified by many different factors including body composition 
(height, weight), obesity, raised arterial blood pressure, altered calf muscle pump function, 
levels of physical activity, outflow obstruction, attenuation of venous smooth muscle tone, 
and female reproductive hormone status. In order to evaluate the literature that relates to the 
involvement of these factors in venous disease, it is necessary to first define the parameters 
that describe these physical and haemodynamic aspects and describe how they are evaluated. 
 
1.6 DEFINING LOWER LIMB VENOUS CHARACTERISTICS  
The physical, mechanical and physiological characteristics of veins have been described by 
Rothe in two excellent reviews (Rothe, 1983 & 1986). When the veins are emptied (supine/ 
head-down Trendelenberg position) they adopt an elliptical shape supported by the 
surrounding tissues (Clarke et al 1989, Zamboni et al. 1997). Their pressure is low and there 
is little resistance to flow. On assumption of the upright posture, blood pools under 
hydrostatic pressure in the leg veins which fill into their circular shape (Figure 1.5). The 
relationship between venous volume contained and pressure is important because it enables 
several characteristics of the veins to be defined. Over at least part of the physiological 
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operating range, the incremental change in volume for a small incremental change in 
transmural pressure tends to be constant; i.e. the pressure-volume relationship may be 
considered linear. At abnormally high pressures, the veins are stiff and there is little change in 
volume as the pressure is increased.  
 
 
 
Figure 1.5. The volume pressure curve for veins depicting the predicted shape 
 that veins take at different volumes and pressures. 
 
Venous capacitance defines contained volume of the veins at a given pressure over the normal 
physiological range and can be altered by changes in the venous tone (i.e. the contractile 
status of venous smooth muscle), allowing the pressure-volume curve to be shifted down by 
venoconstriction and up by venodilation (Figure 1.6). The linear part of the normal pressure-
volume relationship intercepts the volume axis at a positive value, representing what is called 
the unstressed volume. This is the volume contained at zero transmural pressure that does not 
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contribute to vein distension. When fully filled, volume contained can be defined as 
maximum venous capacity. 
 
 
 
Figure 1.6 Pressure-Volume curves with normal, increased and decreased 
 venous tones. The graph shows how it is possible for venous and or whole limb 
 compliance to remain the same as venous tone is altered. 
 
In order to describe the venous pressure-volume relationship insofar as it is determined by the 
properties of the vein wall, two other terms – distensibility and compliance – are often used. 
Distensibilty is a qualitative term implying that when a force is applied to a material, it 
changes its dimensions. Vascular distensibilty has been defined as ΔV/(V°/ΔP), the fractional 
change in volume per unit change in pressure where V° is the total vascular volume at the 
point on the pressure-volume curve under consideration. In practice, venous distensibility 
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should be calculated, for the reasons as explained above, over a linear portion at a defined 
range of pressures. Venous compliance is the ratio of the change in volume (ΔV) to the 
concomitant small change in the transmural distending pressure (ΔP): C = ΔV/ΔP. It is the 
slope of the pressure-volume relationship at a specified pressure or volume. Because of the 
overall nonlinear distensibility characteristics of blood vessels, the location on the vascular 
pressure- volume curve should be specified in terms of the pressure or total contained volume.  
It should be noted that, as shown in Figure 1.6, venous capacitance may be reduced or 
increased by venoconstriction or venodilation respectively without a change in the slope of 
the pressure-volume relationship, i.e. without change in compliance. Venous smooth muscle 
tone can be increased by autonomic sympathetic neural and hormonal activity even though the 
density of adrenergic innervation is much less than in arteries, especially in the smaller veins 
(Rothe, 1983). It is also sensitive to a wide range of local and circulating vasoactive 
substances (see Appendix A). Passive tone is dependent on the elastic properties of the vein 
wall. This property cannot be changed and is the major source of venous tone at rest (Browse 
et al. 1999).  
Moreover, there is another property of the vein wall that impacts upon filling and has 
implications for estimations of distensibility and / or compliance. This is hysteresis which 
refers to the considerable discordance between venous volumes measured during a rise in 
venous pressure versus a fall in venous pressure. It is due to the presence of the elastin and 
collagen components of the vein wall, which impart viscoelasticity and allow for the property 
of ‘creep’ or what is called ‘stress relaxation’ or ‘delayed compliance’. The shape of the 
hysteresis curve during vein filling and emptying is depicted in Figure 1.7, illustrating that 
contained volume at a given venous pressure in the filling phase of venous engorgement is 
less than for the same venous pressure during venous emptying i.e. the effect lags behind the 
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cause. Initially the response as described is overcoming the effect of the elastin fibres in the 
intima. This is the period of rapid expansion of volume with minimal increase in venous 
pressure. Once filling has occurred the resulting stretch is dependent on forces acting on the 
structural strength supplied by the collagen fibres.  This is why the pressure in the vein rises 
rapidly for minimal increase in volume.  
 
 
Figure 1.7. Diagramatic representation of venous filling against pressure and hysteresis in a 
normal vein showing the different structural proteins effects on filling and emptying. 
 
During filling, the early part of the curve can be modified by venous smooth muscle tone, 
whereas differences in vein wall composition - quantity of smooth muscle, elastin and 
collagen - modify the hysteresis curve in the upper pressure range. Because of ‘creep’ or 
‘stress relaxation’, it is considered that a more accurate assessment of the passive elastic recoil 
 18
properties of the vein wall due to elastin and collagen is achieved by recording a pressure-
volume curve during emptying. In any case, alterations in vein wall composition as a 
consequence of venous disease will result in changes in the shape of pressure-volume 
relationship characteristic of increased distensibility and capacity, and reduced compliance.  
 
1.7 METHODS OF ASSESSMENT OF LOWER LIMB VENOUS FUNCTION  
There are three main methods available for examining leg vein properties described by Pang 
(2000). Superficial veins in the foot can be studied for their vasoreactivity by measurement of 
diameter changes using the linear differential transformer technique as described by Aellig 
(1994) in response to local infusion, injection or oral administration of agonists and 
antagonists. For example, Streeten (2001) used this method to show supersensitivity to 
noradrenaline in the foot veins of patients with orthostatic hypotension. Since this method is 
limited to smaller superficial vessels, it may not provide information about the larger and / or 
deeper leg veins which play a greater role in determining pressure within the system. For this, 
venous occlusion combined with limb plethysmography or USS are more suitable methods. 
A widely used approach to study leg venous function is to measure limb volume changes as a 
surrogate for venous vascular volume during filling either by postural manoeuvres or by 
application of a venous occlusion cuff. From red blood cell scintography, it has been 
estimated that up to 65% of total blood volume in the filled limb resides in the venous 
circulation (Gelman, 2008), and pressure-volume curves representative of venous vascular 
volume can be constructed from plethysmographic recordings of limb volume during graded 
pressure increases applied by a proximal cuff. A typical trace obtained from such a filling 
procedure is illustrated in Figure 1.8. The shape of the curve is typical of that shown for 
individual veins in Figures 1.4 and 1.6, displaying a biphasic volume-pressure curve with a 
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steep initial slope representing rapid filling and a more gradual slope that levels off 
representing fluid filtration out of the microcirculation into the tissues (Risk et al. 2003). The 
inflection point between the steep and gradual part of the curve represents filled venous 
capacity and thereafter limb expansion can be attributed to venous wall “creep” during 
maintenance of high venous pressure as well as interstitial fluid accumulation (Knaapen et al. 
2005). 
 
Figure 1.8. The effect of increasing pressure on limb volume demonstrating the venous filling 
and fluid filtration phases. Note that the venous filling and capillary filtration stages can be 
considered linear. 
 
Using limb plethysmography to record volume changes, different venous occlusion protocols 
are employed to determine varying aspects of both arterial and venous haemodynamics. Brief 
occlusions to 40-50 mmHg (5-10 sec) allow the first few seconds of limb expansion as the 
 20
capacitance vessels fill to be measured, equating to the rate of arterial inflow as described by 
Joyner et al. (2001). A longer period of occlusion to record a complete filling curve (e.g. 5 
min) will provide measures of rate of arterial inflow (initial slope), venous capacity (volume 
at inflection point) and fluid filtration (slope of gradual increase). Distensibility may also be 
derived during filling. From the filled state, a controlled rate of deflation of the occluding cuff 
(e.g. 1 mmHg/s) can be used to generate volume-pressure curves from which venous 
compliance (elastic recoil) is calculated. Distensibility and compliance are both measures of 
the volume-pressure relationship. They are different due to the effects of hysteresis. 
Distensibility is difficult to calculate as it is dependent on venous filling which cannot easily 
be controlled. Deflation of the limb can be controlled and compliance can be calculated using 
the technique described by Halliwill et al. (1999) (see methods section 2.2.3D).  
Although many venous occlusion plethysmography protocols employ a step increase in cuff 
pressure, an alternative approach is to apply incremental small pressure steps (8-10 mmHg), 
each lasting ~ 5 min (Gamble et al. 1993). The rationale for this is that it avoids activation of 
the venoarteriolar response, a pre-capillary constriction triggered by venous distension that 
prolongs the time taken for filling by attenuating arterial inflow rate (Henriksen, 1991). The 
relationship between initial limb volume expansion at each step and pressure can be 
extrapolated to zero pressure to provide an estimate of ambient resting venous pressure, while 
the relationship between fluid filtration at each step and pressure represents limb filtration 
capacity and, when extrapolated to zero volume change, the isovolumetric pressure (i.e. 
pressure at which the Starling hydrostatic and oncotic pressures governing filtration are in 
balance).  
Plethysmography at the calf combined with various venous distension protocols described 
above is frequently used to provide information about leg venous function involving all 
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classes of vessels. The recorded volume changes also include soft tissues (skin, adipose 
tissue) and these elements’ contribution must be acknowledged. Doppler ultrasound imaging 
techniques on the other hand can be used to study the properties of specific leg veins, deep or 
superficial, providing that they are of a size to be visualized with good resolution as described 
in the consensus document by Cavezzi et al. (2006). This approach has been used not only to 
detect the presence of venous disease (Hertzberg et al. 1997, Danielsson et al. 2005, Jeanneret 
et al. 2007) but also to compare the anatomy of different leg veins in relation to body size, 
age, gender (Jeanneret at al. 1999, Fronek et al. 2003, Kröger et al. 2003, Bérczi et al. 2005, 
Haenen et al. 1999), to establish the relationship between vein cross-sectional area and 
pressure during cuff inflation (Planken et al. 2006) or tilting (Chauveau et al. 2006), to 
evaluate vein distensibility (Eiken et al. 2004) or compliance (Neglén et al. 1995, De Groot et 
al. 2005, Young et al. 2008, Delaney et al. 2008) and to study modifications to venous 
function during exercise (Ooue et al. 2008), inactivity (Belin de Chantemele et al. 2004, 
Arbeille et al. 2008) and heat stress (Abraham et al. 1994, Ooue et al. 2007). 
In summary, the physical and functional properties of lower leg veins – size, filled capacity, 
distensibility, compliance and hysteresis – can be determined by use of a thigh cuff for venous 
occlusion together with measurement of calf volume by plethysmography or individual vein 
imaging by ultrasound. With plethysmography, the influence of soft tissues, venous ‘creep’ 
and fluid filtration must be acknowledged and taken into account. With ultrasound, the limits 
of image resolution that determine the smallest vessels that can be accurately visualized are an 
important consideration.  
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1.8 FACTORS AFFECTING LOWER LIMB VENOUS FUNCTION 
Exposure to venous hypertension is implicated as a major feature in the pathogenesis of 
venous disease whether the initial defect is valve dysfunction or alterations in vein wall 
properties. Hydrostatic pressure in the leg during quiet standing is approximately 80-100 
mmHg at the ankle depending on height and is equally high in superficial and deep veins 
(Recek, 2006). On walking, pressure decreases in both venous systems by about 50 mmHg 
(Pollack et al. 1949; Stick et al 1992) due to the calf muscle pump, but as pressure in the 
femoral vein does not change, this gradient will favour retrograde flow (Recek, 2006). 
Venous hypertension during walking is defined as the absence of the usual drop in pressure in 
lower leg and foot veins due to valvular incompetence, outflow obstruction or limited joint 
mobility.  
There are a number of important factors that can modulate leg venous function, increase the 
likelihood of high venous pressure and hence predispose to the development of venous 
disease over time. Some of these impose hydrostatic load, e.g. body size, mechanical outflow 
obstruction, impaired calf muscle pump function, whereas others affect vein wall composition 
and hence distensibility and / or compliance more directly, e.g. aging, hormonal and 
metabolic status. The evidence for a relationship between any of these factors and 
development of venous disease will now be discussed.  
 
1.8.1 Body Size, Composition and Occupation 
A) Height  
Increasing orthostatic pressure in the upright position is thought to increase the risk of 
developing venous disease. In healthy young subjects, foot venous pressure measured directly 
during quiet standing and the decrease in pressure on walking were greater with increasing 
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height (Kügler et al. 2001). Despite this association, the Edinburgh study showed only a 
significant risk in females with an increase in height (Lee et al. 2003) as did Beaglehole et al. 
(1975) and Sisto et al. (1995). Abramson et al. (1981) looked at height in the Jerusalem study 
but they found it was not significant when other factors were controlled. There is a lack of any 
data in the literature that reviews the effect of height directly on venous functional measures 
such as distensibility, capacitance or compliance. Fronek et al. (2001) commented upon a 
strong correlation between height and venous disease, but as height corresponds with other 
indices of body composition (e.g. weight, calf size), there were felt to be multiple interactions 
with other factors.  
B) Weight 
In healthy individuals, Kügler et al (2001) demonstrated a greater venous pressure in the foot 
during standing, an increase in FV cross sectional area (CSA) and GSV CSA with an increase 
in body weight associated with greater height and calf muscle CSA, but not with thigh 
circumference. Time to minimal pressure during walking was also longer in those of greater 
weight. Weight was seen as an independent variable in the size of the FV and GSV CSA in a 
study by Fronek et al. (2001). Iannuzzi et al. (2002) suggested that body weight in post 
menopausal women plays a specific and independent role in the development of varicose 
veins. The  EVS by Lee et al. 2003  multi-adjusted for all factors and showed a significant risk 
of truncal varices in women with increasing weight but a reduction in risk in males. This may 
suggest that different environmental factors affect men and women, such as body position at 
their occupation. Weight is not only related to body size and frame but also to levels of body 
fat. Body mass index (BMI) incorporates both height and weight and is thus a commonly-
used measure to indicate obesity in relation to body proportions.  
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C) Body Mass Index (BMI) 
Within a population, BMI, measured in Kg/m2, is defined as normal when it falls between 20-
25, overweight between 25-30 and obese when over 30. Association between BMI and the 
occurrence of varicose veins has been demonstrated in several population-based studies and 
smaller studies (Brand et al. 1988, Danielsson et al. 2002, Ciardullo et al. 2000), and appears 
to hold predominantly for women rather than men (Lee et al. 2003, Beaglehole et al. 1975, 
Seidell et al. 1986). In post-menopausal women, clinical evidence of VV was associated with 
obesity even after adjustment for levels of oestradiol as found by Ianuzzi et al. (2002). 
However, two studies have demonstrated no correlation between obesity and varicose veins 
formation in women (Hirai et al. 1990, Komsuoğlu et al. 1994). This may represent a genetic 
difference in the population but also life style factors may play a role. Danielsson et al. (2002) 
reported from a study of 99 males and 173 females aged 14-90 years, overweight (BMI > 25 
kg/m2) individuals were more likely to have skin changes and ulceration, and there was a 
significant association between clinical severity of venous disease and BMI. Associations 
have also been noted in the severity of the presentation of venous disease in CVI with obesity 
and these correlate with increasing symptomatology (Danielsson et al. 2002). There is, 
however, no consistent link demonstrated between obesity and CVI (Benigni et al. 2006), and, 
as previously described by Padberg et al. (2003), obese patients can exhibit the symptoms of 
CVI without detectable venous dysfunction. This may be due to the fact that the overweight 
are also less physically active, a condition that can impact on calf muscle pump function (see 
section 1.8.1 E). 
It is possible that obesity per se results in adverse changes in structural and functional vein 
wall properties under the influence of the associated haemodynamic and hormonal alterations 
that ensue. Venous compliance of the forearm was lower in obese compared to lean subjects, 
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with a smaller reduction in central blood volume on standing (Stepniakowski et al. 1995). In 
contrast, the greater increase in leg vein size on standing with higher BMI, independent of 
age, implies greater venous distensibility (Kröger et al. 2003). It is not clear, therefore, to what 
extent BMI impacts on vein function through mechanical hydrostatic factors or through 
specific changes that alter wall composition. It must also be taken into account that BMI may 
not always be the best option for studying the effects of obesity in a population as it does not 
give information on the distribution of body fat. Potentially, variations in disposition of 
abdominal rather than peripheral adiposity could present mechanical obstruction to the venous 
outflow from the lower legs and contribute to venous hypertension and disease.  
Venous return on its way back to the heart from the legs passes through the retroperitoneum 
of the abdomen (Figure 1.1) where it is subjected to changes in intra abdominal pressures. 
Multiple studies have shown that an increase in obesity raises the intra-abdominal pressure 
(Cobb et al. 2005, Sugerman et al. 1997, Sugerman, 2001). Arfvidsson et al. (2005) 
demonstrated that the pressure in the femoral vein was directly correlated with the intra 
abdominal pressure in the morbidly obese suggesting that compression in the abdominal 
compartment is acting to inhibit venous return from the limbs. Sugerman et al. (2001) showed 
an improvement in venous symptomatology following weight loss following gastric surgery 
for obesity. Arfvidsson et al. 2005 reinforced this by showing a decrease in venous reflux post 
gastric banding procedures. It is not clear, however, how much of this is due to decreased 
intra-abdominal pressure or general body weight loss.   
Adipose distribution in the region of the hips and thighs may also present mechanical 
hindrance to venous return. For example, the effects of artificial compression on the lower 
limb were investigated by Pottier et al. (1969) who showed that compression of the posterior 
thigh when seated increases lower limb swelling, suggestive of raised venous pressure and 
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fluid filtration. Epidemiological evidence from the Netherlands suggests that the prevalence 
of varicose veins is higher in women who store the majority of their adipose tissue around the 
hip and thigh region, termed gynoid adiposity (Seidell et al. 1986). L’Hermitte et al. (2003) 
suggested that the symptoms of venous and lymphatic congestion seen in women were 
independently related to their gynoid adiposity, shown by a negative correlation with waist-
hip ratio rather than with abdominal adiposity.  
D) Occupation  
Two studies which clearly discuss the impact of occupation on the prevalence of venous 
disease are the EVS by Fowkes et al. (2001) and Tomei et al. (1999) from Rome. Both 
involved targeted questionnaires to ascertain the level of activity undertaken at work 
combined with a clinical examination to evaluate the prevalence of disease. Both studies 
showed the effects of standing at work as the major risk factor for developing venous disease, 
the Italian study suggesting that people who spend greater than 50% of time standing are at 
greatest risk. Prolonged sitting has been shown to cause distension of leg veins and venous 
stasis by Delis et al.  (2004)  investigating the causes of deep venous thrombosis. Ashby et al. 
(1995) measured femoral vein flow velocity and demonstrated that blood moves slowest out 
of the limbs in the seated position. No literature has been found by the author to ascertain if 
occupation has any demonstrable effect on venous compliance. Epidemiological studies have 
linked venous disease to occupation through standing, but how the occupation relates to the 
presence of abdominal and / or gynoid adiposity has not been established and this may well 
play a major part in the overall effect of occupation.  
E) Calf Muscle Pump Function 
As the calf muscle pump is integral to the venous return from the lower limbs and acts to 
counter raised pressure in the upright posture (see section 1.3), any impairment will 
 27
predispose to venous hypertension and chronic venous disease. In healthy subjects, higher 
venous pressures were recorded in the foot during quiet standing in those with larger (>36 
cm) than smaller (< 36 cm) calf cross sectional area (CSA), and pressure decreases on 
walking were bigger (Kügler et al. 2001). This implies that muscle mass is an important factor 
for appropriate muscle pump action. To determine efficiency of the pump, non-invasive 
protocols have been developed which test the ability of calf contractions to empty the lower 
leg venous circulation (Fronek et al. 2000, Haenen et al. 2000). In general these measure 
venous volume indirectly by strain gauge or photoplethysmography, red cell scintigraphy, or 
use ultrasound to measure venous flow velocity, and examine changes during standardized 
calf exercise (dorsi- and / or plantar-flexion) or calf compression as demonstrated by Van Den 
Broek et al. (1991). 
Calf muscle pump dysfunction is well established in patients with chronic venous disease 
(Christopoulos et al. 1989, Yang et al. 1999) but it is not clear how much of this is due to 
reduced size and strength of calf muscle itself or to defective venous valves, because calf size 
is seldom assessed. Moloney et al. (2007) performed MRI imaging to calculate calf muscle 
volume in older patients with chronic venous disease and ulceration and compared this with 
their muscle pump function. They found no correlation between calf size and peak popliteal 
vein velocity during voluntary calf contractions, but because the patients already had severe 
disease (CEAP 6), it is impossible to ascertain cause and effect from this work. Qiao et al. 
(2005) examined calf muscle biopsies from patients with VV and CVI as well as controls, and 
reported morphological abnormalities characteristic of denervation and reinnervation in the 
patients that correlated with poorer calf muscle pump function (assessed by lowering of foot 
venous pressure on walking). Again, this association does not help to explain whether it is 
reduced muscle size that promotes pump dysfunction and chronic venous disease, or whether 
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the disease state compromises pump function and impairs patient mobility, leading to 
inactivity, calf muscle atrophy and worsening of pump function.  
There is evidence from studies in healthy populations without recorded venous disease that 
calf size impacts upon venous function. Convertino et al. (1988) determined the compliance 
of the calf in young males by relating strain gauge volume changes during venous occlusion 
to the applied cuff pressure (i.e. during filling). They showed an inverse relationship between 
this value and calf CSA and volume, estimated from CT scanning, and suggested that 
increased support from the greater muscle mass reduced the ability of the veins to distend in 
response to hydrostatic pressure, hence lowering compliance. Based on a multivariate analysis 
of factors such as muscle size, strength and peak oxygen consumption in trained and untrained 
individuals, they discussed the likelihood that physical training, which can cause muscle 
hypertrophy, would decrease calf compliance. This is at odds with data from studies that have 
measured calf compliance during venous emptying after training and shown significant 
increases in the trained state (Hernandez et al. 2004, Monahan et al. 2001). The discrepancy 
may be related to the mode of testing compliance in that pressure-volume relationships during 
filling will differ from those during emptying because of hysteresis (Convertino et al. 1988, 
see Section 1.6), but studies demonstrating an increase in filling venous capacity after training 
(Kenney et al. 1987, Boutcher & Boutcher 2005) have not concurrently measured calf muscle 
size to assess its impact. 
Those patients with chronic venous disease who have undergone superficial venous treatment 
have been reported to show improvement in the efficiency of the calf muscle pump by 
Struckmann (1987) and abolition of deep venous reflux by Mackenzie et al. (2004). This 
suggests that reduced venous stasis of blood in the limb has a positive effect on the 
functioning of the venous system. 
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1.8.2 Age, Gender, Female Sex Hormones and Pregnancy 
A) Age 
The prevalence of venous disease has been shown to increase with age (Beaglehole et al. 
1975, Criqui et al. 2003). In the EVS the 55-64 year old age groups of men and women 
showed greater than 40% prevalence for truncal disease (Lee et al. 2003, Evans et al. 1999).  
It is, however, difficult to distinguish effects specific to the ageing process because of its 
association with lower levels of physical activity, weight gain etc. The  study by Kröger et al 
(2003) stated that the cross sectional area of the lower leg veins measured by ultrasound 
imaging did not change with age but was positively associated with BMI especially in the 
standing position. Fronek et al. (2001) however noted a decrease in the FV CSA and a marked 
decrease in femoral vein flow velocity with age. Monahan et al. (2004) showed that the 
capacitance of the lower limb was less in young females than young males when measured by 
strain gauge plethysmography and that it reduced in both groups with age. This would fit with 
the decrease noted above by Fronek et al. (2001) in CSA of the FV. The effect of ageing on 
venous compliance in the upper and lower limbs was examined by Young et al. (2006) using 
mercury in silastic strain gauge plethysmography. The group found that venous compliance 
decreases with age in both males and females. This is supported by previous studies (Young 
et al 2006, Monahan et al 2004, Olsen et al 1998, Monahan et al 2004, Hernandez et al 2004). 
This has however been challenged in the literature by Lindenberger et al. (2007) who 
suggested no decrease in venous compliance with increasing age in women. Gascho et al. 
(1989) demonstrated a reduced dilatory response to nitroglycerin in upper limb veins in an 
elderly population, accompanied by reduced distensibility. This was in 40 males and 50 
females ranging from 21 to 78 years in age. Overall the evidence points to a reduction with 
age in the size of the lower limb veins which have become less reactive through exposure to 
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lifestyle factors. This is supported by the epidemiological data although the confounding 
factors and inherent bias in each study makes multivariate analysis complicated and 
unreliable.       
B) Gender 
There is a general preconception that women suffer more from varicose veins than men. 
Beaglehole et al. (1975), Abramson et al. (1981) and Sisto et al. (1995) all reported that the 
condition is more common in females than males, although these studies often rely on self-
reported data. The EVS (Lee et al. 2003) challenged the conception that females suffer more 
from varicose veins because a higher prevalence was found in males on clinical examination. 
This is supported by Scott et al. (1995) who found male gender to be a significant risk factor 
for CVI of the lower limbs, although the authors conceded that this may in part be related to 
concurrent arterial disease.   
Kröger et al. (2003) and Fronek et al. (2001) found as expected (due to smaller body size) that 
the CSA of the FV and GSV was smaller in females than males and that the increase in 
absolute volume when moving from lying to standing was also less. Fronek et al. (2001) 
demonstrated no change in flow in FV when moved to standing positions which equated to a 
higher flow velocity in females in their study.  The studies by Meendering et al. (2005), 
Monahan et al. (2004) and Lindenberger et al. (2007) all demonstrated that the compliance of 
the lower limb was less in females than males. Lindenberger et al. (2007) subsequently 
demonstrated that the venous capacitance of the calf was less in females but their fluid 
filtration was equal to males.   
C) Female Sex Hormones and Oral Contraceptive Usage. 
Females have been shown to have a reduced venous capacitance in line with less tissue mass 
compared to males (Muntinga et al. 1997, Monahan et al. 2001) and a smaller venous 
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diameter as measured by Kröger et al. (2003). Meendering et al. (2005) and Monahan et al. 
(2004) both demonstrated that the compliance of the lower limb was less in females than 
males. The epidemiological evidence that females may or may not have a higher incidence of 
varicose veins has lead to the investigation of three areas of female health that have been 
suggested to be causative factors. 
 
 
 
Figure 1.9. The menstrual cycle showing the levels of females sex hormones and 
 their relation to one another over a 28 day period. 
 
Female Sex Hormones 
Existing evidence shows that healthy venous vascular smooth muscle has functional 
oestrogen and progesterone receptors (Karas et al. 1995, Karas et al. 1994, Haas et al. 2007). 
Perrot-Applanat et al. (1995) demonstrated the presence of progesterone receptors in the 
smooth muscle layer in 90% of surgicaly excised varicose veins but oestrogen receptors was 
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only found in 17% of their samples. This is in contrast to Knaapen et al. (2005) who 
demonstrated smooth muscle hypertrophy directly mediated by oestrogen receptors in excised 
varicose vein samples. Haas et al (2007) demonstrated that 17β-estradiol alone did not affect 
venous contractions in vitro but enhance contractions of endthelin-1. This effect of enhanced 
venoconstriction in the presence of 17β-estradiol was opposite to the effect in the arterial 
system where 17β-estradiol demonstrated arterial vasoconstriction. The studies above all look 
at either cellular biochemical ativity of in vitro reactions. What evidence is there in vivo?  
Walters et al. (1977) demonstrated that the distensibility of the dorsal hand vein during filling 
was increased in the first half of the menstrual cycle (follicular phase, see Figure 1.9) but 
reduced during menstruation. This is in contrast to Fawer et al. (1978)  who showed increase 
venous distensibilty in the luteal phase of the cycle. Goodrich et al. (1966) both demonstrated 
an increase in venous distensibility during venous filling with administration of 17β-estradiol 
measured by calf strain gauge plethysmography in healthy young subjects. The same 
relationship was noted by Ciardullo et al. (2000) in post menopausal ladies with high estradiol 
levels using the same technique. 
Distensibility of the veins is complicated by the rate of limb blood flow. Keates at al. (1969) 
in normal ovulating women demonstrated increased blood flow in the limb in the follicular 
phase of the menstrual cycle by strain gauge plethysmography. In post menopausal women 
Vehkavaara et al. (2000) & Volterrani et al. 1995 have both demonstrated increase in forearm 
blood flow with administration of exogenous 17β-estradiol. It is therefore more appropriate to 
measure complaince of the venous system in order to ascertain the effect of hormonne levels. 
Meendering et al. (2005) could demonstrate no difference in venous tone or compliance 
throughout the menstrual cycle on the calf or during the use of oral contraceptive using whole 
limb plethysmography and quadratic interpretation of deflation protocols for definition of 
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compliance. Mercuro et al. (1997),  using the same investigation but not stipulating how 
compliance when using transdermal oestrogen It also showed an increase in blood flow, 
decreased vascular resistance and increased venous compliance. 
Oral Contraceptive Pill   
The prevalence of varicose veins in patients who have taken oral contraception (OCP) was 
found to be lower but not significantly so than those who had not in the EVS (Lee et al. 
2003). Giribela et al. (2007) reported no significant effect on the venous endothelial derived 
venous dilatation in dorsal hand vein during OCP use although a (non-significant) reduction 
in venous dilatation post use of OCP was reported . Goodrich et al. (1966) demonstrated an 
increase venous distensibility in the lower limb with OCP usage. Gosling et al. (1977) 
reported that the blood flow was reduced by the use of the OCP but that venous distensibility 
was not affected. This is surprising as oestrogen has been shown to inhibit vasoconstriction in 
the presence of norepinephrine (Danielsson et al. 2002). Meendering et al. (2005) could find 
no increase in the the venous complaince of the lower limb with use of the OCP.   
Hormone Replacement Therapy 
In post menopausal women, Ciardullo et al. (2000) found the incidence of varicose veins to be 
higher in those with increased oestradiol levels, but the Edinburgh study showed a decrease 
incidence with the use of HRT (Fowkes et al. 2001). The San Diego Study (Criqui et al. 2007) 
had a greater risk of venous disease in females who had undergone oophorectomy but did not 
comment on the use of HRT. They state that other hormonal factors are at risk in females but 
do not comment on which these are. Nonetheless, this data indicates that high levels of female 
hormones, particularly oestrogen, may be benefical in protecting against venous disease. 
Ceballos et al. (2000) reported that the use of HRT improves veno-dilatation in dorsal hand 
veins but that this effect is quickly lost following withdrawal. This finding is supported by 
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Varbiro et al. (2002) who demonstrated that the decreased distensibility of mesenteric rat 
veins post oophorectomy could be reversed with supplemental oestradiol. 
Multiple techniques have been used to asssess the effects of sex hormones and the variation 
causes confusion. Distensibilty is dependent on filling and oestrogen has a clear affect to 
increase limb blood flow which will affect the rate of filling of the venous system whist 
oestrogen also has been demonstrated to inhibit the effects of adrenergic constrictors and this 
may affect venous distensibility but should not affect complaince. Meendering et al. (2005) 
used filled systems and measured deflation which should exclude the problems with 
distensibilty. The papers that this group published show no effect of the menstrual cycle or 
OCP usage on whole limb/calf compliance. One of the major problems is that the impact of 
oestrogen/OCP/HRT has been measured on the whole limb/calf to establish distensibilty or 
compliance and that capillary filtration has a role to play when this measurement technique is 
used. Direct visualisation of venous properties is being performed and this may exclude this 
problem. 
Overall the effect of exogenous administration of oestrogen/OCP/HRT appears to be an 
increase in arterial inflow and an increase in venous distensibility but no effect on venous 
compliance. This would suggest that arterial inflow is the major contributor to venous 
distensibilty. The menstrual cycle has been suggested to increase blood flow in the follicular 
as well as the luteal phases although the published data is contradictory. There is no clear 
evidence as to the effect of the balance between the sex hormones on the venous wall function 
or the balance of structural elements. It is safe to state that oestrogen and progesterone 
receptors are present but their effect is unclear. The long term effects of raised oestrogen or 
progesterone levels is equally unclear as any structural changes would presumable be related 
to prolonged periods of low or high hormones. Establishment of the effect of long term 
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exposure to low or high levels of female sex hormones may help to answer some of these 
questions.    
D) Pregnancy 
Varicose veins are associated with pregnancy by the medical world but also in the mind of the 
general public. The Edinburgh and San Diego studies (Fowkes et al. 2001, Criqui et al. 2007) 
showed an increased but not significantly higher prevalence of varicose veins with previous 
parity. Jukkola et al. (2006) found in a Finnish population that an association existed between 
parity and varicose veins, but this was only a significant difference between nulliparous 
women and those who had 3 or more pregnancies. The fact that the number of pregnancies 
rather than weight gained in pregnancy is the determinant factor again suggests another mode 
of cause other than mechanical impedance. A 2005 study by Dhawan et al. in rats showed a 
reduced compliance and increased venous tone in rat splanchnic veins which were 
multiparous over nulliparous, suggesting that the effects of pregnancy last after the event. 
The major sex hormone present during pregnancy is progesterone and receptors for this 
hormone have been demonstrated in saphenous veins (Perrot-Applanat et al. 1995).  Sparey et 
al. (1999) investigated the changes that occur in the lower limb veins throughout pregnancy 
and showed a marked increase in venous diameter with pregnancy up to the point of 
parturition. Normal diameter was restored at 6 weeks post delivery. They found no 
development of new venous reflux in their population but that people with reflux disease 
deteriorated. Venous distensibility follows a similar pattern with an increase up to the point of 
term, as demonstrated by Barwin et al. (1976) in the calf and forearm and by Fawer et al.  
(1978) in the forearm. This global effect as opposed to a local effect due to a gravid uterus is 
reinforced as the changes are visible in the first trimester of pregnancy, before any gravid 
effect would be of consequence. The upper limb changes were not however demonstrated in 
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study by Edouard et al. (1998) although lower limb changes were noticed. No studies could 
be identified that have investigated venous parameters both pre and post pregnancy in the 
same population. 
The evidence would suggest that the effect of hormones clinically can be overcome by 
removal of the stimulus, either the presence of the foetus or the hormones associated with 
pregnancy. However increasing numbers of pregnancies is associated with an increased risk 
of venous disease and therefore the changes that occur during and because of pregnancy must 
be assumed to all have a contributing element that has the long term consequence of venous 
damage.  
 
1.8.3 Life Style Factors 
A) Diet and bowel habit 
Studies have looked at the prevalence of varicose veins and CVI and the intake of dietary 
fibre, transit times and straining at stool. Lee et al. (2003) showed an increase risk of VV 
prevalence in men who strained at stool, whilst Beaglehole et al. (1975) reported an increase 
in a South Pacific population with the intake of refined sugars. Constipation and dietary fibre 
were not risk factors, however, in the San Diego study Criqui et al. (2007).  Venous 
compliance or distensibility has not been assessed against these variables. 
B) Insulin and Diabetes  
All insulin resistance states are associated with significant macro- and microvascular defects 
Evcimen et al. (2007). These are well documented for the arterial circulation and include the 
loss of insulin-mediated decreases in large artery stiffness (Yki-Jarvinen et al. 2007, Cameron 
et al. 2007), generalised endothelial dysfunction, reduced insulin-mediated vasodilation of 
pre-capillary vessels, and impaired capillary perfusion (Kim et al. 2006, Serné et al. 2007). In 
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skeletal muscle, these disrupt glucose dispersal and metabolism, while other organs e.g. skin, 
eye, kidney, suffer microvascular and end-organ damage. These defects may cause or be 
caused by sympathetic adrenergic overdrive and hypertension (Serné et  al 2007, Grassi et al 
2007), which together inevitably increase the vascular damage and cardiovascular risk. 
Far less attention has been paid to the venous circulation in insulin-resistance states despite 
the fact that lower limb ulceration affects 15% of people with diabetes (Brem et al. 2007). 
Venous hypertension is a key factor in the development of ulcers by causing microvessel 
inflammation, oedema, skin hardening and impaired oxygen delivery. Skin pre-capillary 
arterial vessels lose their ability to buffer blood pressure in diabetics (Fegan et al. 2003), 
leading to arteriovenous shunting (Fagrell et al. 1999) and raised venous pressure (Purewal et 
al. 1995). There is also, however, evidence that insulin has direct effects on venous vessel 
tone that are altered in insulin-resistant states and could contribute to development of venous 
hypertension. Insulin causes venodilation (Feldman et al. 1993) and can attenuate adrenergic 
venoconstriction (Sung et al. 1998). Vein dilator sensitivity to insulin, tested in the dorsal 
hand vein, was decreased by hypertension (Feldman et al. 1993), obesity (Feldman et al. 
1995) and high cholesterol (Sung et al. 1998). Moreover, in a rat model of metabolic 
syndrome, endothelial dilator modulation of venous tone by nitric oxide was depressed (Song 
et al. 2006). All these changes reduce the ability to counter constrictor tone and encourage 
raised venous pressure. This is of particular importance in light of the hyperadrenergic 
conditions in insulin-resistance states. Epidemiological data from Sisto et al. (1995) in 
Finland, however, suggested a lower incidence of varicose veins in their population with 
established diabetes but the study does not give figures for the number of volunteers with 
diabetes from the population. The San Diego and EVS do not comment on the levels of 
diabetes in their populations. The author was unable to obtain any data from the literature on 
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the relationship between glucose, insulin or insulin resistance and the properties of the lower 
limb venous system.   
C) Hypertension, Renin and Atrial Natriuretic Peptide 
The heart requires a continuous flow of blood to maintain a sufficient arterial pressure to 
perfuse the organs. The venous system acts as a reservoir which can be used to increase or 
decrease blood flowing into the heart as required.  The ability of the veins to distend and 
contract when required is paramount for this. If the system is too compliant, then the 
condition of orthostatic intolerance can develop whereby insufficient blood flow from the 
lower limbs reaches the heart. However if the system is less compliant, it may increase venous 
return and increase cardiac output by overfilling the right side of the heart (Safar et al. 1987). 
Arterial hypertension has been investigated along with multiple endogenous and exogenous 
vasoactive substances to determine their effect on the venous system (Appendix A). Criqui et 
al. (2007) showed that in the presence of hypertension there was a slight reduction in the 
incidence of mild varicose disease. This was not the case in severe venous disease where 
hypertension was more prevalent than the normal population. Brand et al. (1998) in the 
Framingham study reported an increase in the incidence of varicose veins in the presence of 
hypertension but unfortunately the Edinburgh study does not comment in its published results. 
Delaney et al. (2008) looked at the effect of hypertension in the young on the capacitance and 
compliance of the upper and lower limb veins and reported that capacitance is reduced 
(possibly due to raised smooth muscle tone). This study was unable to demonstrate any effect 
of hypertension on venous compliance. Takeshita et al. (1979) demonstrated a decrease in the 
venous distensibility in forearm veins in young borderline hypertensive males which was felt 
to be due to non-adrenergic mechanisms and possibly due to structural changes. 
Stepniakowski & Egan (1995) noted a similar effect of decreased venous distensibility but 
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also recognized the effect of obesity and insulin sensitivity in the process with possible 
additive affect. The study by Simon et al. (1979) from Minnesota on human forearm veins 
demonstrated a similar effect but also demonstrated an increase in the level of capillary 
filtration during occlusion plethysmography suggesting an increase in capillary permeability 
in hypertensive adults. This is possibly an adaptive change to higher arterial and venous 
pressure. All these results were corroborated by Fitzpatrick et al. (1986) who also showed that 
reduced distensibility could be linked to a decrease in renin release and a lower increase in 
heart stroke volume in hypertensive patients when the limb is occluded, blunting the 
physiological response to renin release. 
The effect of Atrial Natriuretic Peptide (ANP) on the venous system has been investigated by 
Schmitt et al. (2003) who showed a venodilatory effect and reduced resting venous tone with 
even small doses of ANP on human forearm veins, whereas Doorenbos et al. (1991) showed 
no alteration in the compliance of the venous system. ANP is thought to have an antagonistic 
affect on Angiotensin 2 and to act by possibly inhibiting noradrenaline release at the pre-
synaptic membrane. This may explain why it has the action of venous dilatation at rest. 
ANP’s maximal venous dilatory response was noted in the presence of high levels of 
venoconstrictors akin to those present in sufferers from congestive cardiac failure (Doorenbos 
et al. 1991). Ando et al. (1992) reported an increase in capillary filtration with ANP in the 
forearm. This is not the same effect in the leg as ANP has been reported to decrease lower 
limb filtration by Watenpaugh et al. (1995). This may perform a protective function to help 
maintain circulating volume and blood return to the heart. The author was unable to locate 
any data on the effect of ANP on the compliance of the lower limb venous system. ANP at 
levels found in the body in the resting state appears to have little effect on the overall venous 
function. The affects of venoconstriction are only visible in times of severe cardiac distress.  
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D) Smoking 
Gourgou et al. (2002) carried out a case-control study of 1806 patients with CVI against 1806 
controls. The population was gathered from primary care and the results showed a significant 
association between smoking and the likelihood of developing CVI. The odds ratio was 1.7 if 
10-19 cigarettes were smoked per day rising to 2.4 for greater than 20. The San Diego study 
(Criqui et al. 2007) showed that smoking in the male gender increased the severity of the CVI 
but no effect was noted in females. The mechanism of action is not clearly understood. 
Higman et al. (1993, 1996) reported that the response of veins to endothelium-derived 
relaxing factor in normal and varicose veins was inhibited in heavy smokers. The group also 
noted a decrease in the nitrous oxide release (a potent venodilator produced in the 
endothelium of the vein) when smokers’ veins where studied. This would suggest that 
smoking damages the endothelium and therefore redusce endothelium-dependent venous 
dilatation. No data could be found in the literature by the author that described the effects of 
smoking on the properties of the lower limb venous system. 
E) Family History 
Major published studies have reported an increase in the prevalence of varicose veins and 
chronic venous disease in people who have a family history of the disease (Criqui et al. 2007, 
Fowkes et al. 2001), but such investigations have suffered from the limitations of self 
reporting. The relationship was evaluated by Ahti et al. (2009) in a longitudinal Finnish study 
showing a positive correlation but this was not as strong as they had expected. Where two 
parents are affected by venous disease, Cornu-Bernand et al. (1994) demonstrated there is a 
90% chance of developing varicose veins but only a 20% chance when neither parent was 
affected. Brinsuk et al. (2003) reported a comparison on the compliance and capacitance of 
the venous system in monozygotic and dizygotic twins. They found a stronger correlation in 
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compliance and capacitance between the monzygotic twins than dizygotic twins. The level of 
evidence for the effect of family history on the venous properties is limited except for that 
described. Family history clearly has a role to play in the development of venous disease but 
the studies examining family history have concentrated more on it as a risk factor and not 
looked at the physiological or genetic predisposition present required for the development of 
venous disease.  
 
1.9 CONCLUSIONS  
The development of venous hypertension is a risk factor for the development of chronic 
venous disease, and various anthropometric and life style factors can modify the functioning 
of lower leg veins in such a way as to predispose to this condition. These include height, 
weight, BMI, age, gender, female hormonal status, pregnancy, calf muscle pump function, 
levels of physical activity, occupation, diet, bowel habits, insulin status, arterial hypertension, 
smoking and family history. Their effects in terms of promoting the venous stasis and valve 
dysfunction that presage CVD are expressed either through adverse changes in venous 
haemodynamics or by impairment of venous tone and disruption of vein wall structure. 
The greater incidence of venous disease in people with high BMI is, on the one hand, related 
to elevated venous pressure associated with height, supported by the relationship between 
disease and occupational time spent in the standing posture. On the other hand, venous 
disease in individuals who are overweight or obese has led to the concept that abdominal 
adiposity can impede peripheral venous return from the legs by mechanical hindrance, in 
accord with the disease prevalence in pregnant women. Such a mechanism would be most 
evident when in the seated position, causing leg vein distension and venous stasis. The 
conventional means for classification of obesity - BMI - does not adequately describe the 
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distribution of body fat in the abdominal region, and specific measures of abdominal obesity 
such as sagittal abdominal diameter and waist-hip ratio are made in the supine and standing 
positions respectively. To date, only one study (Van Rij et al. 2008) has reported a higher foot 
venous pressure on sitting in obese than normal weight individuals based on BMI values, but 
all were patients with symptomatic venous disease and abdominal adiposity was not defined. 
There are no studies that have examined explicitly the relationship between the presence of 
abdominal fat and peripheral venous function in otherwise healthy individuals to see if 
mechanical hindrance occurs and whether it is associated with measurable alterations in leg 
vein physiology consistent with repeated exposure to impeded flow. Demonstration of any 
such relationship would help to establish how obesity over time can present a risk for future 
development of venous disease. 
In view of the multiple factors that can impact on leg vein function, it is also necessary to take 
into account those that are themselves linked to obesity. For example, levels of physical 
activity or inactivity are related to the overweight condition and can lead to alterations in calf 
muscle pump function that either impair venous return or increase distensibility. The female 
reproductive hormones oestrogen and progesterone are venodilators and have been implicated 
in modifying venous tone and distensibility; oestrogen may also alter vein wall properties 
through effects on collagen metabolism. Hormonal changes during the normal menstrual 
cycle, oral contraceptive use and pregnancy (which itself presents weight loading and 
abdominal obstruction) may therefore play a role in the development of venous disease. 
Metabolic status and its effect on the venous system remains a field, which has not been fully 
explored. The factors implicated in the development of arterial disease (hypertension, renin, 
insulin levels, insulin resistance) have been shown to inhibit the venodilation and constriction 
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which are required to control venous return and this inability to react may lead to a loss of the 
natural mechanisms designed to prevent the formation of venous hypertension and disease.   
 
1.10 THESIS AIMS, HYPOTHESES AND OVERALL STUDY DESIGN 
This study aimed specifically to examine people without chronic venous disease to see 
whether leg vein physiology is altered by the presence of abdominal fat in a way that would 
indicate potential risk for future disease development. It is known that varicose and diseased 
veins already display dilatation, reduced distensibility and lower compliance due to the loss of 
elastic wall elements. If signs of similar preliminary changes were to be seen in otherwise 
healthy but obese individuals during sitting, when mechanical impediment to peripheral 
venous return is most likely, this would suggest a mechanism that, over time, could progress 
to overt disease. 
Accordingly, the following hypotheses will be tested. 
1. Increased abdominal obesity in a healthy middle-aged population causes obstruction 
to peripheral venous return in the sitting position.  
 
This will be tested by correlation of anthropometric indices of abdominal fat (sagittal 
abdominal diameter, waist-hip ratio, DEXA scan, ultrasound fat thickness and a new 
measure of seated abdominal fat overhang) with ultrasound measurements of femoral vein 
size and flow velocity in supine and sitting positions. It is hypothesised that greater 
amounts of abdominal fat will be associated with bigger vein size and decreased flow 
velocity due to distension of the vein by impedance to outflow from the legs.  
In order to obtain a quantitative estimate of the degree of mechanical hindrance due to 
abdominal fat when sitting, a needle manometry technique will be used to record inguinal 
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tissue pressure. It is hypothesised that bigger amounts of abdominal fat will be associated 
with higher inguinal pressures and greater obstruction to venous return. A further 
indication of the extent of outflow obstruction will be gained from durometry of the thigh, 
a measure of tissue hardness. It is hypothesised that obesity will be associated with greater 
tissue hardness in the seated position because of compression of the venous 
microcirculation and fluid filtration into the tissues giving rise to turgor.  
2. Increased gynoid (hip, thigh) adiposity in a healthy middle-aged population 
contributes to obstruction of venous return in the sitting position by compression. 
 
This will be tested by correlation of femoral vein size in supine and sitting positions with 
anthropometric measures of leg size and composition (circumference, skinfold 
thicknesses, fat-free cross-sectional area). It is hypothesised that greater vein distension 
will be observed when seated in individuals with greater amounts of peripheral limb fat.  
3. By causing impediment to peripheral venous return, increasing abdominal obesity in 
a healthy middle-aged population leads to venous hypertension which begins the 
process of damage to the lower leg vein walls. 
 
This will be tested by correlation of anthropometric indices of abdominal fat with 
measurements of venous capacity and compliance in the lower leg. In much of the 
previous work examining lower leg venous physiology, strain gauge plethysmography of 
the whole limb has been used as a surrogate for venous volume during occlusion protocols 
to induce vein filling and emptying. This method is not specific to the veins because of 
fluid filtration into soft tissues during periods of venous occlusion. Direct ultrasound 
imaging of individual lower leg veins would enable more accurate examination of the 
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properties of the vein wall. Therefore popliteal and saphenous vein capacity and 
compliance will be measured using ultrasound in tandem with strain gauge 
plethysmography for calf venous capacity and compliance. It is hypothesised that, in 
relation to abdominal obesity, venous capacity will be increased due to loss of elasticity 
while venous compliance will be reduced.  
As indicated above, it is evident from the literature that there are other key factors that impact 
on either venous haemodynamics or vein wall properties. To take these confounding 
influences into account, additional data will be obtained for correlation with femoral vein 
haemodynamics and calf vein capacity and compliance as follows:- 
• Increasing exposure to female sex hormones and long-term oral contraceptive use are 
associated with higher venous distensibility and hence blood levels of oestrogen and 
progesterone will be measured and self-reported oral contraceptive use recorded.  
• To gain insight into the weight burden experienced by individuals over time, a self-
reported body weight history will be taken and the number of full-term pregnancies 
noted. 
• Physical activity can increase venous capacity and current levels will be evaluated by 
a standardised activity recall questionnaire. 
• Since insulin is both an arterial and venous dilator agent, raised pressure in the 
microcirculation combined with an inability to respond with vasomotor tone could 
exacerbate venous distensibility. The metabolic status of the study population will 
therefore be estimated as the HOMA2 index based on fasting blood levels of insulin 
and glucose.  
 46
CHAPTER 2: 
METHODS 
2.1 SUBJECT POPULATION 
The study population was healthy male and female (non pregnant) volunteers recruited by 
advertisements placed in the local press, hospital intranet, local slimming clubs and university 
newspapers. As participants without overt venous disease were required, the age range of 30-
50 years was selected and a duplex ultrasound scan of the femoral vein (FV), the popliteal 
vein (PV), the great saphenous vein (GSV), the sapheno-femoral junction,  the short 
saphenous vein (SSV) and the sapheno-popliteal junction (SPJ) was carried out to rule out the 
presence of any evidence of old or new deep vein thrombosis or deep or superficial clinical 
reflux (defined as greater than 0.5 seconds). This was performed at a screening visit to the 
Vascular Department, Selly Oak Hospital (Appendix B), where volunteers also underwent an 
ankle brachial pressure index (ABPI) measure to exclude peripheral arterial disease (PAD). 
Systolic pressures at the ankle of the dominant leg and the brachial artery were measured 
using a hand-held Doppler device and standard blood pressure cuff inflated to suprasystolic 
pressure around the calf and upper arm respectively whilst subjects lay supine. Volunteers 
were excluded from the study if the ratio of these values lay outside normal limits (0.9-1.1) as 
defined by Al-Qais et al. (2009).  
At the screening visit, a medical history was taken to determine that volunteers fitted the 
exclusion criteria: deep venous thrombosis (DVT), post thrombotic syndrome, Type 1 
diabetes mellitus, pregnancy, heart failure, exercise-limiting arthritis, liver failure, or clinical 
use of steroids. Those participating would later have blood samples analysed for fasting 
glucose level to determine any glucose intolerance or Type II diabetes 
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Subjects of all body size were recruited to include normal weight, overweight, obese and very 
obese individuals. A questionnaire soliciting recall of weight history from the age of twenty to 
the time of study (see Appendix C) was completed by all participating subjects. Men and pre-
menopausal woman were recruited for the study and women completed a reproductive history 
questionnaire to assess their habitual menstrual cycle, oral contraceptive use and past 
pregnancies (see Appendix D). This questionnaire was used to determine the time of all 
testing procedures for women so that they coincided with the menstrual phase of their cycle, 
when endogenous and exogenous female sex hormones would be at their lowest levels 
(Hirshoren et al. 2002). Volunteers were requested to complete the Stanford Seven Day 
Physical Activity Recall Questionnaire in order to assess there daily energy expenditure 
(Washburn et al. 2003). (Appendix E) 
Volunteers who satisfied inclusion and exclusion criteria for the study received a verbal and 
written explanation (see Information sheet, Appendix F) of the study aims, and procedures 
and informed consent was obtained. The study conformed to the Declaration of Helsinki and 
was approved by the Black Country Research Ethics Committee and the local research ethics 
committee of the School of Sport and Exercise Sciences. 
The aim of the study was to look for associations between the presence of abdominal 
adiposity and leg vein haemodynamics and a population with a range of body sizes was 
therefore sought. It was decided to use the BMI categories of normal, overweight and obese 
for group comparisons since BMI is a universal meaure of obesity and would allow for 
comparison with other published data. Abdominal obesity has been described and will be 
measured as such in the study but as this variable does not have a recognised scale of 
categories, correlational analysis with vein function is more appropriate. 
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Initial power calculations were performed to estimate the number of subjects required for 
group comparisons of different obesity levels based on BMI, using published data for one of 
the primary outcome measures, superficial femoral venous flow velocity. Median supine 
femoral flow velocity at rest in normal healthy individuals has been measured at 13 cm/s with 
an interquartile range of 9-18 cm/s and standard deviation of 6.7 cm/s (Fromy et al. 1997). A 
total of 30 participants in each of the three BMI groups would give 80% power to detect a 
difference of 5.5 cm/s between groups for parametric data. For non-parametric data, 30 in 
each group would give 80% power to detect a difference of 6 cm/s in between groups. In the 
sitting position, a median velocity of 3 cm/s, interquartile range 2.7-5 cm/s, standard deviation 
1.5 cm/s (Delis et al. 2004), were used to calculate that 30 participants in each group would 
give 80% power to detect a difference of 1.25 cm/s between groups for parametric data, and 
1.35 cm/s between groups for non-parametric data. Calculations were conducted by Dr Peter 
Nightingale, Wolfson Building, University Hospital Birmingham, Edgbaston, Birmingham, 
UK.  In practice it proved difficult to recruit sufficient numbers of subjects within each BMI 
class, with consequences for statistical analysis and interpretation that will be considered in 
the Discussion.   
 
2.2 MEASUREMENTS 
Participants were tested on one day at two different locations for a range of measures relating 
to body composition, and lower limb venous and vascular function. The protocols for testing 
at these sessions will be described later. Throughout each testing station the mean arterial 
blood pressure and pulse of the volunteers was checked repeatedly to look for fluctuations, 
which may affect the blood flow into the limb. The following sections describe procedures for 
the individual measurements that were made. 
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2.2.1 Body Composition 
A) Anthropometric Measures  
 BMI and Historical BMI 
Subjects’ weight (Seca scales) and height (stadiometer) were recorded to calculated body 
mass index as Kg/m-2.  The volunteers completed a weight history recall questionnaire. They 
were required to recall their weight at 5 year intervals since the age of twenty and this was 
then averaged. Using their present measured height their historic BMI was derived from these 
two figures. (See Appendix C) 
 Waist-Hip Ratio 
Whilst standing, waist (3cm superior to the iliac wing) and hip (at the level of the greater 
trochanter) circumferences were taken with a hand-held tape measure. The waist-hip ratio was 
calculated by dividing waist circumference by hip circumference.  
 Limb Size 
Circumferences were also measured at both wrists and ankles. Thigh and calf circumferences 
were measured 15 cm proximal to the medial femoral condyle and 15cm proximal to the 
medial malleolus respectively with subjects standing. Each subject’s dominant leg was 
determined by asking which leg would be used to kick a football. 
 Abdominal Adiposity 
Abdominal adiposity was estimated by sagittal-abdominal diameter (SAD) measured using 
Holtain calipers. With subjects supine, the caliper base was inserted under the small of the 
back and the caliper arm lowered to rest on the abdominal wall at the level of the umbilicus. 
The recorded distance in centimetres (SAD) correlates significantly with estimates of the 
volume of visceral fat (Després, 2007). A key aim of the study was to investigate the impact 
of abdominal obesity on leg venous function. A novel index to quantify the degree of 
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impingement of the abdominal wall over the inguinal region was calculated in volunteers in 
the seated position with their legs straight out in front of them and their back and thighs 
supported at right angles Figure 2.1. The distance from the sacrum to the most anterior part of 
the abdominal wall (SA) was measured by hand-held tape measure and divided by the sacrum 
patella (SP) distance. The index SA/SP was designed as a measure of the obstructive effect of 
fat in the abdominal/inguinal region when in the seated position. 
 
 
Figure 2.1. Diagram of the measurements made to  
calculate the SA/SP ratio. 
 Body Composition by DEXA Scan 
Body composition was also determined by Dual Energy X-ray Absorptiometry (DEXA) scan. 
This is a low energy X-ray giving a radiation dose of 0.15mSv (approximately 0.7% of 
background one year radiation exposure). The principle of the technique is that two different 
wave lengths of x-rays are passed into the body and the absorption of the waves is known in 
different materials. By subtracting out the known absorption patterns of bone, fat or lean 
tissue it is possible to accurately estimate the percentage of each type of tissue in different 
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body compartments. The scan takes approximately 7 minutes and is not painful or invasive. 
The information obtained using previously recorded height and weight allowed for estimation 
of truncal and limb proportions of fat, lean tissue and bone content as percentages of each 
individual body section. This percentage truncal adiposity was used for analysis. This 
technique has been validated by Haderslev et al. (2005) and is effective for measuring soft 
tissue in obese subjects.   
 
B) Measures of Abdominal and Lower Body Composition by Ultrasound and Skinfold 
Calipers 
 Ultrasound Tissue Depth 
With subjects lying supine and rested for 10 min, skin and subcutaneous tissue depth were 
imaged at five sites in B mode ultrasound mode with a Philips EnVisor HD© Ultrasound 
machine, 3-12 MHz linear probe. Using frozen static images, the in-built automatic calipers 
were used to measure in centimetres the distance:-  1) at the abdomen from the skin surface to 
the anterior rectus sheath at a level 3cm below the umbilicus; 2) from the skin surface to the 
level of deep fascia overlying the muscle groups at 15 cm up from the medial femoral condyle 
on each thighs; 3) from the skin surface to the level of deep fascia overlying the muscle at 
15cm above the medial malleolus in each calf. In all cases care was taken to make sure that 
there was a gel offset for the probe so that it did not press on the tissues, that the long 
saphenous vein did not obscure the image, and that the underlying structure was muscle not 
bone. Readings were taken by one observer in duplicate, and averaged to reduce sampling 
error. 
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 Skinfold Thickness 
Harpenden calipers were used at the same sites as described above to record skinfold 
thickness in centimetres. A pinch-fold of skin was taken between thumb and forefinger and 
the calipers applied perpendicular to this and allowed to close. All readings were taken by one 
observer in duplicate and averaged to reduce sampling error.  
 
C) Tissue Hardness Measured by Durometry 
 Tissue Hardness 
To investigate the effect of body composition on skin tissue hardness or ‘turgor’, a Rex Gauge 
Durometer© was used (Figure 2.2). This device is used in industry to assess the hardness of 
materials in production. It has been used to aid the identification of serious skin disease such 
as systemic sclerosis, Raynaud’s and fibrosing syndromes, and durometer measures have been 
correlated against ultrasound skin thickness measures (Falanga et al. 1993). In venous disease, 
the technique has been correlated against the venous skin severity score and found to have a 
direct linear relationship (Romanelli et al. 1995).  
With subjects in the supine position with knees bent to 20° and legs externally rotated at the 
hips allowing the lower limbs to fall laterally, the probe was placed in the positions described 
in the above sections (abdomen, both thighs and calves) and the sites marked on the skin 
surface to enable repeated measurement (avoiding underlying bone). The dominant limb was 
the limb chosen for measurement. The durometer was placed on the skin surface at 90° to the 
skin and the under its own weight (400g) allowed to rest and give an analogue reading of 
hardness scaled 0-100 (Figure 2.3). No pressure was applied to the probe and the highest 
reading was recorded. Skin creep has been noted in previous studies suggesting that 
interstitial fluid is moved out of tissue by probe pressure. Repeat measures at each site were 
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separated by 20 seconds to allow the tissue to return to its resting state. Subjects were then 
moved into the seated position as described for the measurement of SA/SP index (see Figure 
2.1) for 5 minutes and repeat measurements were made at thighs and calves (no abdominal 
reading was possible). All readings were taken twice and averaged by one observer to reduce 
sampling error for further analysis. 
 
Figure 2.2. A 1600 Rex Gauge Durometer© 
 
Figure 2.3. Representation of the Durometer probe and the indentation  
of the spring mounted probe on the skin. 
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 D) Effect of Body Composition on Inguinal Tissue Pressure 
Subjects lay supine on a mechanical bed and rested for 20 minutes. A pressure transducer line 
was prepared and attached to a Hewlett Packard ProPac© recorder. An EnVisor HD 
ultrasound machine in B mode was used to image the SFV, the GSV and the SFJ. In the groin 
skin crease in line with the SFJ, 10mls of 1% lignocaine was introduced and given 5 minutes 
to take effect. Under direct ultrasound guidance a 14 gauge Optiva® 2 cannula was passed 
through the skin to rest medial to the SFV and superior to the SFJ. This was aspirated to 
check it was not in a venous structure (Figure 2.4). The metal trochar was removed to leave 
the plastic cannula. This was attached to the prepared transducer line and flushed for 1 second 
with saline 0.9%. The transducer was placed at the level of the mid thigh and the system was 
zeroed. The subjects rested for two minutes and on each of the next 2 minutes a baseline 
pressure reading was taken and recorded in mmHg. The mechanical bed was then used to 
move the subject from the supine to seated position, with trunk at 90o to legs straight out, 
requiring the individual to make no effort. Once in position, the line was flushed again for 1 
second to check it was not kinked and readings were taken at the end of each subsequent 
minute for a further 5 min to record tissue pressure in mmHg. Subjects were then returned to 
the supine position using the mechanical bed and the line was flushed and readings taken at 
the end of a further two minutes of supine rest (total of 9 readings). The process was repeated 
four more times, giving 5 sets of readings of resting, maximum seated and difference in 
moving from supine to seated pressure (mmHg) in the inguinal region. Pressure was applied 
to the region upon removal of the cannula to arrest any bleeding post-procedure. The 
procedure was carried out by one observer trained in vascular surgery and duplex ultrasound 
imaging of the groin. 
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Figure 2.4. Positioning of the plastic cannula for the measurement of  
inguinal tissue pressure. 
 
In order to evaluate the reproducibility of tissue pressure measurements with this method, the 
typical within-subject error was calculated from the readings for the 5 repeat trials for each 
subject as the group mean standard deviation expressed as a % of the group mean, i.e. 
coefficient of variation (Hopkins, 2000). This was done separately for the supine and seated 
repeated readings.  The minute values (2 supine and 5 seated) were averaged for the normal 
BMI group and displayed graphically as pressure against time (see Results figure 3.5). This 
demonstrated a step increase in pressure over all volunteers from supine to the seated position. 
For each individual, the change in pressure on sitting was calculated as the difference between 
the mean supine and the mean seated values after averaging their data for all 5 trials.  These 
figures were used for further analysis.  
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2.2.2 Measures of Venous Function 
 A) Clinical Venous Status 
Subjects were classified for any visible signs of lower extremity venous dysfunction or 
disease by the Clinical Etiologic Anatomic Pathophysiologic (CEAP) scoring system as 
described by Porter & Moneta, (1995)  see Table 1.1 & 1.2.  
 B) Venous Refill Time 
Photoplethysmography (PPG) is a non-invasive test that measures the time taken for the 
venous system to refill following activation of the veno-muscular pump. This technique has 
been shown to correlate well with ambulatory venous pressure by Abramowitz et al. (1979) 
and has been used successfully by Fronek et al. (2000) to study venous valvular dysfunction. 
More recently the technique has been questioned, but Sam et al. (2006) showed that it is 
reproducible for superficial venous disease. It involves the use of infrared light passing into 
the tissue. The different absorption spectrum of tissue with blood in and that without allows 
for the time taken for the leg to refill with blood after emptying to be calculated. (Figure 2.5) 
 
With volunteers in a seated position with feet flat on the floor, a PPG probe connected to a 
Huntleigh Vascular Assist Device© was attached at 10cm above the medial malleolus on the 
dominant limb. A base line reading was achieved and the patients were asked to perform ten 
dorsiflexions of the foot with the heel placed on the ground, followed by 45 seconds of rest. 
The time taken for the PPG reading to return to base line was taken. Readings greater than 
25seconds were taken as normal, readings 15-25 seconds as signs of venous impairment and < 
15 seconds are taken as diagnostic of venous insufficiency (Figure 1.3). This test was used as 
a screening tool and was not used for further analysis. 
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Figure 2.5. Photoplethysmograph sensor. LED emitting infrared light with photosensor to 
detect changes in spectral signal 
  
 C) Diameter, Velocity and Flow in the Femoral Vein 
The study employed ultrasound technology to image the femoral vein and measure vein 
diameters using the Envisor HD© in-built calipers. The measurement of venous flow velocity 
was carried out using pulse wave mode using duplex ultrasound which is based on the 
Doppler effect (Figure 2.6 & 2.7). The sound reflected from a moving structure shows 
variation in frequency called the Doppler effect. The shift in frequency can be converted into 
an audible frequency which forms the principle of the Doppler probe. The probe produces a 
high frequency sound wave normally 4 or 8MHz that is passed through the tissue, the 
frequency of the returning waves being detected by the probe. When measuring flow of blood 
in a vessel it is possible to calculate the speed of movement by the formula: 
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(As c, the speed of sound in tissues, and Fi the incident frequency of sound, are constant and 
if Θ, the Doppler angle is kept constant, the frequency shift depends directly on the blood 
flow velocity V) (Armstrong & Wastie, 1998). 
 
Figure 2.6. The effect of fluid moving away from the Doppler probe on the frequency of the 
returning ultrasonic signal. 
 
Figure 2.7. The effect of fluid moving towards the Doppler probe on the frequency of the 
returning ultrasonic signal. 
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Diameter and flow velocity were measured in the Femoral Vein (FV) of subjects’ dominant 
leg in the supine and seated position. The FV was imaged at the lower end of the femoral 
triangle where it lies next to and not behind the superficial femoral artery (Figure 2.8). This 
position was marked and, in B mode ultrasound longitudinal plane, the intra luminal diameter 
(cm) of the FV was measured with the in-built caliper, readings being taken twice to reduce 
sampling error. The mode was then changed to spectral analysis and a standard 3-lead ECG 
signal was input to the Envisor HD© to produce a cardiac trace. The mean systolic velocity, 
time averaged velocity mean, peak systolic velocity and the diastolic velocity were recorded 
from the spectral trace all in cm/s. These supine resting readings were averaged over 15 
cardiac cycles as denoted by the ECG trace and repeated twice to compensate for any 
variations in cardiac and respiratory cycles. Subjects were advised to maintain normal 
respiratory rhythm and avoid gasping or taking deep breaths during recording. The calculation 
of flow was performed by using the mean of the two readings of FV diameter and the mean of 
the two readings of the FV time averaged mean velocity. The cross sectional area (CSA) of 
the FV was calculated and multiplied by the FV time average mean velocity to calculated the 
total FV flow. This was the result used for further analysis.  
A cuff attached to a Hokanson Rapid Inflation system was then placed around the dominant 
calf with the foot supported to remove pressure from the calf tissue. The cuff was inflated to 
80 mmHg for approximately 5 sec. to squeeze the calf and, in spectral mode, the peak systolic 
flow velocity in the FV was recorded. This was repeated three times after a 45 second pause 
to allow for venous refilling in between inflations, and the average of the three readings was 
taken to represent the peak FV flow velocity. Peak FV flow was then calculated by 
multiplying FV CSA and FV peak flow velocity.  
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Figure 2.8. The position of the major blood vessels and nerves in the Femoral Triangle for 
measurement of Femoral Vein cross-sectional area and Femoral Vein flow velocity. 
 
The same sequence of measurements and calculations as described above of FV diameter, FV 
flow velocity, FV flow, peak FV flow velocity and peak femoral vein flow during calf 
compression was repeated with the subjects placed in the seated position with the trunk and 
legs at 90° with legs out stretched. (Figure 2.9)  
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Figure 2.9. Change in position for the measurement of Femoral Vein flow velocity. 
 
2.2.3 Venous Occlusion Plethysmography 
Venous occlusion plethysmography applied to the lower leg can provide information on 1) 
rate of arterial inflow, 2) venous vascular volume or capacity, taken as the magnitude of 
increase in limb volume after rapid filling is complete, 3) microvascular fluid filtration, as the 
rate of slow volume increase once filling is complete and (Wilkinson & Webb, 2001) 4) 
venous compliance, taken from the volume-pressure relationship of the calf during emptying 
once the occluding cuff is released as described by Halliwill et al. (1999) & Meendering et al. 
(2005) further explained in section 2.2.3D. 
The underlying principle of venous occlusion plethysmography (VOP) is simple: when 
venous drainage is interrupted, arterial inflow is unaltered. Blood can enter but not leave the 
limb past the inflated cuff. Volume rises in a linear fashion until the potential space in the 
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venous volume has been filled. The increase can be measured as percentage change in limb 
volume and be used to calculate the blood flow into the limb. Although this technique was 
developed for the forearm it has been used successfully on the lower limb. (Hewlett and van 
Zwaluwenberg, 1909, Wilkins & Bradley, 1946, Wilkinson & Webb, 2001)    
 A) Calf Blood Flow 
Subjects rested supine on an examination couch, with feet and calves elevated to aid drainage 
(i.e. above or at the level of the heart) (Figure 2.10) Both feet were secured using an 
evacuated bean bag pad.  
 
 
 
Figure 2.10 Positioning for lower limb occlusion plethysmography with the limbs elevated. 
Ankle and thigh cuffs are shown in place. 
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Cuffs were applied to both ankles to exclude pedal circulation (inflated to 160mmHg prior to 
all venous occlusions). Cuffs were applied around both thighs and attached to a Hokanson 
Rapid Inflation system that provided simultaneous inflation to 50 mmHg. Bilateral calf 
maximal circumferences were measured and strain gauges of 2 cm smaller were selected and 
fixed around the both calf maximal circumferences and connected to Hokanson 
Plethysmographs from which the outputs were routed via a Powerlab module (AD 
Instruments) to a computer running Chart v5.2.2 for Windows© (Figure 2.11). 
 
 
 
Figure 2.11. Equipment and volunteer placement for the evaluation of whole limb and Great 
Saphenous Vein distension and controlled deflation during lower limb occlusion 
plethysmography. 
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The limbs were supported by elasticated straps at knee level to reduce the requirement for 
muscle activity to support the limbs. Resting blood flow measurements were obtained by 
inflating the thigh cuffs to 50 mmHg for 10 seconds three separate times. Arterial inflow was 
measured as the rate of increase in limb volume against time (ml/100ml/min) (figure 2.12).  
The average of the three readings was used for analysis as this is standard practice given the 
reproducibility of calf plethysmographic flow values (8 – 24%, Thijssen et al 2005). 
 
 
 
Figure 2.12. Example of a blood flow trace produced with 10seconds of occlusion 
plethysmography. 
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 B) Venous Capacity 
Calf venous capacity is determined from the increase in limb volume during venous occlusion 
that is maintained for several minutes, long enough to allow for vascular filling but excluding 
fluid filtration (Lindenberger & Länne, 2007) Although the rapid vascular filling phase when 
venous outflow is occluded will occur at different rates depending on arterial inflow and the 
time it takes for pressures to equilibrate throughout the venous circulation, it is accepted that 
filling is mostly completed within 2 min. Beyond this time, the increase in limb volume 
includes a component due to fluid filtration out into the tissues as venous valves become 
incompetent above a back pressure of 40 mmHg (Brown et al. 1966) and capillary hydrostatic 
pressure equates to occluding cuff pressure (Mahy et al. 1995). In the same situation as 
described above (Figure 2.10), the cuff around the dominant thigh only was inflated by the 
pressure system of a DRT4 laser Doppler flux monitor (Moor Instruments) which allowed for 
both rapid inflation and a controlled rate of deflation. Inflation was to a pressure of 50 mmHg 
over five seconds and was maintained for 5 min (300 sec). Deflation was set to occur at a rate 
of 1 mmHg per second to enable calculation of the whole limb compliance by the method 
described Halliwell et al. (1999) and Meendering et al. (2005) (see later 2.2.3D). The signal 
from the strain gauge around the dominant calf was recorded both to the computer running 
Chart via the Powerlab©, and to the DRT4© running Moorsoft© analysis software, for the 
determination of whole limb venous capacity and calculation of microvascular fluid filtration 
as described below.  
During venous distension, the change in limb volume recorded by the strain gauge was 
averaged in 10 sec. bins using the chart software. The volume increase of the limb follows the 
course of a rapid phase (venous filling) and slow phase (fluid filtration) (Figure 2.13). 
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Figure 2.13. Occlusion Plethysmography causes swelling of the limb in two phases. Initial 
venous filling takes approximately 2 minutes. Fluid filtration occurs once the venous capacity 
has been exhausted and fluid is forced to move out of the venous system into the tissues. 
 
Venous capacity (ml/100ml) was taken as the volume increase at two minutes after onset of 
cuff inflation. This coincides with the inflection of the curve from rapid to slow change and 
allows sufficient time for filling of the venous vascular volume as described by Gamble et al. 
(1993) and Olsen & Länne, (1998). The maximal limb capacity was also recorded at the end 
of the five minute inflation period. These were the two results used for analysis. 
 C) Microvascular Filtration Capacity 
Limb volume changes were recorded during cuff inflation to 50 mmHg for 5 min on AD 
Instruments Chart v5.2.2 for Windows© as described above. In order to determine the 
capillary filtration (Kf) that occurred during the occlusion period the trace was analysed by 
taking 10 second averages throughout the distension. Having allowed for venous filling to 
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occur over the first two minutes of the distension (Figure 2.13), the following 120 seconds or 
12 average readings were analysed. The difference between the volume at 4 minutes and 2 
minutes was calculated and divided by 2 to give a minute value. This value was then divided 
by the venous occlusion pressure (50 mmHg) to give the rate of volume change per unit of 
pressure for this distension or the capillary filtration rate (Kf).  
There are, however, problems that have been identified with this method. Single large (>25 
mmHg) steps in cuff pressure have been shown to decrease arterial inflow to the limbs over a 
period of a cuff inflation as shown by Gamble et al. (1998) , by activation of a veno-arteriolar 
local response thought to be stimulated by stretch receptors in the distended veins and vessels, 
even at sub-diastolic pressures (Henriksen et al. 1991). Small stepwise increases in venous 
occlusion pressure have been used to avoid this venoarteriolar response (Christ et al. 2000, 
Gamble et al. 2002) (Figure 2.14). In this study, in order to avoid activation of the veno-
arteriolar response and potential consequences for estimation of filtration, a stepwise 
incremental venous occlusion protocol was used, increasing the occlusion pressure by 10 
mmHg at a time. For each step a period of venous filling occurred followed by a period of 
capillary filtration recorded by strain gauge plethysmography.  
For this protocol, an electromagnetic strain gauge around the calf was used instead of the 
mercury-in-silastic gauge and the thigh cuff inflation was driven by the in-built software of a 
Filtrass machine. The use of this type of strain gauge has been validated against the mercury-
in-silastic gauge by Christ et al. (2000) and shown to yield comparable values. A protocol of 
six four minute inflations in 10 mmHg steps up to 60 mmHg was initiated taking a total of 24 
minutes (Figure 2.14).  
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Figure 2.14. A multi step cuff inflation protocol of venous occlusion plethysmography using 
the Filtrass© Machine. 
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 Figure 2.15. An example of the limb volume response to one of the small pressure increments 
of 10 mmHg. 
 
The filtration slope at each increment of pressure or Jv (Figure 2.15) is plotted against thigh 
cuff pressure. The derivation of this slope provides the microvascular fluid filtration value, Kf 
using this technique. The variables of Pvi (mmHg) and Pvest were calculated by the filtrass 
inbuilt software using the same regression slope (Figure 2.16).  
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 Figure 2.16. Relationship of Jv to Cuff pressure Pv. Microvascular filtration is the slope of 
the linear regression. Pvi is the venous pressure required for fluid filtration to occur. 
 
Reading Explanation 
Pvest The venous pressure in the limb which has been shown to be equivalent to the 
pressure in the limb cuff  
Va Once the cuff is inflated there is a rapid period of venous filling due to arterial 
inflow. This is measured in ml/100ml/min.  
Jv Once venous filling is complete for each pressure step, filtration continues to occur. 
The gradient of this slope is defined as Jv in ml/100ml/min 
Kf 
 
Regression analysis of Jv in ml/100ml/min against cuff pressure mmHg gives Kf or 
the filtration coefficient 
Pvi The cuff pressure that must be applied before the filtration will occur in the limb. 
This is called the isovolumetric venous pressure. This is calculated by regression 
analysis of the Filtration Coefficient Kf against cuff pressure and is the point of 
intercept. 
 
Table 2.1. The results that can be measured and calculated from a stepwise inflation protocol 
of venous occlusion plethysmography of the limb. 
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 D) Whole Limb Compliance 
In order to calculate whole limb compliance, the volume – pressure relationship for the 
decrease in limb volume during controlled cuff deflation at 1 mmHg/sec was constructed 
using the limb volume signal recorded to the DRT4 computer. The DRT4 Moorsoft 
programme sampled data from the strain gauges at 10 Hz. The advantage of this machine was 
that it allowed for an accurate pressure trace alongside the volume changes. During deflation 
this gave the protocol required for calculation of compliance described below. The data was 
transferred to Microsoft Excel for analysis (Figure 2.17).  
 
 
Figure 2.17 A standard plethysmographic trace showing controlled deflation. 
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 Figure 2.18 Polynomial regression analysis of deflation protocol. The  0, 1 and 2 constants 
were extracted and used in the calculation of whole limb and venous compliance. 
 
Each individual’s deflation pressure-volume curve (Figure 2.18) was then fitted by 
polynomial regression analysis using Excel such that the quadratic equation - change in limb 
volume = 0 + 1 x (cuff pressure) + 2 x (cuff pressure)2 – described the relationship.  
0 reflects the volume of the limb with no pressure in the cuff (Y axis intercept on the graphical 
representation). 0 is highly variable and dependent on venous tone, arterial inflow, fluid 
filtration and hysteresis effect of venous emptying and is therefore difficult to interpret.  1 and 
2 reflect the slope of the curve at different pressures. Therefore, as described by Halliwill et 
al. (1999), Meendering et al. (2005), limb compliance can be calculated at each pressure using 
the formula compliance = 1 + 2 · 2 · (cuff pressure), and plotted against pressure to give a 
compliance / pressure slope. In other words, compliance was defined as the derivative of the 
pressure-volume curve. The slope of this line measures the rate of change of compliance in an 
individual and it is this rate of change in venous compliance over a range of pressure which 
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can then be used for comparison between individuals (Figure 2.19) and this is the figure used 
for analysis in the Results section. 
 
 
Figure 2.19. Compliance pressure curve using the 1 and 2 constants derived by quadratic 
analysis of distension. Here the compliance of the calf or vein decreases with increasing 
venous pressure. 
 
In total the limb underwent three periods of cuff inflation and deflation for the measurement 
of compliance. The first cycle provided data from a control period of venous distension and 
compliance of the whole limb was derived during cuff deflation. The second and third venous 
distensions were used to image the Great Saphenous Vein and Popliteal Vein respectively and 
derive their compliance during cuff deflation. Between each period, 10 minutes of leg 
elevation at rest was to allow a chance for venous emptying and restoration of normal limb 
volume.  
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2.2.4 Great Saphenous Vein and Popliteal Vein diameter and compliance measured by 
ultrasound imaging  
During the 2nd and 3rd period of venous distension, a 3-11 MHz linear probe attached to the 
ultrasound (Envsior©) machine was used to image the GSV and the popliteal respectively. 
The GSV was marked with the patient standing 5 cm above the medial femoral condyle prior 
to positioning the patient in the leg elevated position. The vein was imaged in longitudinal 
section in B mode ultrasound. The video signal was routed from the ultrasound machine into a 
PC running Vascular Imaging Analysis (VIA) Software©. Originally designed by Newey & 
Nassiri, (2002) to measure arterial diameter during flow mediated dilation (Sidhu et al. 2002), 
this detects the interface between two different echogenic substances. VIA software was 
written together with the virtual US scanner using National Instruments LabVIEW and IMAQ 
(Austin, Texas, USA) and uses a neural network to interpret the samples taken and ascertain 
the position of the blood / vessel wall boundary. By calculating the difference between the 
anterior and posterior wall boundaries the vessel diameter can be calculated, see figure 2.20. 
Initially the operator is required to interpret the image on the computer display and define the 
region of interest (ROI) for the analysis software. Once the wall edge is detected the software 
carries out an analysis of its position, sampling at 25 frames per second. The data is stored 
online as a continuous read out of the vessel diameter throughout the distension. For analysis 
of data, a macro program running in Excel was created to reduce the output by averaging 
diameters first for each second and then for each 10 sec. This data could then be displayed 
against time to give a graphical representation of change in vein diameter.  
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Figure 2.20. Images taken using ultrasound displaying the GSV in cross section when a) 
underfilled and b) filling. Image c) shows the region of interest measured by the VIA software 
displaying the near and far borders (in green) of the great saphenous vein wall. 
 
During venous distension, the point of maximum vein filling at the end of the 5 min. was 
recorded as filled vein capacity for further analysis. Diameter values over the next 50 sec 
during deflation were noted. Any outlying points (an occasional complication of the sampling 
error due to movement artifact) were removed. A line of polynomial regression was fitted to 
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obtain a quadratic equation for the vein diameter / pressure deflation curve as described above 
for the whole limb, with the intercept taken as ß0, and ß1 and ß2 coefficients describing the line 
of slope. From this a compliance / pressure curve was plotted using the formula: 
Compliance = 1 + 2 x 2 x (cuff pressure) as previously described. The gradient of this line is 
the value used for analysis as previously described for whole limb compliance. 
The VIA software was initially designed to be used with arterial flow mediated dilatation 
where the continuous changes of the cardiac cycle means that arterial diameter is rarely 
constant. This situation does not exist in the venous system and with occlusion 
plethysmography there is initial filling of the vein and, if present, some gradual viscoelastic 
creep of the vessel wall. This means that any movement is operator artifact. Attempts were 
made to support the ultrasound probe in the positions required with mechanical devices but 
this was found impractical and hand-held ultrasound was eventually used.     
 
2.2.5 Blood Sampling and Insulin HOMA index calculation  
Blood samples (24mls) were taken from the antecubital vein using aseptic techniques and 
divided into five separate tubes: 
• 4ml in a grey top Sodium Fluoride/Potassium Oxalate Vacuette® tube for analysis of 
fasting blood glucose levels. 
• 4ml in a yellow top Serum separator clot activator Vacuette® tube for analysis of 
sodium, potassium, urea, creatinine, albumin, alkaline phosphatase, alanine 
transaminase, aspartate trasnsaminase and bilirubin. 
• 4ml in a purple top K3EDTA Vacuette® tube for analysis of haemoglobin, white 
blood cell count, platelets, haemaocrit and mean cell volume. 
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• 6ml in a red top serum clot activator Vacuette® tube for analysis of 17 ß-estradiol and 
progesterone levels. 
• 6ml in a red top serum clot activator Vacuette® tube for analysis of fasting blood 
insulin levels. 
All samples taken above were processed by the University Hospital Birmingham NHS 
Foundation Trust in the Clinical Chemistry and Haematology laboratories of the Queen 
Elizabeth Hospital of the UHBNHSFT, Birmingham, England except the fasting glucose level 
which was carried out at the University of Birmingham School of Sport and Exercise 
Science’s laboratory. 
Analysis of insulin levels was carried out using the DRG Human Insulin EIA-2935© assay 
technique and two samples were analysed to test reproducibility. Once the results of the 
samples of fasting blood insulin levels were known, they were used with the fasting blood 
glucose levels to calculate the HOMA index of insulin resistance original devised by 
Matthews et al. (1985) and updated to HOMA2 (Levy et al. 1998 & Wallace & Matthews, 
2002) by the same group in Oxford to allow for the calculation of their individual insulin 
resistance levels. The computer program HOMA Calculator Version 2.2.2 © Diabetes Trial 
unit, University of Oxford http://www.dtu.ox.ac.uk/homa was downloaded and the data was 
inputted as displayed in figure 2.21. The output IR was then used as the insulin resistance of 
the volunteers. 
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Figure 2.21. An example of the input and output fields in the HOMA2 calculator. 
 
2.2.6 Gynaecology Questions 
All volunteers completed a questionnaire on the aspects of their gynaecological history. Two 
primary measures were used in the study. The total number of full term pregnancies as 
reported by the volunteers and the length of time for which the volunteer had used the oral 
contraceptive pill throughout their lifetime reported in months. These results were both used 
as they were reported. 
 
2.3 PROTOCOLS 
Each subject participated in two testing sessions, one in each of two locations. The first took 
place at the University of Birmingham School of Sport and Exercise Vascular Laboratory (1). 
The second took place at the Wellcome Clinical Research Facility at the Queen Elizabeth 
University Hospital Birmingham (2). Participants informed the principal investigator on the 
first day of their menstrual period. Arrangements were then made for testing to take place 
within the next two days to maintain parity of female hormone levels throughout the 
population study group. They were asked to fast from midnight (no food, no caffeinated 
drinks, no sugary drinks) on the morning that they attended for study. They were asked to 
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drink 500mls of water on waking on the morning of the study to obtain a satisfactory level of 
hydration as per the euhydration protocol (Veldhuijzen van Zanten et al. 2005). Participants 
had been given the questionnaires (Weight Recall and Gynaecological history) at the 
screening visit. A full explanation of what was required to complete the form was given at this 
time. Filled questionnaires were recovered from participants when they attended for testing 
sessions. Room temperature was maintained at 21±1ºC in both testing locations and subjects 
were allowed to acclimatize for 20 minutes after arrival in both venues (Abraham et al. 1994 
& Jorfeldt et al. 2003). 
 
2.3.1 Test Session 1: University of Birmingham School of Sport and Exercise Science 
(Appendix G) 
Basic data was recorded on arrival as follows:- the study number was assigned, gender was 
checked, date of birth, age and dominant limb recorded. The subjects were required to re-
confirm their consent for the study and any questions raised were answered at this point. 
Anthropometric data – height, weight, waist / hip / limb circumferences – were measured and 
recorded. Following inspection and palpation of the limb, a CEAP score for evidence of 
venous disease was determined as per Table 1.2. 
Subjects moved to an examination couch for measurements of abdominal obesity. The Sacro 
abdominal/Sacro patella index (SA/SP) was measured whilst they sat upright with legs 
outstretched straight in front. Whilst supine, their sagittal-abdominal diameter (SAD) was 
recorded. Durometry measures of tissue hardness were then made at previously marked sites 
on the abdomen, both thighs and calves, in supine and sitting positions. Skin thicknesses were 
measured at these same sites using Harpenden calipers and ultrasound imaging. Venous refill 
times were determined following dorsiflexion using the Huntleigh Vascular Assist Device©. 
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With subjects lying supine, the femoral vein was located in the dominant limb in the thigh, 
10cm distal to the groin skin crease and imaged with colour duplex in cross section to verify 
anatomical position and circular vein profile (the limb was held in approximately 15º of 
external rotation). In longitudinal B mode image, vein diameter was measured using the 
ultrasound machine inbuilt calipers. In pulse Doppler mode, resting femoral flow velocity 
(averaged over 15 cardiac cycles) was recorded in duplicate as mean velocity, time-averaged 
velocity mean, systolic and diastolic peak velocities. Peak femoral velocity during calf 
compression was then measured in triplicate. All resting and peak femoral velocities were 
then repeated with subjects seated upright at 90º with legs externally rotated at 15 º on the 
couch.  
Leg blood flow and filtration and venous function (capacity, compliance) were then measured 
using a combination of venous occlusion plethysmography and ultrasound imaging. Systolic, 
diastolic and mean arterial blood pressures were recorded by a Portapres© finger cuff on the 
non-dominant hand and heart rate was derived from this trace. Subjects were positioned with 
their limbs as shown in figure 2.10. Three measurements of calf resting blood flow were made 
followed by three 5 min periods of venous distension (cuff inflation to 50 mmHg) and 
emptying (cuff deflation at 1 mmHg/sec). The first distension (control) provided calf 
plethysmographic data and the 2nd and 3rd yielded ultrasound imaging data on the GSV and 
popliteal vein respectively to estimate venous capacity, filled vein diameter (GSV, popliteal), 
limb fluid filtration, and calf (limb) and vein compliance. Microvascular fluid filtration was 
then determined using the small incremental pressure step protocol and the Filtrass machine 
as described above (Section 2.2.3C).  
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2.3.2. Test Session 2: Wellcome Research Facility University Hospitals Birmingham 
(Appendix H) 
Following the measurements above, participants moved (still fasted) from the University of 
Birmingham Sport and Exercise Sciences building to the Wellcome Research Facility at the 
Queen Elizabeth University Hospital, a journey of 0.25 mile taking approximately 15 
minutes. Subjects were admitted onto the Wellcome Trust computer system and a 
UHBNHSFT unit number was generated or retrieved. They were required to re-confirm their 
consent for the study and any questions raised were answered at this point.  
Blood samples were taken from an arm vein as described in section 2.2.5. Subjects then 
underwent a Dual Energy X-ray Absorptiometry scan performed by the onsite DEXA 
qualified radiographer. Once this was completed they lay supine on a electronic hospital bed 
in the study room with ambient temperature set at 21ºc. Mean arterial blood pressure and 
pulse were monitored on a Hewlett Packard Propaq© throughout the testing period.  
After a period of 5 minutes rest the previously marked sites on the bilateral thigh and calves 
were located so that durometry measures could be taken in both the supine and upright seated 
positions. Following a further rest period, tissue pressure was measured at the groin by 
manometer in supine and seated positions. This concluded the test session. 
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2.4 DATA ANALYSIS AND STATISTICS 
 
2.4.1 Reduction of Bias and Sampling Error 
All readings taken in the study were made under the same controlled conditions in an attempt 
to maintain comparability of data. All subjects were studied in the same phase of the 
menstrual period (Barwin et al. 1977), the same room temperature (Jorfeldt et al. 2003), and 
fasted for at least 8 hours prior to the study which included the exclusion of caffeine. 
Volunteers were hydrated during there fast as per the euhydration protocol designed to 
maintain normal blood volume (van Zanten et al. 2005). All anthropometric, venous and 
whole limb function measures were taken twice by one investigator so that reproducibility 
could be assessed. Patients were encouraged to remain as relaxed as possible throughout to 
reduce movement artefact particularly for those measurements where it was important e.g. 
ultrasound imaging. Where there was concern raised by any member of the testing team as to 
the validity of a reading taken the test was reset and repeated after a necessary time delay to 
allow for return of normal tissue function if required.  
 
2.4.2  Medical statistics software 
Microsoft® Office Excel 2003 was used to collate data at the time of investigation. 
Descriptive statistics were derived by the inbuilt analysis software and all graphical data were 
produced using this program. Two different statistics packages were used in analysing and 
interpreting the data. These were chosen because the investigator had experience using them 
prior to commencing the study. MedCalc® Version 10.1.4.0 and StatView® for Windows 
version 5 were used to perform comparisons as described below.  
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2.4.3 Review of data 
Data from the study was reviewed with input from the University Hospital Birmingham NHS 
Foundation Trust statistician Dr Peter Nightingale. All data underwent Kolmogorov-Smirnov 
testing for closeness of fit to the normal distribution (MedCalc® Version 10.1.4.0) and were 
found to be parametric (Appendix I). However, the study contained small numbers (26 
female) of volunteers and it was felt that to avoid making assumptions and Type II errors, it 
would be better to treat the data as non-parametric. Therefore all group, paired and correlative 
analyses were made using non-parametric tests.  
 
2.4.4  Box and Whisker plots. 
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Figure 2.22. An example of a box and whisker plot showing the results of oestrogen taken 
from the study volunteers. Two points clearly lie beyond the 91st percentile of the patient 
population and these were removed from analysis to alter any skewing of the results. 
 
Each individual variable was displayed for the whole study cohort on a box and whisker plot 
using StatView® for Windows version 5 to show the median, upper and lower quartile, 9th and 
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91st percentiles. The advantage of this type of graphical display is that it clearly demonstrates 
if a value lies outside the expected range for the sample population. The investigator can then 
decide whether to include or exclude this value from the analysis. Data analysis was 
supported by previously published results in the literature or known normal ranges described 
by laboratories.   
 
2.4.5 Statistical Tests 
The study population was described using the mean and standard deviation of measured 
variables. Comparison between the three BMI class groups - classes <25, 25-30 and >30 
kg/m2 – was made by the Kruskal-Wallis test. This was applied to all anthropometric data, all 
measures of abdominal adiposity, tissue pressure, durometry readings, vein sizes, capacities, 
vein compliance and flow, and blood levels of female hormones and metabolic indicators 
(glucose, insulin) as dependent variables with BMI group as the independent variable.  
Correlational analysis was performed to test for associations between body size / dimensions 
and measures of abdominal adiposity, and between these variables and data on vein size 
(diameter, CSA, capacity), venous compliance, femoral vein flow with and without calf 
compression, calf blood flow and filtration. Results are presented in tabular form, giving 
Spearman’s Rank Correlation coefficient Rho (ρ), and the level of significance. Blood 
concentrations of female hormones and metabolic indicators were also correlated with all of 
the above parameters to determine their influence. The possibility of a multiple regression 
model to test for key influences on venous function was considered but would not have been 
robust with the low n numbers involved. 
Where duplicate or more readings were made of the same parameter, e.g. groin tissue 
pressure, skin thicknesses or vein flow values, reproducibility was determined by calculating 
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the coefficient of variance (SD/mean * 100). Where two different methods were applied to the 
same parameter, e.g. skin thickness by ultrasound or skinfold calipers, the limits of 
measurement agreement were estimated by correlation (Spearman’s Rank) and by Bland 
Altman plot to illustrate any consistent bias. 
Where measurements were made in both supine and seated position, e.g. femoral vein size 
and flow, groin tissue pressure, a paired comparison by the Wilcoxon test was performed to 
see if a significant alteration had occurred as a result of the change in posture.  
Data are presented in the results section as mean and standard deviation unless otherwise 
stated. The level of significance was taken as p=0.05. 
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CHAPTER 3: 
RESULTS 
3.1 BODY COMPOSITION 
3.1.1 Study Volunteer Characteristics 
The “OBVIOUS” study ran from 1st April 2007 to 1st October 2008 at University Hospitals 
Birmingham NHS Foundation Trust and the University of Birmingham School of Sport and 
Exercise Sciences. Fifty-seven volunteers responded to advertisements and 50 females and 7 
males were screened for entry into the study. Seven volunteers (6 female, 1 male) did not 
meet the inclusion criteria and 18 females were screened but unable to complete the study, 
leaving 26 female and 6 male participants. With these small numbers in the male group, it was 
deemed that there would be insufficient power for analysis of gender differences. 
Consequently, data was collected and will be reported from a total of 26 females. The 
consequences of this lower than expected response to request for study participants and small 
number included in the study will be dealt with in the Discussion. 
At initial screening, arterial and venous haemodynamics were assessed. None of the 26 
participants had venous reflux > than 0.5 sec at the sapheno-femoral or sapheno-popliteal 
junctions as measured by duplex ultrasound in standard clinical practice. Venous refill times 
(Sam et al. 2006) and ankle-brachial pressure index are shown below and fall within the 
normal range (Al-Qais et al. 2009). 
The primary outcome measures from the study were indices of venous function that could be 
related to body composition and the presence of abdominal obesity. The demographic and 
physical characteristics of the participants are therefore shown for the whole group, and for 
the group divided in categories of BMI (normal, overweight, obese) as described in the 
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Methods. There were no differences in age or height between the BMI categories but weight 
was significantly greater in the overweight and obese individuals as would be expected. 
 n Mean (Standard Deviation) 
Age (yrs) 26 41.2 (3.91) 
Ankle Brachial Pressure Index 26 1.05 (0.09) 
Venous Refill times (s) 26 40.9 (6.01) 
Heart Rate (bpm) 26 70.9 (10.25) 
Mean Arterial Blood Pressure mmHg 26 87.9 (11.71) 
Height (cm) 26 167.0 (7.44) 
Weight (Kg) 26 83.8 (19.22) 
BMI (Kg/m2) 26 30.0 (6.24) 
Glucose (mmol/l) 20 4.9 (0.74) 
Albumin (g/dl) 12 44.7 (3.94) 
Haemoglobin (g/dl) 21 13.4 (0.90) 
Haematocrit (fl) 21 0.4 (0.03) 
Oestrogen (pmol/l) 18 167.9 (110.3) 
Progesterone (nmol/l) 18 1.8 (1.02) 
Insulin 22 9.8 (7.69) 
HOMA index 17 1.34 (1.04) 
 
Table 3.1. Demographic and physical characteristics of the 26 female volunteers. (No 
volunteers fell outside the normal range for any reading taken or they would have been 
excluded from the study.) 
 
In the volunteer population no clinical parameter or biochemical reading taken was found to 
lie outside of the normal range either designated from the literature, e.g. ABPI, or designated 
by the laboratory performing the testing respectively. These data are displayed in table 3.1. In 
the volunteer population there were 23 (88.5%) right leg and 3 (11.5%) left leg dominant 
woman and 22 (84.6%) volunteers who had never smoked. 3 (11.5%) volunteers were present 
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smokers and 1 (3.8%) woman was an ex-smoker. CEAP classification demonstrated 14 
(53.8%) class 0 volunteers and (46.2%) class 1 volunteers. 
As previously discussed in methods the BMI was used as the reference range of body habitus 
for the volunteers. For analysis, the volunteers were divided into three groups according to 
BMI classifications of the World Health Organization (1995) as normal, overweight or obese. 
Physical characteristics of these groups are shown in Table 3.2. 
  BMI Kg/m2 Age Height cm Weight Kg 
 n Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
BMI 20-25 normal 7 23.2 (1.6) 41.0 (5.7) 165.0 (8.4) 63.3 (7.5) 
BMI 25.1-30 overweight 9 28.2 (1.3) 40.4 (3.4) 169.4 (7.3) 81.2 (6.7) 
BMI 30+ obese 10 36.1 (4.9) 41.9 (3.0) 166.2 (7.0) 100.3 (17.7)
 
Table 3.2. BMI, age, height and weight are shown as mean (SD) for the 3 sub-groups 
according to BMI classification. 
 
Kruskal Wallis testing revealed no significant difference between the groups in age (p=0.72) 
or height (p=0.52) although as expected the difference was significant between the weight 
(p=0.0002) and BMI (p<0.0001) by different BMI class. 
Wrist and ankle circumferences were measured and correlated with BMI, height and weight. 
Table 3.3 shows that wrist circumference was correlated significantly with all three 
parameters, and ankle circumference with BMI and weight but not height.  
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 ρ p 
Wrist vs BMI 0.531 0.008 
Wrist vs Height 0.576 0.004 
Wrist vs Weight 0.735 0.0002
Ankle vs BMI 0.464 0.02 
Ankle vs Height 0.257 0.200 
Ankle vs Weight 0.560 0.005 
 
Table 3.3. ρ and p value for the correlation of wrist or ankle circumference with BMI, height 
or weight for all participants (n=26). 
 
 
Figure 3.1. Demographic data, body mass index and indices of abdominal obesity in the 
normal (n=7), overweight (n=9) and obese (n=10) females grouped by BMI class. Values 
shown are mean ± S.E.M. and the units for each variable are shown below the columns. 
 
 90
3.1.2 Validation of Sacro-Abdominal/Sacro-Patella index (SA/SP) 
The most commonly-used simple non-invasive indices to evaluate central abdominal 
adiposity are sagittal-abdominal diameter (SAD), % truncal fat as determined by DEXA scan, 
waist circumference or waist-hip ratio (W-H), and subcutaneous tissue thickness measured by 
skinfold calipers or ultrasound. These measures are usually made with subjects in the supine 
position. In order to assess the impact of abdominal fat on venous return from the leg when 
seated, a new ratio – SA/SP – that measured the distance from sacrum to patella that is 
overhung by abdominal fat in the sitting position was devised (see Methods). This ratio was 
compared against the other established estimates of abdominal adiposity as illustrated in 
figure 3.1.  
 
 
Figure 3.2. Scatter plot with regression lines to show correlation between SA/SP and other 
indices of abdominal fat (SAD, DEXA % truncal fat, waist-hip ratio) and body composition 
(BMI) in 26 females. 
 91
The SA/SP index was greater in obese > overweight > normal, as were BMI, SAD, and % 
truncal fat; W-H ratio did not distinguish between the groups. Within the study population as 
a whole, there was very good correlation between SA/SP and SAD (ρ=0.85, p<0.0001) or % 
truncal fat (ρ=0.87, p=0.009) but no association with W-H ratio (ρ= 0.19, p=0.3329). SA/SP 
also correlated significantly with BMI (ρ=0.90, p<0.0001). 
 
3.1.3 Comparison of Ultrasound and Skinfold Caliper in the measurement of abdominal 
and peripheral fat 
Ultrasound measurements of subcutaneous fat thickness have been compared against the more 
traditional skinfold caliper technique at various body sites. Both methods displayed greater 
measurement error in obese than non-obese subjects but this was reported to be less apparent 
at the abdominal site (Demura & Sato, 2007). In order to characterize body fat distribution in 
the abdomen and legs in the present study, prior to consideration of its impact on venous 
function, an analysis was first made of the agreement between these two techniques in 
measuring at the abdomen, thigh and calf. Duplicate readings were made at each site using 
ultrasound and skin fold caliper. The coefficient of variance (SD as % mean) as a measure of 
reproducibility at abdomen, thigh and calf were 4.0%, 3.3% and 5.2% for ultrasound and 
3.9%, 3.3% and 4.4% for caliper.  
Figure 3.3 shows the correlation between caliper and ultrasound measurements with 
Spearman’s rank correlation coefficients of ρ=0.83 for abdomen (p<0.0001), ρ=0.77 for thigh 
(p<0.0001) and ρ=0.61 for calf (p<0.0001). The readings obtained from the ultrasound were 
consistently lower than those from the calipers at all three sites (Table 3.6). The Bland-
Altman plots (Fig. 3.4) demonstrate agreement between the two techniques at all three sites 
but with consistent differences (ultrasound – caliper) of -0.63 cm for abdomen, -1.23 cm for 
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thigh and -1.10 cm for calf. The difference between the two measurements was not related to 
magnitude for the abdomen and thigh, but in the calf, the difference increased with greater 
magnitude (Spearman’s correlation coefficient -0.44, p<0.005). 
 
 
Fig 3.3. Scatter plots of relationship between caliper and ultrasound measurements of 
subcutaneous fat tissue thickness at the abdomen, thigh and calf in 26 female; data shown 
include duplicate measures at each site and values for both left and right legs 
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   Ultrasound cm Calipers cm  
 n 
Mean (standard 
deviation) 
Mean (standard deviation) P values 
Abdomen  26 4.42 (1.65) 5.07 (1.68) 0.103 
Thigh 26 3.04 (1.12) 3.93 (1.32) 0.006 
Calf 26 1.67 (0.56) 2.65 (0.72) <0.0001 
 
Table 3.4. Mean (SD) values of skin thickness measured by ultrasound and skinfold calipers 
for the abdomen, thigh and calf in 26 females. P values are for paired Mann-Whitney test. 
 
 
 
Fig 3.4. Bland-Altman plot of difference between DUS and caliper measurement of 
subcutaneous tissue thickness against mean of the two measurements in 26 females, including 
duplicate measures each site and values for both left and right legs. 
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Having established that abdominal fat thickness could be measured directly using ultrasound 
with good accuracy, the values were compared against the other indices of abdominal 
adiposity – SAD (ρ=0.823, p=<0.0001), % truncal fat (ρ=0.636, p=0.056), W-H ratio 
(ρ=0.375, p=0.609) and the SA/SP ratio (ρ=0.777, p=0.0001) and against BMI (ρ=0.847, 
p=<0.0001).  
 
3.2. EFFECT OF BODY COMPOSITION AND ABDOMINAL ADIPOSITY ON 
INGUINAL TISSUE PRESSURE, FEMORAL VEIN FLOW 
 
3.2.1 Measurement Inguinal Tissue Pressure 
The presence of fat in the central abdominal region was considered to present potential 
impediment to femoral venous flow by providing mechanical hindrance in the groin region 
especially when seated. Inguinal tissue pressure was therefore measured directly by needle 
and manometer with participants lying supine (2 min) and then passively moved to an upright 
seating position with the legs extended (5 min). It can be seen from Fig. 3.5 that in the normal 
subjects, pressure readings showed a step increase, remaining stable at the higher value for the 
duration of sitting. 
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 Figure 3.5. Inguinal tissue pressure (means) recorded each minute during 2 minutes of supine 
and 5 minutes of seated position in the normal BMI female volunteers. 
 
The coefficient of variation of repeated inguinal tissue pressure measures for those of normal 
BMI in the supine position was 6.5% and in the seated position was 11.1%. This was 
calculated across the five supine and four seated measurement cycles. Inguinal tissue pressure 
data were obtained from 21 of the 26 participants in the study. No significant difference was 
demonstrated in supine tissue pressures between the BMI groups (p=0.70; figure 3.12). On 
moving to the seated position, pressures did change significantly for the normal (p=0.0008) 
and obese BMI group (p=0.02) with the greatest difference in the obese group, measured at 
8.2 (3.5) mmHg. The difference from supine to seated was not quite significant in the 
overweight group (p=0.07). The relationship between inguinal tissue pressure and BMI is 
borne out by correlation, which was significant for seated values (ρ= 0.62, p=0.007) but not 
supine (ρ= 0.25, p=0.27). 
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Figure 3.6. Inguinal tissue pressure (means) measured supine and seated in 21 females 
according to BMI class. The seated, supine and measured difference between them are shown 
with significant differences between BMI groups displayed between the obese seated and 
obese difference groups and their normal and overweight seated and difference measures. 
 
Correlations between the seated pressure and the indices of abdominal adiposity were also 
noted (Table 3.5). They were particularly good for those indices that specifically detect 
abdominal fat i.e. SA/SP, ultrasound of the abdominal wall and sagittal abdominal diameter. 
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 Figure 3.7. Correlation between BMI and seated and supine inguinal tissue pressure 
measures for 21 females. 
  
Seated Inguinal Tissue 
Pressure 
Difference supine to 
seated 
 n ρ P ρ P 
Body Mass Index (BMI) Kg/m2 21 0.620 0.007 0.410 0.080 
Supine Sagittal- Abdominal diameter 
cm (SAD) 
18 0.647 0.008 0.311 0.200 
DEXA percentage Truncal Fat 10 0.500 0.130 0.176 0.60 
Waist-Hip 
Ratio 
19 0.492 0.040 0.460 0.050 
Sacro-Abdominal/Sacro-Popliteal index 
(SA/SP) 
20 0.709 0.003 0.500 0.040 
Ultrasound Abdomen wall 
subcutaneous tissue depth cm 
19 0.700 0.03 0.440 0.060 
Table 3.5. Correlations between inguinal tissue pressure and indices of abdominal adiposity. 
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Supine inguinal tissue pressure is not affected by any measure of body habitus. The seated 
inguinal tissue pressure can be seen to have a positive correlation with indices of body 
composition. The difference between these two readings is greatest and significant only in the 
obese group and this significance is seen with measures looking at the abdominal wall 
adiposity.  
 
3.2.2 Relationships between body composition, abdominal adiposity and femoral vein 
size. 
FV CSA was calculated from ultrasound measurements of diameter in the femoral triangle in 
the supine and seated position in 22 participants. The values obtained were similar to those 
published by De Groot et al. (2005), and pilot work in this laboratory (G. D. Bishop, PhD 
Thesis, University of Birmingham) has established that within-subject variability of vein 
CSAs calculated from diameter measured using VIA software yields a coefficient of variation 
of 2.6 – 6.1% for repeat measures within a session and 2-2 – 4.4% between sessions. There 
was no significant difference between the BMI classes comparing the supine FV CSA 
(p=0.83). Seated FV CSA was larger in the obese than the overweight or normal BMI groups 
but these differences were also not significant (p=0.14). The change in the size of FV CSA 
upon moving from supine to seated was significant in all three BMI groups (normal 
p=<0.0001, overweight p=0.018 and obese p=0.008). 
The percentage increase in CSA on changing position was also similar between the BMI 
groups (p=0.13). Although femoral vein size did not appear to be related to BMI across the 
three groups, there was a significant correlation between BMI and seated CSA (ρ=0.50, 
p=0.02) and the percentage increase in CSA (ρ=0.55, p=0.01) (fig 3.8). FV CSA was not 
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related to height in any postural position, implying that weight, and hence adiposity, play a 
greater role. 
 
 Supine Femoral Vein 
CSA cm2 
Seated Femoral Vein 
CSA cm2 
% change from 
Supine to Seated 
 n Mean (SD) Mean (SD) Mean (SD) 
BMI 20-25 
normal 
6 
0.406 (0.244) 0.549 (0.220) 60.4 (57.5) 
BMI 25.1-30 
overweight 
7 
0.428 (0.132) 0.774 (0.291) 91.7 (66.5) 
BMI 30+ obese 9 0.386 (0.173) 0.880 (0.480) 128.5 (47.9) 
 
Table 3.6. Cross sectional area (CSA) of the femoral vein (means ± SD) in 22 females when 
supine and seated and the percentage difference on changing position. 
Figure 3.8. Scatter plot of the correlation of BMI against the supine and seated cross 
sectional area of the femoral vein. The percentage change between supine and seated is also 
shown. 
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To examine the effect of abdominal adiposity on femoral vein size, supine, seated and 
percentage change in CSA were correlated with SAD, % truncal fat, W-H ratio, SA/SP index 
and ultrasound abdominal tissue thickness. None of these indices were correlated with supine 
femoral vein CSA. Only SAD was marginally correlated with seated femoral vein CSA (ρ = 
0.41, p=0.07). However, all indices except W-H ratio were significantly correlated with the 
percentage change in CSA on moving from supine to seated position (SAD ρ = 0.42, p=0.05; 
% truncal fat ρ = 0.71, p=0.06; SA/SP ρ = 0.48, p=0.03; ultrasound abdominal tissue 
thickness ρ = 0.46, p=0.04). Thus the greater the measure of abdominal fat, the larger the 
increase in femoral vein size when sitting. 
In the previous section (3.2.1), seated inguinal tissue pressure was also shown to be correlated 
with abdominal adiposity assessed by W-H ratio, SA/SP index ultrasound tissue thickness and 
SAD but not % truncal fat. It was expected therefore that changes in femoral vein size would 
be associated with seated inguinal tissue pressure. However, neither seated femoral CSA nor 
percentage increase in the FV CSA were, related to seated inguinal tissue pressure (ρ = 0.33, 
p=0.20; ρ = 0.24, p=0.34 respectively) or change in pressure (ρ = 0.05, p=0.85; ρ = 0.36, 
p=0.20). Other body size factors may therefore impact upon the size of the femoral vein when 
sitting. One possibility is leg size because with the legs extended, thigh and calf tissues may 
act by compression to displace blood volume along the venous circulation.  
Anthropometric estimations of leg size and composition were made using standard 
circumferential measures. Dominant thigh and calf CSA were calculated and, following 
correction of circumference for subcutaneous tissue thickness based on ultrasound / skinfold 
caliper measurement, lean CSA was also calculated for these two segments. Data were 
obtained from 23 of the female subjects yielding a mean (SD) thigh CSA of 224.1(55.6) cm2 
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and calf CSA 124.8(26.5) cm2. Lean CSA (thigh 89.3(20.1) cm2, calf 67.6(13.1) cm2) 
represent 39.8% and 54% of the leg CSA respectively.  
None of the CSA values were related to supine FV CSA. However, seated FV CSA was 
significantly correlated with both thigh (ρ = 0.53, p=0.02) and calf (ρ = 0.53, p=0.01) CSA, as 
was the percentage change in FV CSA on moving from supine to sitting (vs thigh CSA ρ = 
0.56, p=0.01; vs calf CSA ρ = 0.59, p=0.07). 
Lean thigh CSA was not related to seated femoral CSA (ρ = 0.10, p=0.63) although there was 
association with lean calf CSA (ρ = 0.43, p=0.05). Figure 3.9 illustrates these relationships.  
 
 
Figure 3.9. Scatter plot showing the correlation between percentage change in femoral vein 
cross sectional area CSA on moving from supine to sitting with legs extended and 
anthropometrically determined leg and lean CSA of the dominant thigh and calf in 23 
females. 
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3.2.3 Relationships between body composition, abdominal adiposity and femoral vein 
flow  
Resting femoral vein mean flow was estimated from ultrasound measured vein diameter and 
flow velocity averaged over 15 cardiac cycles in the supine and seated positions in 22 
females. The coefficient of the variance of the repeated readings was 5.6%. Table 3.7 shows 
that there were no differences between BMI classes in mean flow either supine (p=0.17, 
Kruskal-Wallis) or seated (p=0.28), or in the percentage change in flow on changing position 
(p=0.33). Flow tended to decrease slightly on sitting in the normal and overweight groups on 
paired comparison of normal and overweight but not in the obese group. Since femoral vein 
diameter increased on sitting, a decrease in flow represents a decrease in flow velocity. 
Peak femoral vein flow was estimated from resting diameter and peak flow velocity during 
application of rapid calf compression in supine and seated positions (Table 3.8). The 
coefficient of variance of the repeated readings was 3.4%. When supine, peak flow was 15-18 
times higher than at rest but there was no difference between the BMI classes (p=0.21). On 
sitting, peak flow increased in all groups but the results were only significant in the 
overweight (p=0.028) and the obese group (p=0.008). There were no BMI class differences 
(p=0.40 for peak sitting flow, p=0.91 for percentage change in peak flow). The lack of 
association between BMI and femoral vein flow is confirmed by correlational analysis (Table 
3.10).  
Femoral mean and peak flows were also correlated against indices of abdominal adiposity and 
there were no associations in either supine or seated positions (Tables 3.9 & 3.10). The only 
factor impacting significantly on mean femoral flow was inguinal tissue pressure but this was 
evident only in the supine resting condition. Body composition and abdominal adiposity 
therefore appear to have little effect on the peak femoral flow as determined by ultrasound of 
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the femoral vein in either the seated or supine position or the change that occurs in the flow 
when a volunteer moves from the supine to seated position. 
 
  
Supine mean 
flow ml/min 
Seated mean 
flow ml/min 
Percentage Change in Mean 
flow Supine to Sitting 
 n Mean (SD) Mean (SD) Mean (SD) 
BMI 20-25 
normal 
6 152.5 (96.4) 96.1 (39.8) -9.8 (59.4) 
BMI 25.1-30 
overweight 
7 212.5 (69.2) 152.2 (66.7) -25.6 (31.3) 
BMI 30+ obese 9 155.1 (82.6) 115.7 (40.8) 8.4 (51.6) 
 
Table 3.7. Femoral vein mean volume flow (mean (SD)) in the supine and seated with legs 
extended position, and percentage change in flow on moving posture. Values are shown for 
22 females and when grouped according to BMI class. 
  
Supine peak 
flow ml/min 
Seated Peak Flow 
in ml/min 
Percentage Change in Peak 
Flow Supine to Sitting 
 n Mean (SD) Mean (SD) Mean (SD) 
BMI 20-25 
normal 
6 2690.2 (2180.0) 4978.8 (2339.6) 142.0 (89.3) 
BMI 25.1-30 
overweight 
7 3201.4 (1080.7) 7153.0 (2954.6) 140.9 (108.0) 
BMI 30+ obese 9 2550.4 (878.6) 5898.9 (2399.1) 151.3 (120.8) 
 
Table 3.8. Femoral vein peak flow (mean (SD)) in the supine and seated with legs extended 
position, and percentage change in flow on moving posture. Values are shown for 22 females 
and when grouped according to BMI class. 
 
 
 104
  
Supine Femoral 
Vein Mean Flow 
ml/min 
Seated Femoral 
Vein Mean Flow 
ml/min 
Percentage 
change from 
Supine to Seated 
 n ρ p ρ p ρ p 
Body Mass Index (BMI) 
Kg/m2 
23 -0.62 0.80 0.30 0.18 0.18 0.43 
Supine Sagittal- 
Abdominal diameter cm 
(SAD) 
22 -0.006 0.98 0.23 0.31 0.21 0.36 
DEXA percentage Truncal 
Fat 
9 0.286 0.45 0.21 0.60 -0.25 0.54 
Waist-Hip Ratio 23 -0.22 0.31 0.15 0.52 0.18 0.42 
Sacro-Abdominal/Sacro-
Popliteal index (SA/SP) 
23 n/a n/a 0.61 0.79 0.17 0.46 
Ultrasound Abdomen wall 
subcutaneous tissue depth 
cm 
23 -0.219 0.32 0.22 0.32 0.20 0.37 
Supine Inguinal Tissue 
Pressure mmHg 
17 0.57 0.029 n/a n/a n/a n/a 
Seated Inguinal Tissue 
Pressure mmHg  
17 n/a n/a 0.25 0.35 -0.20 0.46 
Change in Inguinal Tissue 
Pressure mmHg 
17 n/a n/a -0.21 0.42 0.67 0.80 
 
Table 3.9. Correlational analysis of femoral vein mean flow supine and seated and 
percentage change in mean flow with BMI, indices of abdominal adiposity (SAD, % truncal 
fat, W-H ratio, SA/SP index, ultrasound abdominal tissue thickness) 
 and inguinal tissue pressures (supine, seated and change on moving).  
Values shown are Spearman’s ρ and significance. 
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Seated Femoral 
Vein Peak Flow 
ml/min 
Seated Femoral 
Vein Peak Flow 
ml/min 
Percentage 
change from 
Supine to Seated 
 n ρ p ρ p ρ p 
Body Mass Index (BMI) 
Kg/m2 
23 -0.14 0.95 0.10 0.83 0.36 0.67 
Sacro-Abdominal/Sacro-
Popliteal index (SA/SP) 
23 n/a n/a -0.04 0.85 -0.70 0.75 
Waist-Hip Ratio 23 -0.34 0.88 0.13 0.58 -0.53 0.81 
Supine Sagittal- 
Abdominal diameter cm 
(SAD) 
22 0.17 0.44 0.06 0.80 -0.17 0.45 
DEXA percentage Truncal 
Fat 
9 -0.17 0.66 -0.14 0.73 0.25 0.54 
Ultrasound Abdomen wall 
subcutaneous tissue depth 
cm 
23 0.007 0.97 0.08 0.74 -0.11 0.64 
Height cm 23 n/a n/a 0.03 0.89 0.29 0.19 
Supine Inguinal Tissue 
Pressure mmHg 
17 0.22 0.40 n/a n/a n/a n/a 
Seated Inguinal Tissue 
Pressure mmHg  
17 n/a n/a 0.24 0.37 -0.86 0.75 
Change in Inguinal Tissue 
Pressure mmHg 
17 n/a n/a 0.22 0.41 -0.25 0.36 
Table 3.10. Correlational analysis of femoral vein peak flow supine and seated and 
percentage change in mean flow with BMI, indices of abdominal adiposity (SAD, % truncal 
fat, W-H ratio, SA/SP index, ultrasound abdominal tissue thickness) and 
 inguinal tissue pressures (supine, seated and change on moving).  
Values shown are Spearman’s ρ and significance. 
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3.2.4 Tissue Durometry  
From the previous sections, it has been shown that inguinal tissue pressure when seated is 
higher if individuals have a larger BMI and greater abdominal adiposity. Likewise, femoral 
vein CSA increases more on sitting with greater abdominal adiposity, but is also positively 
affected by size of the thigh and calf. On the other hand, femoral vein flow when seated is not 
influenced by BMI, abdominal adiposity or inguinal tissue pressure. Although flow in this 
conduit vein is not affected, the pressure effects of abdominal obesity may act upon venous 
microcirculation, possibly leading to fluid filtration into tissues at the thigh and causing tissue 
hardness. To investigate this, the novel technique of durometry was used. A hand-held device 
is allowed to rest under its own weight on the skin surface and provide a reading of 
indentation load or hardness. Tissue durometry has been shown to detect the increase in tissue 
hardness for patients with systemic sclerosis (Kissin et al. 2006). 
Skin hardness may be influenced by skin thickness as well as elasticity and oedema. Previous 
studies reported a correlation between durometer readings and skin thickness measured by 
ultrasound in healthy controls and patients with systemic sclerosis in regions of the upper 
limb – hands, forearm, upper arm and validated in this condition by Kissin et al. (2006). To 
assess the impact of skin thickness on durometer readings in the present study population with 
high BMI and obesity, these two variables were compared in the supine position after twenty 
minutes rest and in the seated position after 5 min. The dominant thigh and calf in 23 females 
were examined. There was no correlation between durometry values (mean of the two 
readings) and ultrasound tissue thickness at either the thigh (ρ=0.14, p=0.54) or calf (ρ=0.30, 
p=0.17).  
The coefficient of variance for repeated readings was 4.4% over both thigh and calf. No 
significant difference (increase) was demonstrated between the supine and seated thigh tissue 
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durometry readings in all three BMI groups (normal p=0.22, overweight p= 0.66, obese 
p=0.062). In all three BMI groups there was a significant difference between the calf supine 
and seated tissue value with increase in values across the groups (normal p=0.04, overweight 
p= 0.01, obese p=0.006).   
 
 Change in Thigh Durometry 
Supine to Seated (units) 
Change in Calf Durometry 
Supine to Seated (units) 
 n Mean (SD) Mean (SD) 
BMI 20-25 normal 6 2.0 (2.3) 3.0 (1.2) 
BMI 25.1-30 overweight 7 2.2 (1.7) 3.6 (2.5) 
BMI 30+ Obese 10 1.9 (2.7) 3.7 (4.8) 
 
Table 3.11. Changes in skin hardness measured by durometry at thigh and calf on moving 
from supine to seated in 26 females. 
 
Table 3.11 gives values for the change in durometry readings on moving from supine to 
sitting for all participants and according to BMI class. There was no significant difference 
between the different BMI classes when compared against each other using a Kruskal Wallis 
test (thigh p=0.84 and calf p=0.71).  
The lack of effect of BMI on change in skin hardness with seating was also evident in 
correlational analysis (figure 3.11). Whereas the increase in inguinal tissue pressure was 
greater with larger BMI (as described in Section 3.2.1 above), there was no such relationship 
for the thigh (ρ=0.05, p=0.85) or calf (ρ=0.29, p=0.22). Neither did the durometry change 
correlate with seated inguinal pressure (thigh p=0.88; calf p=0.86), increase in inguinal tissue 
pressure on sitting (thigh p=0.21; calf p=0.08) or SA/SP (thigh p=0.89; calf p=0.12).  
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There is insufficient data to say that the BMI or the SA/SP ratio can explain the changes in 
lower limb tissue durometry. Height, being a major contributor to the lower limb orthostatic 
pressure demonstrated no correlation.  
 
 
 
Figure 3.10. Scatter plot of the correlation between the change in skin hardness on moving 
from supine to seated, measured by durometry in thigh and calf against BMI in 23 females. 
Also included for comparison are data on the increase in inguinal tissue pressure on sitting. 
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3.3. EFFECT OF BODY COMPOSITION ON LOWER LEG VENOUS PROPERTIES 
(WHOLE LIMB CAPACITY, WHOLE LIMB AND VEIN SIZE) 
The previous sections have demonstrated that body composition and in particular, abdominal 
adiposity, are related to femoral vein size but not to volume flow within the vein either supine 
or sitting. Adipose tissue as a percentage of the thigh is greater than that of the calf. This 
could mean that the support for the veins offered by the lean tissue of the limb would be less 
in the thigh compared to the calf.  Described below are the studies evaluating venous function 
of the lower leg using a combination of strain gauge plethysmography (SGP) and ultrasound 
(US). With SGP and venous occlusion protocols, calf blood flow, venous vascular volume 
(capacity) and capillary filtration coefficient were determined and related to body size (BMI) 
and abdominal adiposity. Ultrasound was used evaluate changes in the diameter of the GSV 
and the Popliteal vein.  
 
3.3.1 Calf blood flow 
Calf blood flow values are shown in Table 3.12 and there was no difference between the BMI 
classes (p=0.23). There are several factors that can influence resting calf blood flow including 
limb size, anatomical vascular capacity and resistance vessel tone. Correlational analysis was 
carried out between calf blood flow and indices of body size, abdominal adiposity and calf 
size and composition. Although blood flow was not associated independently with age or 
height, it was clearly positively related to body size through BMI (Table 3.12).  It also 
correlated with the SA/SP index with higher flow values linked to bigger abdominal 
adiposity. The impact of body fat on calf blood flow was further shown by significant 
correlations with thigh and calf CSA but not with lean CSA for these limb segments (Table 
3.13). Further analysis of other independent variables is shown in section 3.5.  
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Calf blood flowMean 
(SD) ml/100ml/min 
 n Mean (SD) 
BMI 20-25 normal 7 1.70 (0.37) 
BMI 25.1-30 overweight 9 1.98 (0.73) 
BMI 30+ Obese 10 2.33 (0.72) 
 
Table 3.12. Mean (SD) of calf blood flow for 26 females as a group and according to BMI 
class. 
 
 Dominant Calf Mean Blood Flow
 n ρ p value 
Age years 26 0.28 0.18 
Height cm 26 -0.16 0.43 
BMI kg/m2 26 0.46 0.02 
SA/SP 26 0.52 0.01 
Mean Arterial Blood pressure mmHg 24 0.13 0.53 
Dominant Calf Cross Sectional Area cm2 25 0.46 0.02 
Dominant Calf Lean Cross Sectional Area cm2  25 0.26 0.21 
Dominant Calf Lean Cross Sectional Area 
as a percentage of whole calf CSA 
22 -0.04 0.84 
Dominant Thigh Cross Sectional Area cm2 22 0.58 0.01 
Dominant Thigh Lean Cross Sectional Area cm2 22 0.16 0.45 
Dominant Thigh Lean Cross Sectional Area 
as a percentage of whole thigh CSA 
22 -0.62 <0.005 
 
Table 3.13. Correlational analysis of resting calf blood flow with physical characteristics 
relating to body size and composition. 
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3.3.2 Venous Capacity 
  
Calf venous capacity after
2 min ml/100ml 
Maximum calf capacity
after 5 min ml/100ml 
 n Mean (SD) Mean (SD) 
BMI 20-25 normal 7 2.09 (0.69) 3.34 (1.16) 
BMI 25.1-30 overweight 9 2.81 (0.81) 3.59 (1.08) 
BMI 30+ Obese 10 2.32 (0.37) 2.62 (0.56) 
 
Table 3.14 Mean (SD) calf venous capacity measured as the increase in limb volume either 
after 2 min of venous occlusion (rapid vascular filling phase) or after 5 min of venous 
occlusion (vascular filling + fluid filtration) for 26 females as a group and according to BMI 
class. 
 
Venous capacity after 2 min and, more noticeably, the increase in calf volume after 5 min 
(capacity + fluid filtration) were different between the BMI classes (p=0.08 and p=0.02 
respectively) with higher values in the overweight group than the normal or obese groups 
(Table 3.14).  No correlation was noted between the indices of body composition and the 
venous filling capacity measured at 2 min. Venous capacity has been shown to be dependent 
on anatomical limb size, but no correlation was noted between the indices of body 
composition and the venous volume measured at 2 min. The effects of female hormones on 
venous capacity will be presented in section 3.5. 
However, significant correlations were noted between indices of body composition and 
venous volume after 5 min. The correlation between this and BMI (ρ=-0.617, p=0.002) is 
shown in the figure 3.11, and correlations with SA/SP (ρ=-0.516, p=0.010), SAD (ρ=-0.464, 
p=0.230), ultrasound abdominal wall thickness (ρ=-0.401, p=0.045) and dominant thigh cross 
sectional area (ρ=-0.605, p=0.006) were also demonstrated. Since calf volume changes after 
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venous occlusion represents fluid filtration, once filled capacity is reached (2 min), this 
component was analysed separately. 
 
 
Figure 3.11 Body mass index versus the maximum limb capacity after 5 min of venous 
occlusion (vascular filling + fluid filtration) for 26 females. 
 
3.3.3 Microvascular Filtration Capacity  
Fluid filtration (Kf) measured from calf volume increases between 3-5 min after venous 
occlusion was associated with higher BMI and adiposity. Mean data for the BMI classes are 
shown in Table 3.15 and there was a significant difference between the three groups (p<0.05). 
Filtration in overweight and obese individuals was lower than that of normal BMI 
participants.  It was inversely correlated with BMI and with other indices of abdominal 
adiposity as shown in Table 3.16. Calf filtration is a product of permeability and 
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microvascular surface area for fluid exchange the effect of the latter is shown by the 
significant correlation of Kf with dominant calf total and lean CSA (Table 3.16). Limb size is 
therefore a factor in determining filtration capacity. 
The protocol for venous occlusion by small incremental increases in thigh cuff pressure (see 
Methods section 2.2.3) allows an estimate of calf venous pressure (Pvest) to be obtained by 
extrapolating the volume-pressure relationship at each pressure step to zero volume change.  
The values of Pvest for the normal, overweight and obese BMI groups (Table 3.15) did not 
differ significantly (p=0.36) although in the overweight and obese group, pressures were 
double those in the normal BMI subjects. Another parameter derived from small step 
increases in venous occluding pressure is Pvi, the isovolumetric venous pressure at which 
point the hydrostatic and oncotic Starling forces are in balance and there is no net fluid 
filtration or absorption. These values (Table 3.15) were also similar in the three BMI groups 
(p=0.65), indicating no effect of body composition on this variable.  
 
 
Calf Fluid Filtration Kf 
ml/100ml/min/mmHg 
Pvi mmHg P vest 
 n Mean (SD) n 
Mean 
(SD) 
n 
Mean 
(SD) 
BMI 20-25 normal 7 0.0031 (0.0012) 3 16.3 (9.2) 4 6.0 (4.9) 
BMI 25.1-30 overweight 9 0.0015 (0.0013) 7 18.8 (6.8) 5 
15.0 
(9.9) 
BMI 30+ Obese 8 0.0012 (0.0010) 8 17.3 (8.3) 9 
12.2 
(8.5) 
 
Table 3.15 Mean (SD) calf fluid filtration, isovolumetric pressure (Pvi) and estimated venous 
pressure (Pvest) according to BMI class in 26 females. 
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Capillary  Filtration Kf (filtration)  
ml/100ml/min 
 n ρ p 
BMI Kg/m2 24 -0.55 0.005 
Supine Sagittal- Abdominal diameter cm
(SAD) 
23 -0.442 0.038 
SA/SP ratio 24 -0.514 0.014 
Ultrasound Abdomen wall 
subcutaneous tissue depth cm 
24 -0.412 0.048 
DEXA percentage Truncal Fat 8 0.119 0.753 
Waist-Hip Ratio 24 -0.079 0.706 
Dominant Calf Cross 
Sectional Area cm2 
24 -0.434 0.041 
Dominant Calf Lean Cross 
Sectional Area cm2 
24 -0.369 0.084 
Dominant Thigh Cross 
Sectional Area cm2 
24 -0.451 0.049 
Dominant Lean Thigh Cross 
Sectional Area cm2 
24 0.180 0.432 
 
Table 3.16. Correlational analysis of calf fluid filtration against body composition and 
indices of abdominal adiposity 
 
Significant negative correlation was found between the measures of adiposity and the 
measures of fluid filtration in the leg. Pvest measures of venous pressure increased with 
adiposity but did not reach levels of significance.  
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Figure 3.12. Scatter plot of correlation between calf filtration capacity and Pvi for 25 
females. 
3.3.4 Lower limb Vein Parameters.  
The previous section has shown similar blood flow but impaired fluid filtration in the calves 
of overweight and obese females. Venous capacity determined from calf volume change 
during venous occlusion and rapid vascular filling was not different between BMI classes. On 
the other hand the femoral vein was distended to a larger CSA on sitting in obese and 
overweight than normal BMI individuals. Since plethysmographic change in calf volume 
represents filling of both large and small venous vessels, ultrasound was used to examine 
individual large veins of the lower leg and their properties during distension and emptying.  
Maximal filled diameters of the great saphenous vein (GSV) and popliteal vein were imaged 
by ultrasound after venous occlusion for 5 min. Mean (SD) diameters for the whole group 
were 3.8 (1.0) for the GSV and 9.3 (3.1) for the popliteal vein in a total of 13 subjects. Figure 
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3.13 illustrates maximal vein diameters separated by BMI group. Although the obese group 
tended to have large maximal popliteal diameters, there were no overall differences between 
the BMI classes (p=0.56). However, the GSV showed a graded increase in size with BMI and 
a significant difference between groups (p=0.03).  
 
 
Figure 3.13. Maximal diameters (means ± SD) of the popliteal and great saphenous veins 
during venous distension by thigh cuff inflation in BMI class groups (normal n = 3 and 5 for 
popliteal and GSV respectively, overweight n = 5 and 4, obese n = 5 and 4). 
 
The size of the popliteal vein was not significantly correlated with BMI (ρ = 0.16, p=0.59). 
The relationship is shown in figure 3.14. The popliteal vein was not related to calf size (calf 
whole CSA ρ = 0.04, p=0.89; calf lean CSA ρ = 0.06, p=0.84) or indices of abdominal 
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adiposity (SAD, W-H ratio, % truncal fat, SA/SP index, ultrasound abdominal thickness, 
thigh CSA.  
In contrast, the GSV size was positively related to BMI (ρ = 0.74, p=0.01) shown in figure 
3.14, and to leg size through both calf (ρ = 0.70, p<0.02) and thigh CSA (ρ = 0.69, p<0.05). It 
was also correlated with indices of abdominal adiposity, SAD (ρ = 0.61, p<0.05), SA/SP (ρ = 
0.76, p<0.01) and ultrasound abdominal fat (ρ = 0.51, p<0.07) but not with % truncal fat or 
waist-hip ratio. Further analysis of independent variables oestrogen, OCP, glucose, insulin 
and HOMA2 is shown in section 3.5. 
 
 
Figure 3.14 Body mass index plotted against Popliteal and Great 
 Saphenous Vein Maximal Diameter. 
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3.4. EFFECT OF BODY COMPOSITION ON LOWER LEG VENOUS 
COMPLIANCE 
Venous compliance has been assessed in two ways – one by measuring calf volume 
plethysmographically as a surrogate for venous vascular volume, and the other by imaging 
individual calf veins using ultrasound. With both approaches, compliance was evaluated 
during emptying of the filled venous system so that the derived volume / diameter – pressure 
curves represented the passive elastic recoil properties of the veins.  The fitting of polynomial 
regression lines is described in the methods section 2.2.3. 
 
Compliance (percentage volume change/pressure) against pressure for Popliteal vein 
distensions. 
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Figure 3.15. Plots of compliance of the whole calf, derived from diameter-pressure curves 
during emptying, against pressure for 14 female subjects. 
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Whole Limb Compliance 
ml/100ml/mmHg/mmHg 
Popliteal Vein 
Compliance in 
mm/mmHg/mmHg 
Great Saphenous Vein 
Compliance in 
mm/mmHg/mmHg 
 n Mean (SD) n Mean (SD) n Mean (SD) 
BMI 20-25 
normal 
7 
-0.0013 
(0.0012) 
4 
-0.0022 
(0.0019) 
5 
-0.00148 
(0.0005) 
BMI 25.1-30 
overweight 
6 
-0.0015 
(0.0008) 
5 
-0.0018 
(0.0013) 
4 
-0.00065 
(0.0018) 
BMI 30+ 
Obese 
8 
-0.0012 
(0.0010) 
5 
-0.00008 
(0.0030) 
4 
-0.00030 
(0.0010) 
 
Table 3.17. Venous compliance (means ± SD) of the whole calf, the popliteal vein and the 
GSV vein in different BMI groups. 
 
Compliance of the calf measured plethysmographically did not differ with BMI (p=0.31, 
Table 3.18). Calf compliance was unrelated to indices of abdominal adiposity although it 
tended to be positively associated with larger leg size through calf and thigh CSA (Table 
3.19.). In all three BMI groups, the compliance – pressure slopes were similar see figure 3.19. 
Although there was no overall significant difference between popliteal vein compliance the 
BMI groups (p=0.45) it was similar for the normal and overweight BMI classes but tended to 
be different in the obese group (Table 3.18). Figure 3.20 illustrates that, based on the group 
mean slopes and intercepts, popliteal compliance in the obese group did not decrease with 
increasing pressure, whereas it did in the normal and obese groups. Despite this difference, 
compliance of the popliteal vein did not significantly correlate with any measure of body size, 
body composition, abdominal adiposity or leg size (Table 3.19). 
Similarly, GSV veins tended to show a decrease in compliance with increasing BMI (Table 
3.18), but because of variability in this measure, the difference was not quite significant 
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between groups (p=0.08). For the obese group, GSV compliance plotted against pressure 
showed no decrease with increasing pressure compared to the other two groups shown in 
figure 3.21.  The slope of the GSV compliance – pressure plot was positively correlated with 
BMI, was linked with abdominal adiposity through SAD and SA/SP index and was strongly 
associated with larger leg size (Table 3.19.). There was thus a mismatch between venous 
compliance determined for the calf and for the popliteal vein, which were not related to body 
size, composition or adiposity, and compliance of the GSV vein which was associated with all 
these factors and with leg size.  
 
 
 
Figure 3.16. Bar chart depicting the compliance (means ± SE)) of the whole calf,  
the popliteal vein and the GSV vein in different BMI groups. 
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Calf Compliance 
ml/100ml/mmHg/m
mHg 
Popliteal Vein 
Compliance in 
mm/mmHg/mmHg 
GSV 
Compliance in 
mm/mmHg/mm
Hg 
 
n (Calf/Pop/ 
GSV) 
ρ p ρ p ρ P 
BMI Kg/m2 21/14/14 0.192 0.402 0.342 0.236 0.603 0.037 
Age adjusted BMI 13/9/9 -0.122 0.685 -0.065 0.863 -0.167 0.659 
SAD cm 20/13/14 -0.078 0.741 0.453 0.133 0.672 0.020 
W-H ratio 21/14/14 0.346 0.131 -0.191 0.508 -0.291 0.313 
SA/SP 21/14/14 -0.030 0.897 0.284 0.325 0.618 0.032 
Ultrasound Abdominal 
wall thickness cm 
21/14/14 -0.065 0.777 0.166 0.565 0.218 0.449 
Truncal % fat measured 
by DEXA 
8/5/6 0.170 0.678 0.400 0.488 0.600 0.230 
Dominant calf CSA cm2 21/14/14 0.401 0.080 0.304 0.293 0.580 0.045 
Dominant lean Calf CSA 
cm2 
21/14/14 0.210 0.360 0.265 0.358 0.790 0.006 
Dominant lean Calf CSA 
% 
21/14/13 0.007 0.975 -0.036 0.896 0.023 0.936 
Dominant Thigh CSA cm2 19/9/13 0.425 0.080 0.606 0.069 0.715 0.018 
Dominant Thigh Lean 
CSA cm2  
19/9/13 0.460 0.058 0.300 0.368 0.337 0.263 
Dominant Thigh Lean 
CSA % 
19/13/12 -0.137 0.560 -0.325 0.304 -0.383 0.204 
 
Table 3.18. Correlational analysis of calf venous, popliteal and GSV vein compliance with 
body size and composition and other factors in females. 
 
No correlation was noted between calf compliance and femoral vein cross-sectional area or 
inguinal tissue pressure. No correlation was noted between popliteal compliance and femoral 
vein cross-sectional area. No relationship was noted between GSV compliance and maximum 
CSA of the femoral vein, percentage change in the CSA of the femoral vein or change in 
inguinal tissue pressure.  
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Figure 3.17. Compliance of the calf over a range of pressures for the three BMI classes. 
 
 
Figure 3.18. Compliance of the popliteal vein over a range of pressures for the three BMI 
classes. 
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Figure 3.19. Compliance of the Great Saphenous Vein over a range of pressures for the three 
BMI classes. 
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3.5 OESTROGEN, ORAL CONTRACEPTIVE PILL, FULL TERM PREGNANCIES, 
HISTORICAL BMI, PHYSICAL ACTIVITY GLUCOSE, INSULIN AND HOMA2 
INDEX  
Epidemiological data has been used to try to explain the causative factors of venous disease. 
Several areas in the literature have highlighted investigation into these areas via various 
methods but using people with known disease process. This section looks at the various 
variables believed to have an effect on formation of venous disease in a population without 
any definable disease in an attempt to identify any patterns. 
 
3.5.1 Blood Oestrogen levels and Oral Contraceptive Pill Usage 
Table 3.20. shows no difference between the BMI groups in their level of blood oestrogen 
(p=0.54) or the length of oral contraceptive usage (p=0.4474). There was no significant 
correlation between BMI (ρ= 0.013, p=0.97) or SA/SP index (ρ= 0.04, p=0.86) and oestrogen 
levels. All females who completed the questionnaire in the study had used the oral 
contraceptive pill. There was no significant correlation between BMI (ρ= -0.08, p=0.71) or 
SA/SP index (ρ= 0.02, p=0.91) and oral contraceptive pill usage. Exposure to either 
endogenous or exogenous female reproductive hormones was thus independent of body size 
and abdominal adiposity. 
 Blood Oestrogen pmol/l Oral contraceptive pill usage (months)
 n Mean (SD) n Mean (SD 
BMI 20-25 normal 4 162.8 (48.5) 5 93.6 (76.6) 
BMI 25.1-30 overweight 7 187.1 (167.0) 7 125.1 (61.6) 
BMI 30+ obese 7 151.7 (68.5) 9 87.0 (70.0) 
 
3.19. Blood oestrogen levels at the time of investigation and self reported use of the oral 
contraceptive pill. 
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 Blood Oestrogen Levels pmol/l
 n ρ P 
BMI Kg/m2 18 0.100 0.967 
SA/SP 18 0.042 0.862 
Femoral vein diameter supine (mm) 18 -0.026 0.913 
Femoral vein diameter seated (mm) 18 -0.084 0.737 
% change femoral vein diameter 
from supine to seated 
18 -0.133 0.595 
% change in femoral vein mean flow 
from supine to seated 
19 0.242 0.365 
% change in femoral vein peak flow 
from supine to seated 
19 0.313 0.241 
Blood Flow ml/100ml/min 20 0.080 0.740 
Capacitance at 120 seconds ml/100ml 18 0.317 0.179 
Capacitance at 300 seconds ml/100ml 18 0.392 0.106 
Kf fluid filtration ml/100ml/min 18 0.471 0.070 
Pvi mmHg 17 0.124 0.642 
Pvest mmHg 15 0.324 0.261 
Popliteal vein maximum filled diameter (mm) 10 0.327 0.386 
GSV maximum filled diameter (mm) 11 0.083 0.813 
Whole limb compliance 12 0.015 0.963 
Popliteal vein Compliance mm/mmHg/mmHg 12 0.092 0.795 
Great Saphenous Vein compliance mm/mmHg/mmHg 12 0.015 0.964 
 
Table 3.20. Spearman’s rank correlation (ρ) co-efficient analysis of blood oestrogen levels 
against measures of venous function. 
 
There were no demonstrable correlations between the blood oestrogen level at the time of 
investigation and the measured variables of venous function in the study (Table 3.21). 
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 Oral contraceptive pill usage (month)
 n ρ p 
BMI Kg/m2 21 -0.082 0.713 
SA/SP 21 0.024 0.914 
Femoral vein diameter supine (mm) 19 -0.152 0.518 
Femoral vein diameter seated (mm) 18 -0.178 0.464 
% change femoral vein diameter 
from supine to seated 
18 -0.041 0.867 
% change in femoral vein mean flow 
from supine to seated 
19 -0.301 0.260 
% change in femoral vein peak flow 
from supine to seated 
19 0.349 0.192 
Blood Flow ml/100ml/min 21 0.150 0.490 
Capacitance at 120 seconds ml/100ml 21 0.153 0.493 
Capacitance at 300 seconds ml/100ml 21 0.175 0.435 
Kf fluid filtration ml/100ml/min 19 0.166 0.481 
Pvi mmHg 17 -0.058 0.553 
Pvest mmHg 15 -0.547 0.582 
Popliteal vein maximum filled diameter (mm) 12 0.070 0.817 
GSV maximum filled diameter (mm) 10 0.418 0.210 
Whole limb compliance 17 -0.099 0.711 
Popliteal vein Compliance mm/mmHg/mmHg 17 0.194 0.561 
Great Saphenous Vein compliance mm/mmHg/mmHg 17 0.129 0.715 
 
Table 3.21. ρ analysis of oral contraceptive pill usage against measures of venous function. 
 
There were no demonstrable correlations between oral contraceptive pill usage in the 
volunteer population and the measured variables of venous function in the study (Table 
3.22).Thus, exposure to either endogenous oestrogen or exogenous female hormones did not 
impact upon any of the measured venous properties.  
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3.5.2 Pregnancy and Historical Body Mass Index   
To investigate the impact of previous the number of full term pregnancies and the effect of 
previous body weight history the following data was collected. (Table 3.23).  
 Full term Pregnancies number Historical BMI Kg/m2 
 n Mean (SD) N Mean (SD 
BMI 20-25 normal 5 2.0 (0) 4 24.1 (4.8) 
BMI 25.1-30 overweight 7 0.9 (1.2) 5 27.2 (3.6) 
BMI 30+ obese 9 1.4 (1.0) 9 30.5 (4.1) 
 
Table 3.22. Number of full term pregnancies and self reported historical BMI of the volunteer 
population. 
 
There was no difference between the different BMI groups in the number of full term 
pregnancies (p=0.213). The historical BMI was significant in its correlation to present BMI 
(p=0.003) but not related to the SA/SP ratio. Demonstrated in the two tables below 3.24 and 
3.25 are the Spearmans’ rank correlation coefficients of the number of full term pregnancies 
and Historical BMI against the variables of venous function measured in the study. No 
significant correlations could be demonstrated. 
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 Full term Pregnancies number
 N ρ P 
BMI Kg/m2 21 -0.009 0.969 
SA/SP 21 -0.094 0.674 
Femoral vein diameter supine (mm) 19 0.042 0.859 
Femoral vein diameter seated (mm) 18 0.053 0.827 
% change femoral vein diameter  
from supine to seated 
18 0.135 0.579 
% change in femoral vein mean flow 
from supine to seated 
19 0.177 0.515 
% change in femoral vein peak flow  
from supine to seated 
19 0.346 0.196 
Blood Flow ml/100ml/min 21 -0.153 0.493 
Capacitance at 120 seconds ml/100ml 21 -0.204 0.361 
Capacitance at 300 seconds ml/100ml 21 -0.175 0.435 
Kf fluid filtration ml/100ml/min 19 0.160 0.945 
Pvi mmHg 17 -0.018 0.949 
Pvest mmHg 15 -0.089 0.757 
Popliteal vein maximum filled diameter (mm) 11 0.093 0.768 
GSV maximum filled diameter (mm) 10 0.076 0.820 
Whole limb compliance  17 0.315 0.238 
Popliteal vein Compliance mm/mmHg/mmHg 17 0.397 0.234 
Great Saphenous Vein compliance mm/mmHg/mmHg 17 0.500 0.157 
 
Table 3.23 ρ analysis of number of full term preganacies against measures of venous function. 
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 Historical BMI Kg/m2
 N ρ p 
BMI Kg/m2 18 0.713 0.003 
SA/SP 18 0.611 0.012 
Femoral vein diameter supine (mm) 16 -0.038 0.880 
Femoral vein diameter seated (mm) 15 0.204 0.446 
% change femoral vein diameter  
from supine to seated 
15 0.257 0.336 
% change in femoral vein mean flow 
from supine to seated 
17 0.181 0.536 
% change in femoral vein peak flow  
from supine to seated 
17 -0.214 0.458 
Blood Flow ml/100ml/min 18 0.318 0.189 
Capacitance at 120 seconds ml/100ml 18 0.086 0.722 
Capacitance at 300 seconds ml/100ml 18 -0.065 0.789 
Kf fluid filtration ml/100ml/min 16 -0.176 0.481 
Pvi mmHg 16 -0.437 0.115 
Pvest mmHg 13 0.077 0.790 
Popliteal vein maximum filled diameter (mm) 9 0.524 0.166 
GSV maximum filled diameter (mm) 9 0.167 0.659 
Whole limb compliance  13 -0.076 0.794 
Popliteal vein Compliance mm/mmHg/mmHg 9 0.070 0.840 
Great Saphenous Vein compliance mm/mmHg/mmHg 8 -0.167 0.659 
 
Table 3.24 ρ analysis of historical BMI against measures of venous function. 
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3.5.3 Physical Activity 
The level of physical activity which the volunteers undertook was assessed by the means of a 
seven day recall questionnaire (Washburn et al. 2003) 
 
 Physical Activity Kcal/day 
 n Mean (SD) 
BMI 20-25 normal 5 1728.0 (472.5) 
BMI 25.1-30 overweight 7 1790.3 (245.0) 
BMI 30+ obese 8 1965.8 (532.6) 
 
Table 3.25 Self reported level of physical activity in the volunteer population. 
There were no significant correlations identified between the physical activity levels of the 
volunteers and any measures of body habitus or the assessed measures of venous function in 
the study. 
 
3.5.4 Fasting Blood Insulin and Glucose levels, and HOMA2 index  
  
The HOMA2 data for the whole study group showed a normal distribution.Kruskal wallis 
testing showed no difference between the different BMI groups in the level of blood glucose 
(p=0.17), level of blood insulin (p=0.25). However there was a significant difference between 
the three BMI groups when the HOMA2 index was calculated on the volunteer population 
(p=0.023).  
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  Glucose mmol/l Insulin µIU/ml HOMA2 index 
 n Mean (SD) n Mean (SD) N Mean (SD) 
BMI 20-25 normal 4 4.6 (0.2) 6 5.8 (3.4) 4 0.5 (0.2) 
BMI 25.1-30 overweight 6 4.7 (0.5) 7 9.2 (7.0) 5 1.3 (0.9) 
BMI 30+ obese 8 5.0 (0.4) 9 12.9 (9.4) 8 1.8 (1.2) 
 
Table 3.26 Fasting blood glucose and insulin levels of the study volunteer population and the 
calculated HOMA2 Index. 
 
Fasting blood glucose levels did not correlate with the indices of venous function that were 
analysed in the study except for a significant correlation to GSV maximum filled diameter 
(ρ=0.929, p=0.014) and tended towards significance with the compliance of the GSV 
compliance measures. The implications of this are considered in the discussion. 
The co-efficient of variation of the two readings of fasting insulin levels was 5.1%. The 
measurement of fasting blood insulin level did demonstrate any correlation with the measured 
indices of venous function analysed in the study. The insulin levels were all within the 
manufactures described normal range. There was significant positive correlation between 
fasting blood insulin levels and BMI (ρ=0.446, p=0.040) and SA/SP index (ρ=0.507, 
p=0.020) see figure 3.22 below).  
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 Glucose mmol/l 
 n ρ p 
BMI Kg/m2 18 0.375 0.122
SA/SP 18 0.436 0.072
Femoral vein diameter supine (mm) 16 -0.359 0.165
Femoral vein diameter seated (mm) 15 -0.046 0.862
% change femoral vein diameter  
from supine to seated 
15 0.253 0.344
% change in femoral vein mean flow 
from supine to seated 
15 0.010 0.970
% change in femoral vein peak flow  
from supine to seated 
15 -0.246 0.358
Blood Flow ml/100ml/min 16 -0.016 0.947
Capacitance at 120 seconds ml/100ml 18 -0.147 0.544
Capacitance at 300 seconds ml/100ml 18 -0.330 0.174
Kf fluid filtration ml/100ml/min 17 -0.159 0.526
Pvi mmHg 13 -0.073 0.801
Pvest mmHg 13 0.232 0.421
Popliteal vein maximum filled diameter (mm) 10 -0.164 0.624
GSV maximum filled diameter (mm) 8 0.929 0.014
Whole limb compliance  14 -0.066 0.812
Popliteal vein Compliance mm/mmHg/mmHg 10 0.173 0.604
Great Saphenous Vein compliance mm/mmHg/mmHg 8 0.667 0.078
 
Table 3.27 ρ analysis of fasting blood glucose levels against measures of venous function. 
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 Figure 3.20. The Study volunteers BMI against fasting blood glucose, insulin and their 
calculated HOMA2 index. 
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  Insulin µIU/ml 
 n ρ p 
BMI Kg/m2 22 0.446 0.040
SA/SP 22 0.507 0.020
Femoral vein diameter supine (mm) 20 -0.406 0.077
Femoral vein diameter seated (mm) 19 0.136 0.564
% change femoral vein diameter 
from supine to seated 
19 0.431 0.067
% change in femoral vein mean flow 
from supine to seated 
19 0.275 0.243
% change in femoral vein peak flow 
from supine to seated 
19 0.214 0.365
Blood Flow ml/100ml/min 22 0.388 0.757
Capacitance at 120 seconds ml/100ml 22 -0.049 0.822
Capacitance at 300 seconds ml/100ml 22 -0.300 0.169
Kf fluid filtration ml/100ml/min 21 -0.336 0.133
Pvi mmHg 17 0.255 0.308
Pvest mmHg 16 0.091 0.723
Popliteal vein maximum filled diameter (mm) 10 -0.152 0.650
GSV maximum filled diameter (mm) 13 0.070 0.808
Whole limb compliance 18 0.198 0.414
Popliteal vein Compliance mm/mmHg/mmHg 10 0.152 0.649
Great Saphenous Vein compliance mm/mmHg/mmHg 13 0.070 0.808
 
Table 3.28. ρ analysis of fasting blood insulin levels against measures of venous function. 
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HOMA2 index demonstrated a significant correlation with BMI (ρ=0.681, p= 0.006) and 
SA/SP (ρ=0.632, p=0.011) as would be expected. Only two variables could be demonstrated 
to have a significant correlation with the HOMA2 index, the percentage change in the CSA of 
the FV on moving from supine to seated (ρ=0.698, p=0.012) and calf blood flow (ρ =0.607, 
p=0.015)  (see figure 3.23).      
 HOMA2 index 
 n ρ P 
BMI Kg/m2 9 0.681 0.006
SA/SP 9 0.632 0.011
Femoral vein diameter supine (mm) 15 0.504 0.060
Femoral vein diameter seated (mm) 14 0.401 0.145
% change femoral vein diameter  
from supine to seated 
12 0.698 0.012
% change in femoral vein mean flow 
from supine to seated 
14 0.379 0.172
% change in femoral vein peak flow  
from supine to seated 
14 0.311 0.262
Blood Flow ml/100ml/min 17 0.607 0.015
Capacitance at 120 seconds ml/100ml 17 0.194 0.439
Capacitance at 300 seconds ml/100ml 17 -0.197 0.430
Kf fluid filtration ml/100ml/min 16 -0.218 0.398
Pvi mmHg 12 0.028 0.926
Pvest mmHg 12 0.416 0.168
Popliteal vein maximum filled diameter (mm) 9 0.040 0.890
GSV maximum filled diameter (mm) 8 0.060 0.875
Whole limb compliance  13 0.040 0.890
Popliteal vein Compliance mm/mmHg/mmHg 10 0.648 0.052
Great Saphenous Vein compliance mm/mmHg/mmHg 8 0.506 0.181
 
Table.3.29. ρ analysis of the calculated HOMA2 index against measures of venous function. 
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Figure 3.21. Body Mass Index, the percentage change in femoral vein cross sectional area 
and dominant calf blood flow against the HOMA2 index of study volunteers. 
 
The analysis of fasting blood glucose and insulin levels and the HOMA2 index has yielded 
results that suggest that glucose may affect the distensibility and compliance of the GSV. 
Insulin levels relate to the level of obesity and this may be a summative factor in the effects of 
obesity on venous function. HOMA2 index and insulin resistance may give rise to a change in 
the distensibility of the FV and this may in part be due to an increase in inflow. 
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CHAPTER 4: 
DISCUSSION 
Venous disease is a major contributor to the burden of health care provision. An 
understanding of the risk factors that cause venous disease has been attempted through 
epidemiological studies. On the basis that venous hypertension makes a major contribution to 
venous wall and valvular damage in the lower limbs, resulting in the classic signs of venous 
disease, skin changes and ulceration, factors likely to exacerbate raised venous pressure have 
been of particular interest.  The evidence for an association between increased body size 
(height, weight, BMI) and incidence of venous disease has been derived from large 
population-based studies where the subjects already exhibit overt venous disease to varying 
degrees. However, since the effects of venous hypertension must accrue over time before 
chronic disease is diagnosed, it is not yet known if changes in venous structure and function 
prior to this are also associated with body size and obesity. Aside from a large BMI and high 
levels of body fat, there is also evidence that fat specifically in the abdominal region could 
contribute to venous hypertension and disease particularly when in the sitting position through 
mechanical compression in the abdominal compartment and restriction of venous return. In 
addition high body fat levels might be associated with hormonal changes that affect the vein 
wall.  
The aim of the work presented in this thesis was to observe a normal middle-aged healthy 
female population and determine if risk factors previously identified have any association 
with venous properties in the absence of venous disease. Using a combination of ultrasound 
imaging and plethysmographic techniques, specific measures were made of lower limb 
venous function to ascertain the impact of a sitting position on FV size and flow, calf venous 
volume, and GSV and popliteal vein size and compliance. These were related to indices of 
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body size and composition, and to descriptive measures of abdominal obesity so that 
associations could be determined. The study comprised relatively small numbers of 
volunteers, which reduced the power of statistical comparisons. The key findings summarised 
below must take this into account before conclusions can be drawn: 
• A new measure of abdominal adiposity when seated, the SA/SP ratio, was devised to 
assess mechanical impediment to venous return from the legs. It correlated well with 
BMI, the most common proxy for human body fat, and with other measures of 
subcutaneous abdominal fat (SAD, ultrasound thickness) but less well with % truncal 
fat by DEXA scan. Since the latter includes visceral as well as subcutaneous fat, 
SA/SP more closely reflects the presence of subcutaneous as opposed to visceral 
abdominal adipose tissue.  
• In the sitting position, the size of the distended FV was positively associated with 
increasing obesity, described by BMI. Furthermore, the greater the measure of 
abdominal fat, the larger the increase in FV size and the bigger the reduction in vein 
flow velocity when sitting.  FV distension on sitting also correlated with thigh and calf 
cross sectional areas and this relationship was dependent on the presence of 
subcutaneous fat. 
• Inguinal tissue pressure on sitting also increased to higher values as abdominal 
adiposity increased. There was no evidence, however, that this presented impediment 
to femoral venous outflow because the increase in vein size compensated for the 
reduced velocity such that volume flow was not affected. The increase in thigh tissue 
hardness on sitting was also unrelated to body size or abdominal fat levels in this 
small sample size. 
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• Lower leg filled venous capacity determined by calf plethysmography – a surrogate 
measure of venous vascular volume – and popliteal vein size measured by ultrasound 
were not related to BMI, abdominal adiposity or leg size. However, the cross sectional 
area of the GSV was significantly positively correlated with all three measures of body 
composition.   
• The compliance of the popliteal vein showed no significant differences when 
compared against measures of BMI and abdominal obesity although there was a 
tendency for it to be raised in obese individuals. GSV compliance, on the other hand, 
did show significant correlation with measures of abdominal adiposity and body size 
but the sample size was too small to detect differences between BMI classes. These 
data suggest that there may be some changes to vein wall elasticity in obesity that are 
consistent with alterations in wall structure allowing for greater dilitation.  
• In contrast, compliance of the calf venous circulation was not associated with BMI or 
the presence of abdominal fat indicating possible heterogeneity of changes in large 
versus smaller vessels or results from differing testing methodology.  
• Contrary to expectation, there was no association between lower leg venous 
distensibility and circulating levels of oestrogen or progesterone or with duration of 
oral contraceptive use. Neither was it associated with the number of full term 
pregnancies in the female volunteers studied or with body weight history, possibly 
reflecting paucity of data collection in this area.  
• Physical activity assessed by recall questionnaire showed no correlation to obesity or 
to the measures of venous function taken in the study.  
• Metabolic status as assessed by HOMA2 index did not correlate with an increase in 
leg vein size on positional movement. No relationship was noted with venous 
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compliance or calf venous capacity. Positive significant association were noted 
between increasing abdominal adiposity, increasing body size and with higher calf 
blood flow, the latter most likely due to elevated insulin levels in the obese 
individuals.  
 
4.1 STUDY POPULATION 
Since the EVS (Evans et al. 1999) identified incidence of venous disease to be more prevalent 
in those aged greater than 55 (men 25.3% and women 12.3%) than under 55 (men 2.5-7.7% 
and women 3.8-7.9%), this study aimed to investigate healthy men and women aged between 
30-50 years without venous disease. The choice of a healthy population was so that the impact 
of abdominal obesity per se on leg venous haemodynamics could be examined before the 
pathological changes known to occur in the diseased vein wall are established. Since the 
completion of work in this thesis, two new studies have confirmed an obstructive effect of 
abdominal obesity on femoral vein flow in healthy individuals (Willenberg et al. 2010, 2011).  
Despite the perception that women are more prone to venous disease than men, the EVS 
reported a higher incidence of clinical disease in men as shown above. During subject 
recruitment for the current study, it became apparent that far fewer men were volunteering for 
screening (6 males and 54 females). The reason for this was most likely the method of 
recruitment, which involved travelling to slimming clubs, advertisement on the intranet of 
UHB, and recruitment from the hospital wards/theatre staff. With such small numbers of 
males there was a lack of statistical power to make any association within this group and it 
was therefore decided to analyse only the population of 26 females. 
The numbers required for the study in normal weight, overweight and obese BMI categories 
were based on power calculations using published data on femoral vein flow velocity (Fromy 
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et al. 1997) and with totals of 7, 9 and 10 in these groups, fell well short of the estimated 30 
per group. Accordingly, the study did not reach sufficient power for statistically significant 
results to be detected.  
 
For the 26 women included in the final analysis, CEAP classification was 0 for 54% and 1 for 
46% of the volunteers. These values are lower than the level expected for the age range as 
reported in the EVS for the prevalence of varicose veins in a similar population (see data in 
paragraph above) but the recruitment information did stress that volunteers were needed who 
did not have varicose veins or known venous disease. With this low incidence of venous 
symptoms, the study population can be classified as essentially healthy and free from venous 
disease. The exclusion criteria applied by history-taking and bedside testing prevented entry 
into the study of volunteers with co-morbidities (known to the volunteer or identified) likely 
to affect the venous and vascular function. The fact that all blood tests performed in the study 
reported values within laboratory normal limits reinforces the study population as healthy. 
BMI ranged from 21 to 47 across all three BMI matched groups (7 normal, 9 overweight, 10 
obese). Biggest variation in BMI was in the obese group, as shown by the standard deviation, 
mainly due to one individual of very high BMI. Even without this subject, the BMI categories 
were statistically distinguishable so as to enable comparisons between them. 
Since the study population was entirely female and pre-menopausal, hormonal status and 
parity had to be considered as possible influences on venous function. Raised oestrogen and 
progesterone during the menstrual cycle, OCP use or pregnancy have been shown to increase 
venous distensibility (Goodrich & Wood 1966, Barwin & Roddie, 1976, Walter & Sheilds, 
1977, Edouard et al. 1998). In order to control for this, all measurements were made during 
the menstrual phase of the normal cycle, which corresponds to the time of lowest levels of 
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endogenous hormones (Hirshoren et al. 2002), and to the ‘withdrawal phase’ of OCP use 
when serum concentrations of the active ingredients ethinyloestradiol and levonorgestrel are 
also lowest (Endrikat et al. 2002).  Plasma levels of oestrogen and progesterone in the study 
population were within the normal ranges for this period of the menstrual cycle with no 
differences between BMI groups. The relationship between female hormonal status and 
venous compliance is more complicated with no effect of menstrual cycle or OCP use on 
lower leg compliance (Meendering et al. 2005) but an increased venous tone together with 
decreased compliance identified in rats with multiple pregnancies (Dhawan et al. 2005).  The 
incidence of varicose veins has been associated with the number of full-term pregnancies 
(Jukkola et al. 2006) but the current study population displayed no differences between the 
BMI classes for the number of pregnancies or the length of use of the OCP even though the 
latter covered a large range from 3-240 months. Overall, it can be concluded that the 
participants in the study were comparable with regard to hormonal status. 
Physical activity levels were assessed using the Stanford 7 day Physical Activity Recall 
Questionnaire (Washburn et al. 2003). The validity of self-report for assessment of energy 
expenditure has been debated by Westerterp et al. (2008), with questionnaires showing 
relatively low agreement with the gold-standard doubly labeled water method. However, 
Westerterp stated that recall questionnaires are reliable when compared against each other and 
across various weight ranges and are therefore suitable as an activity-ranking instrument for 
group comparisons. Daily energy expenditure – around 1800 kcal/day – was slightly lower 
than levels reported for moderately overweight young women (2633 kcal/day; Washburn et al. 
2003) but higher than in obese women before they undertook a weight loss program (1145 
kcal/day; Racette et al. 1995). Such variation is due in part to the need for aggressive follow-
up and persistent questioning in order to gain an accurate picture of the physical activity 
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levels in all recall studies. There were, however, no differences noted between the levels of 
physical activity among the BMI groups in the current study and hence this was not a 
confounding factor in group comparisons. 
With respect to metabolic status, glucose levels in the study population fell within the normal 
fasting range (4-6.8mmol/l) as recommended by Diabetes UK and although there was an 
increase across the BMI groups this was not significant. Fasting plasma insulin levels in the 
study population also lay within the range described in the literature (Vogeser et al. 2007). 
Insulin resistance status (IR) used to be determined by HOMA1 model calculation but more 
recently has been redefined by the HOMA2 (Levy et al. 1998) as this shows better correlation 
to gold-standard physiological tests of insulin sensitivity and β-cell function i.e. glycaemic 
clamp or fasting glucose testing. The calculated HOMA2 levels in the current study are 
reflective of normal ranges for a healthy population based on published values 
(Stepniakowski & Egan 1995, Vogeser et al. 2007) and the online calculator as described in 
methods section 2.2.5. A recent article by Geloneze et al. (2009) on a Brazilian study 
(BRAMS) reported a cut-off point for defining insulin resistance at a HOMA2 value of >1.8 
in healthy individuals. In the present study higher values of HOMA2 were correlated with 
increasing BMI, and with a mean of 1.8 in the obese group, this may be reflective of early 
stage insulin resistance in these individuals. The increase across the range of BMI was felt to 
suggest a possible difference across the study population. It was felt that analysis in the study 
was warranted and not just used as an establishment of volunteer normality. 
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4.2 ESTABLISHMENT OF THE DISTRIBUTION OF ABDOMINAL ADIPOSITY. 
Obesity is a relatively permanent characteristic as described by Seidell et al. (1986). BMI is a 
universal measure of overall body fat applicable to adults but there are other methods which 
specifically evaluate fat distribution in the abdominal region. Of these, the SAD is a measure 
of ‘supine abdominal height’ that reflects obesity. It has been shown to predict insulin 
resistance and cardiovascular mortality (Després et al. 2007) with better precision than 
computed tomography (CT) of abdominal compartment fat (Guzzaloni et al. 2009). SAD 
measures also correlate with regional-specific DEXA scanning of fat (Bertin et al. 2000) 
whereas waist-hip ratio shows least agreement with a criterion measure of total abdominal fat 
by CT (Clasey et al. 1999). This is borne out by the present data which showed distinction 
between BMI groups in SAD and % truncal fat (DEXA) but not W-H ratio. The measurement 
of abdominal adiposity is important as previously research has demonstrated that this can be 
linked to an increase risk of hypertension, cardiovascular disease and the development of non-
insulin dependent diabetes, reviewed by Haffner (2007). 
Although SAD and % truncal fat agreed well with BMI in the study population, both these 
indices of abdominal fat were measured in the supine position and therefore do not indicate 
the effects of abdominal adiposity in presenting mechanical obstruction to venous outflow 
from the legs in a sitting position. To address this, a novel method of assessing abdominal 
adiposity was devised, namely the sacro-abdominal/sacro-popliteal (SA/SP) index. This 
specifically set out to evaluate the degree of ‘overhang’ of abdominal fat along the legs in the 
seated position. SA/SP values showed good correlation with BMI, SAD and % truncal fat, 
supporting the notion that the new seated index defines abdominal obesity as such. This is 
confirmed because the correlation of SA/SP with BMI was only through weight, not height, 
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and SA/SP was unrelated to W-H ratio, which incorporates hip size that does not contribute to 
the former.  
While the SA/SP index was derived to assess abdominal fat that might contribute to 
mechanical impairment of venous return from the lower leg, adiposity in the abdominal 
region is not confined to the subcutaneous compartment. There is also a significant amount of 
intra-abdominal visceral fat (Snijder et al. 2006) that could also play a role in obstruction of 
venous flow. To separate out these two compartments, ultrasound imaging of abdominal 
subcutaneous fat thickness was undertaken, and values correlated highly with SAD and 
SA/SP index, which both detect subcutaneous abdominal wall adiposity albeit in supine and 
seated positions respectively. Association with % truncal fat was less good, consistent with 
the fact that the latter includes both subcutaneous and visceral fat. The ultrasound abdominal 
thicknesses determined in the present female study population were larger than those reported 
for women of similar age by Murakami et al. (1997) (26.8 mm compared to 21.1 mm); 
however, their population was of a smaller BMI range (21.8 - 23.25 kg/m2) than group of the 
same age.  
To validate the ultrasound method for this study, abdominal thickness was compared against 
measurements obtained using the traditional skinfold caliper technique. Values correlated 
highly, as shown in other studies (Black et al. 1988, Demura & Sato, 2007). There was, 
however, a persistently lower reading (by 0.63 cm) for ultrasound than calipers, a systematic 
error that has been noted previously in abdominal (Demura & Sato 2007) and calf (Weits et 
al. 1986) fat measurements. This occurs possibly because imaging measures thickness at a 
single plane through the tissue whereas the skinfold encompasses a greater tissue sample area, 
averaging out regional variations. Studies have reported closer agreement between caliper 
measurements with the criterion measure computed tomography (CT) than ultrasound, 
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particularly at the abdominal region (Orphanidou et al. 1994, Stevens-Simon et al. 2001, 
Gradmark et al. 2010). Despite this, ultrasound values were better able than calipers to predict 
body density in a population of young men (Weits et al. 1986), and there was no evidence 
from Bland-Altman analysis in the present study that the systematic error in abdominal fat 
thickness was altered in obesity. 
To further validate ultrasound against calipers and provide information on peripheral limb 
obesity, subcutaneous fat thicknesses at the thigh and calf were recorded using both methods. 
These are not the classical measuring points over which skin calipers are used i.e. triceps or 
lower end of scapulae. Over the legs, the tissue is not as lax as the points above and it was 
anticipated that the calipers would have difficulty obtaining accurate readings as they require 
a “good” pinch of skin in order for readings to be made. Indeed, this was found to be the case 
as the difference between ultrasound and caliper values was greater for thigh and calf than for 
the abdomen, and became more pronounced with increasing tissue thickness consistent with 
the increase in skin tightness on moving from trunk to calf. In future the author expects 
opinion of Fomage et al. (1993) to be the norm; i.e. that high resolution ultrasound is used for 
assessment of subcutaneous tissue depth due to its ease of use and flexibility for use in all 
areas of the body and the contrary to CT does not involve radiation. 
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4.3 LEG VEIN SIZE AND CALF VENOUS CAPACITY IN RELATION TO BODY 
DIMENSION AND ADIPOSITY 
The maximum filled size of leg veins - femoral, popliteal and GSV - was determined by 
ultrasound, and calf venous vascular volume – capacity of entire venous circulation - by 
plethysmography in order to investigate their relationship to body size and composition.  
 
4.3.1 Vein Size 
Ultrasound imaging has become the technique of choice for investigation of large superficial 
and deep veins of the lower limb (Cavezzi et al. 2006). Diagnostic scanning of leg veins is 
normally carried out in the standing position since this allows for venous filling and 
observation of reflux if present. In the laboratory, many tests of venous characteristics are 
carried out supine, and under this condition veins do not necessarily have a circular profile 
due to incomplete filling. Studies examining vein size therefore adopt procedures that induce 
filling to maximum size, such as Valsalva’s manoeuvre or head-up or –down tilting. In this 
study the seated position was used when imaging the FV, and a venous congesting cuff for the 
popliteal, GSV and calf volume. Vein CSAs were calculated from intra luminal diameter 
measures. 
In the study population of healthy females aged 34-49 years, seated FV maximum diameters 
were slightly larger (mean 9.6 mm) than those reported for healthy volunteers of mixed 
gender and all ages by Jeanneret et al. (1999) (mean 7.3 mm during a Valsalva manoeuvre) 
but similar to those of Hertzberg et al. (1997) and Haenen et al. (1999) of 9.2 mm. Likewise, 
popliteal vein diameter (mean 9.3 mm) corresponded with that of De Groot et al. (2005), 
mean ~ 10 mm), both during venous congestion., with 8.9 mm measured during sitting by 
Haenen et al. (1999) and 8.8 mm during Valsalva manoeuvre by Hertzberg et al. (1999). The 
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GSV diameter (mean 3.8 mm) was also similar to that reported during sitting (mean 4.0 mm, 
Haenen et al. 1999) and standing (mean 3.2 mm, Seidel et al. 2005). These observations 
indicate that the protocol for measuring vein size, which involved careful control of the 
ultrasound probe angle to the vessel for optimal imaging, and the edge-detection VIA 
software that measured wall-to-wall distance, yielded appropriate data on the maximum filled 
diameter. The measurement locations were also standardized along the limb to minimize 
variations because vein size decreases by about 11 mm from the proximal common femoral to 
the distal tibial vessels (Haenen et al. 1999, Hertzberg et al. 1999). 
Maximal FV and GSV size in the present study correlated significantly with BMI across the 
three groups. An association between vein size and body dimensions has been described 
previously in normal weight healthy subjects (Mortensen et al. 1990) with bigger diameters of 
both FV and GSV when BMI was > 22.5 kg.m2 (Jeanneret at al. 1999). Kröger et al. (2003) 
also showed that FV and GSV CSA on standing were graded with BMI from slim (<20) to 
obese (>30) in a mixed age and gender group but with CEAP classification of zero. Even in 
patients of CEAP 5-6, FV diameters on standing were larger in those weighing > 90 kg (mean 
13.3 mm) than those weighing < 90 kg (mean 10.2 mm) (Van Rij et al. 2008). The scaling of 
vein size with BMI in the present study was through the effect of body weight because there 
was no correlation of FV or GSV CSA, either supine or seated, with height, and femoral size 
was unrelated to other indices of body size such as wrist or ankle circumference. By contrast, 
popliteal vein dimensions were not significantly associated with body size, although showing 
a slight tendency to increase with BMI. Moreover, whereas both FV and GSV showed 
correlation of their maximal size with leg size through thigh and calf CSA, there was no such 
correlation for the popliteal vein. Before considering the reasons for this difference, the 
impact of abdominal and peripheral obesity on vein size will be discussed.  
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It was hypothesized that fat in the abdominal region could impede venous outflow from the 
legs when seated by mechanical hindrance, and that this would cause greater distending 
pressure to be transmitted to the leg veins. A significant difference in FV CSA was noted in 
all BMI groups on moving from the supine to seated position. It increased 1.6-fold in normal 
BMI subjects, 1.9-fold in overweight, and 2.3-fold in obese individuals. All measures of 
abdominal adiposity (SA/SP, SAD, % truncal fat, ultrasound abdominal wall thickness) 
except W-H ratio (positive but not significant) demonstrated positive correlation with 
percentage change in the FV CSA. This does not, however, clarify whether larger vein size is 
related simply to body weight or specifically to ‘overhang’ and compression from abdominal 
adiposity. When standing, body weight is one of the main determinants of foot vein pressures 
(Kügler et al. 2001) and higher venous pressures were recorded on standing in obese (> 90 kg, 
110 mmHg) than normal weight (< 90 kg, 93 mmHg) individuals (Van Rij et al. 2008). 
Although in the latter study the majority of subjects already had CEAP class 5 disease, of 
interest is that foot vein pressure increased on moving from lying to sitting with a straight 
back, similar to the postural move employed in the present study, and that the increase was 
greater in the obese (68 mmHg) than in the normal weight subjects (59 mmHg). Moreover, 
when subjects were sitting but leaning forwards 45o, foot vein pressure increased a further 2 
mmHg in the normal weight subjects but by 8 mmHg in the obese (Van Rij et al. 2008). This 
implies that mechanical obstruction by abdominal fat when seated can present additional 
impediment to outflow and induce venous hypertension. A similar situation can be envisaged 
for the GSV since its maximal size was also correlated with SAD, SA/SP and ultrasound 
abdominal wall thickness but not % truncal fat or W-H ratio. Again, a contradictory finding 
was that there was no relationship between the size of the popliteal vein and measures of 
abdominal adiposity.  
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In seated posture, abdominal fat ‘overhang’ projects along the upper thigh, and the SA/SP 
index specifically estimated the extent of this. It is possible that peripheral adiposity in the 
thigh region also contributes to mechanical compression in this position and hence vein sizes 
were compared with leg dimensions and measures of peripheral fat. The FV CSA was 
correlated with thigh total size CSA and ultrasound fat thickness but not lean CSA. Greenleaf 
et al. (2004), in a review of the evidence for deep venous thrombosis in long haul 
flights/seated position, considered the evidence for thigh compression as a risk factor for limb 
swelling, decreased venous flow and alteration in lymphatic drainage. Pottier et al. (1969) 
showed that when only the posterior of the thigh was compressed that there was an increase in 
foot swelling compared to a normal rested dependent leg, and Olszewski et al. (1977) 
demonstrated decreased venous flow with thigh compression at level sufficient to induce 
lymphatic but not venous occlusion. They concluded that the presence of increased pressure 
on the back of the thigh while seated increases venous and lymphatic congestion and 
subsequently decreases lymphatic clearance of fluid filtrate, thus facilitating oedema. In the 
present study, the obese individuals had greater peripheral fat thickness in the thigh and it can 
be assumed that this contributes to additional compression and FV distension.  
In a similar way, the GSV maximum size was significantly correlated with calf and thigh total 
CSA and with calf and thigh ultrasound fat thickness. These measures were made during 
venous occlusion rather than the seated position but illustrate that the GSV, which is invested 
on the outside of the deep compartments of the leg, surrounded by a loose fascia (Caggiati et 
al. 1999), may also be distended more when there is a higher proportion of soft tissue in the 
calf. Again, the popliteal vein displayed different characteristics, being unrelated in size to 
calf or thigh total CSA or calf or thigh ultrasound fat thickness.  
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Why does the popliteal vein show no association with body size, leg size or abdominal 
adiposity whereas the FV and GSV do? It is unlikely to be because of the different methods 
used to induce maximum vein size. FV size was measured in the seated position allowing the 
hydrostatic pressure in the venous system to fill the FV from the level of the heart. This was 
acceptable as the position seated with legs straight out is comfortable for short periods. 
Popliteal vein and GSV size was measured during inflation of a thigh cuff to 50 mmHg in 
supine subjects. Christ et al. (1997) have shown that the cuff pressure is transmitted to the 
deep venous system and under ultrasound, it could be clearly seen that there was no flow in 
GSV once the cuff was applied and minimal or static flow in the popliteal vein. Although 
measurement conditions were different for the FV and GSV, they were both dependent on 
body dimensions while the popliteal was not.  
Other reasons may lie in the anatomical and haemodynamic connections between the GSV, 
FV and popliteal vein. The popliteal vein lies deep in the popliteal fossa behind the knee joint 
and is the confluence of the venae committantes of the anterior and posterior tibial veins and 
receives venous return from the calf muscle pump via the sural veins (Browse et al. 1998). It 
lies deep to the artery between the two heads of the gastrocnemius muscle which, in 
combination, offer it structural support. The GSV, as already stated, lies superficially and is 
far more easily compressible. One of the ways of identifying this vein for ultrasound imaging 
is a compression test – light pressure exerted with the transducer probe – which squashes the 
vein profile to a more elliptical shape whereas arterial vessel profiles are unchanged (Bérczi et 
al. 2005).  
According to Recek, (2000), the normal direction of flow within the calf during ambulatory 
muscular contraction is from the superficial system (GSV) to the deep (popliteal in this case) 
veins. In the standing position, pressure in the popliteal vein was equal (80-100mmHg) to that 
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of the hydrostatic pressure due to gravity. On activation of the calf muscle pump, pressure in 
the superficial system fell by nearly 40 mmHg while popliteal vein pressure remained 
constant. This would suggest that the popliteal vein is under longer periods of sustained high 
pressure in the upright posture while the GSV experiences fluctuating levels. Chronic 
exposure to high pressure e.g. during arterial grafting induces significant structural 
remodelling of the GSV (Loesch & Dashwood, 2009,  Monos et al. 1995) but the popliteal 
vein wall seems less susceptible to pressure, in keeping with its resistance to aneurysms 
(Roche-Nagle et al. 2009). There are no data, to the best of the author’s knowledge, that 
describe the exact histology of the popliteal vein compared to other segments but it is possible 
that it acts purely as a large conduit. In support of this, it does not respond to interventions 
that evoke sympathoexcitation (Young et al. 2008, Phillips, 2010) indicating a lack of 
innervation and ability to regulate vascular tone.  
The FV, on the other hand, is a proximal continuation of the popliteal vein and shows the 
same maintenance of pressure during ambulation as the latter while the superficial lower leg 
vein pressure lowers because of the muscle pump (Recek, 2000). However, it will also be 
subject to any mechanical forces arising because of abdominal and / or thigh-related pressures 
which the popliteal vein does not experience. Whether this may or may not explain why the 
femoral but not popliteal vein is related to body dimensions will be explored further in a 
subsequent section. The presence of female hormones or metabolic status cannot explain the 
disparity between the different veins because circulating factors would impact on all vessels. 
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4.3.2 Venous Capacity 
With regard to calf venous capacity, plethysmography has been the modality of choice for the 
investigation of vascular function in the limbs due to its wide availability. Venous capacity of 
the whole limb is the volume of arterial inflow which is required to fill all the venous vessels, 
estimated from red cell scintography as 10% of total calf volume (Vissing & Nielsen, 1988). 
The study demonstrated values of 2.39 ml/100ml venous filling at 120 seconds similar to 
those reported for the calf by Lindenberger et al. (2007) (2.24ml/100ml) and Monahan et al. 
(2001) (3.0ml/100ml). Although the latter data were obtained in young women while the 
present study group were approximately 40 years old, there is no decrease in capacity with 
age in females (Lindenberger & Länne, 2007), and values are therefore as expected.  
For the present study, despite the wide range of body size, there was no association of calf 
venous capacity with BMI. Venous capacity was also unrelated to any measure of abdominal 
adiposity. It has been reported previously that venous capacity was lower in the obese forearm 
than in normal weight healthy individuals (Stepniakowski & Egan, 1995) but Ianuzzi et al. 
(2002) found no association between calf venous volume and BMI in post-menopausal 
women even though some of them had overt venous disease. Of the calf filled venous volume, 
only 30 % is due to filling of the major large superficial and deep veins (Cirovic et al. 2006), 
the rest residing in small veins and venules.  Therefore while large veins such as the GSV are 
scaled in size to body dimensions, it appears that the rest of the venous circulation is not.  
Monahan et al. (2004) demonstrated that men with larger calf volumes have a greater venous 
capacity than women, suggesting an anatomical effect of calf size. However, calf venous 
capacity did not relate to leg size (calf total or lean CSA or ultrasound fat thickness). The 
proportions of skin and subcutaneous fat in the calf, based on the calculated lean and total calf 
CSA, were 43% and 41% in normal weight and overweight groups, but 51% in the obese 
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group. Although there are differences in the vascularity of these soft tissue components (skin, 
fat, skeletal muscle) (Elia & Kurpad, 1993) the variation in proportions does not affect venous 
capacity. 
The time taken for venous filling is debated in the literature but is dependent on the venous 
volume to be filled and the rate of arterial inflow (Hollenberg et al. 1972). Brown et al. (1966) 
found disparate rates of individual vein filling in the forearm but noted that 120 seconds was 
sufficient to allow venous circulation to reach capacity under normal conditions, and 
Halliwell et al. (1999) estimated filling time for the calf also as 120 seconds. This was the 
time point used in the present study to measure venous capacity. There was a significant 
positive correlation between BMI and resting calf blood flow, and increasing limb blood flow 
by heating has been shown to increase the rate of limb volume expansion on venous occlusion 
(Brown et al. 1966, Jorfeldt et al 2003). Even if blood flow and hence venous filling were 
more rapid in the obese group, a greater blood flow into a greater limb volume gives an 
equivalent increase in percentage volume – the units of plethysmographic measurements - to a 
smaller flow into a smaller limb, and this may account for the similar venous capacities of all 
BMI groups.  
There is a considerable body of evidence demonstrating that filled venous volume in the limbs 
is greater under the influence of female hormones, oestrogen in particular. For example, 
Goodrich et al. (1966) demonstrated an increase in venous distensibility with administration 
of exogenous oestrogen, with oral contraceptive use and during pregnancy. The present study 
found no association between venous capacity and blood oestrogen levels but this may be 
because it was designed to minimize variations in oestrogen by testing in the menstrual phase 
of the cycle and correlation was hence performed over a limited range of values. However, a 
lack of effect of female hormones is also supported by non-significant correlations of capacity 
 155
with OCP use or number of pregnancies. Ciardullo et al. (2000) observed greater calf venous 
volume to be associated positively with oestrogen levels in post-menopausal women but both 
parameters were also correlated with the incidence of varicose veins and it is thus not possible 
to determine cause or effect from this study. The current finding suggests that prior to the 
development of venous disease, there is no evidence that oestrogen exposure increases calf 
venous distensibility. A very similar conclusion was drawn for young healthy women by 
Meendering et al. (2005). 
Physical activity levels can also increase venous capacity. Boutcher & Boutcher, (2005) 
demonstrated larger calf venous capacity in trained athletes than untrained volunteers. In the 
present study, there was no relationship between daily physical activity derived from the 7 
day recall questionnaire and capacity, but the study was not intended to recruit highly trained 
individuals and the overall low activity levels of the subject cohort may explain why no effect 
was observed. 
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4.4. LOWER LEG VEIN AND CALF VENOUS COMPLIANCE IN RELATION TO 
BODY DIMENSIONS AND ADIPOSITY 
As explained in the Introduction, venous compliance defines the relationship between applied 
pressure and either individual vein size or limb venous volume. Whilst this can be derived 
during venous filling to indicate distensibility, the measurement of compliance during 
emptying of a distended full limb/vein in small pressure steps by a controlled deflation 
protocol allows for the more accurate assessment of the elastic passive recoil properties of the 
vein without the effects of hysteresis. These can be related to vein wall structure and the 
balance of the major structural proteins elastin and collagen and smooth muscle tone (Risk et 
al 2003). Risk mapped an initial rapid filling of the vein under the influence of elastic 
properties (elastin) when small pressure increases causes large volume changes. This gives 
way to a slower period of filling beyond a break point when the pressure in the lumen is 
stretching against the structural proteins (collagen).  Understanding the relationship between 
the two phases enable the investigator to understand balance of the structural proteins that 
make up the venous wall. 
 
4.4.1 Calf Venous Compliance 
The compliance of the whole calf will be discussed first as there are far more published data 
using the same protocol with which to compare the present findings. Compared to data 
reported by Halliwill et al. (1999) obtained in young men, the slopes of the calf compliance – 
pressure relationship of the normal weight group were slightly flatter (slope -0.0013 vs. -
0.00204 ml/100ml/mmHg), i.e. compliance was lower especially in the lower pressure range. 
This may be partly a gender difference because Meendering et al. (2005) found lower 
compliance slopes in young women than men, and partly due to age difference because 
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Young et al. (2006) showed lower calf compliance in old than young subjects. In relation to 
body size, however, no significant difference in calf compliance was found in the present 
study between the three BMI groups and no correlation observed with any other measure of 
body size (height, weight, ankle size) or calf size (total or lean). Convertino et al. (1988) 
reported an inverse relationship between calf compliance and calf cross-sectional area based 
on computed tomography, suggesting that a large muscle mass would provide structural 
limitation to expansion of the venous circulation. However, that study measured compliance 
during venous filling rather than emptying and would therefore be subject to variation because 
of delayed hysteresis. Moreover, subjects were all men who have a greater proportion of 
muscle than subcutaneous tissue in the calf than women (Abe et al. 2003). 
Calf compliance was also not significantly correlated to the recorded measures of obesity, 
abdominal or peripheral, or any other factors examined in the study such as female hormones, 
physical activity levels or metabolic status. Based on plethysmography, there is therefore no 
evidence for any structural changes in venous properties in relation to obesity that could be 
taken as indication of subsequent venous disease. It is not surprising that compliance was 
unrelated to oestrogen levels. Meendering et al. (2005) also found no effect of menstrual cycle 
phase or OCP use on calf compliance. Dhawan et al. (2005) demonstrated decreased venous 
compliance with multiple pregnancies in the splanchnic circulation of multiparous rats but 
this is difficult to extrapolate to human limbs.  Hernandez & Franke, (2004) found higher calf 
compliance in fitter individuals irrespective of age but the present study population showed 
no difference in levels of physical activity. There was no association of compliance with 
measures of insulin resistance. Bell et al. 1988 showed a decrease in venous compliance in 
diabetes of duration greater than 15 years but used different assessment from the deflation 
protocol used in this study.   
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4.4.2 Vein Compliance 
Previously published data on the compliance of the popliteal and GSV is limited and it is only 
relatively recently that attempts have been made to measure compliance of individual veins 
using ultrasound. De Groot et al. (2005) used CSA of the popliteal vein to derive compliance-
pressure plots based on quadratic regression coefficients from the original diameter-pressure 
curves during deflation. This correlated with whole calf plethysmographic compliance in 
healthy and spinal cord-inured subjects. Young et al. (2008), on the other hand, reported that 
popliteal vein compliance was higher than, and did not agree with, calf compliance in young 
healthy individuals. Popliteal compliance-pressure plots for the normal weight group in the 
present study (Figure 3.20) are similar to those shown by Young et al. (2008) with slopes of -
0.0021 and -0.0017 respectively. For the whole study population, popliteal compliance did not 
correlate with whole calf compliance (ρ = 0.31, p=0.36) and there was no significant 
difference between the BMI groups. However, comparison of the plots which are based on 
group mean values does indicate differences related to body size. The overweight group had a 
similar slope (-0.0018) to normal weight albeit shifted slightly downward indicating a lower 
compliance over the whole pressure range. The obese group plot was completely flat 
demonstrating lower compliance at low pressures and a lack of decrease in compliance as 
pressure increased, such as would be seen in an infinitely elastic tube.  
The author has been unable to locate any previously published data on GSV compliance 
measured using a comparable deflation protocol using ultrasound. In patients with venous 
disease Zamboni et al. (1998) compared GSV compliance based on diameter versus pressure 
plots during postural changes (lying, sitting, standing) with that of vein segments in vitro after 
stripping. They were able to show that compliance in vivo reduced in relation to severity of 
CEAP classification, but there are no data from deflation protocols. In the present normal 
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weight group, GSV compliance slopes (Figure 3.21) were similar to those of the popliteal 
vein and again were unrelated to whole calf compliance. Although not quite significant 
between the three BMI groups, it is clear from Figure 3.21 that GSV compliance does alter 
with increasing body size, showing the same flattening of slope in the overweight and obese 
group as the popliteal vein. Overall, GSV compliance showed a significant negative 
correlation with BMI, abdominal adiposity and calf size (total and lean CSA), but not calf fat 
thickness.  It is difficult to say if calf muscle plays a significant role in GSV compliance as 
the absence of correlation with calf adiposity means interpretation of the remaining tissues is 
relying on muscle and non-reactive substances. 
These changes in individual leg vein passive elastic recoil are notable given that the study 
group displayed no overt signs of any venous disease. Risk et al. (2003) pointed out that 
compliance at low pressures is more dependent on elastin and SMC components of a vessel 
wall while at high pressures, it is determined by collagen content. Reduced venous 
compliance is recognized as a consequence of established disease such as varicose veins, and 
the post-thrombotic state (Neglén & Raju, 1995, Molnár et al. 2006). Both elastin and 
collagen III have been noted to decrease in VV and old age (Venturi et al. 1996, Sansilvestri-
Morel et al. 2001) accompanied by an increase in the structural elements of the vein wall 
provided by collagen I (Sansilvestri-Morel et al. 2001, Gandhi et al. 1993) and 
disorganization of the structure of the internal and external architecture of the initimal smooth 
muscle cells (Venturi et al. 1996). The decreasing compliance of the GSV and popliteal vein 
in this study suggests that similar changes in the vein wall may already be taking place in this 
asymptomatic obese group, supported by the increase in vein size during maximum 
distension. This would suggest that the forces or process that has caused the increase of 
diameter is the same as those causing a decrease in compliance.   
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Without histological evidence, it is not possible to say which wall elements are most affected. 
It is also not possible to determine what causes the changes which were associated with body 
dimensions in one case (GSV) but not in the other (popliteal). The only additional factor that 
showed a borderline significant relationship to popliteal compliance was the HOMA2 index. 
This could be explained by the increase in blood flow noted with increasing BMI discussed 
later as the popliteal vein acts only as a passive conduit to the transfer of blood from the limb. 
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4.5. EFFECT OF ABDOMINAL ADIPOSITY ON VENOUS OUTFLOW FROM THE 
LEG 
In Section 4.3 above, it was established that FV CSA was similar in the three BMI groups 
when supine but CSA increased significantly in each group on moving to the seated position 
with legs straight out. The extent of change was highest in the obese > overweight > normal 
weight group and if it is assumed that the hydrostatic pressure at the inguinal region from the 
postural change was similar between groups because standing heights were the same, greater 
vein size with obesity could be due to i) impedance to outflow due to abdominal fat causing 
the vein to dilate as an adaptive change, ii) additive compressive effects of thigh tissue, or iii) 
greater inflow into the vein.  To investigate the first of these, the effects of the seated position 
on inguinal tissue pressure, FV flow, and thigh tissue hardness were studied.  
 
4.5.1 Inguinal Tissue Pressure 
One aim of the study was to determine if the ‘overhang’ generated by abdominal adiposity 
when seated could be demonstrated to have an effect on the subcutaneous tissue pressure 
measured in the groin through which the venous and lymphatic drainage must pass. Accurate 
measurement of interstitial fluid pressure is technically difficult. Guyton et al. (1971) 
described a method, which involved the placement of a perforated capsule in the 
subcutaneous tissue of the leg which could fill with fluid over time and found pressures of 
approximately -6mmHg. Christenson et al. (1986) used needle manometry to measure 
subcutaneous and intramuscular pressures in normal and post-phlebitic limbs (showing an 
increase in pressure in phlebitic limbs) with pressure ranging from -2 to +4 mmHg in the 
supine position. It has also been used clinically to measure pressures in the intramuscular 
compartments in patients suspected of compartment syndrome. Olsen et al. (1998) reported 
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normal resting intramuscular pressures of approximately 5-9 mmHg and stated that this 
combined fluid and solid tissue pressure. The manometer technique was preferred over 
Guyton’s capsule method as it would allow for immediate measurement of change in pressure 
in real-time. To the author’s knowledge, this method has not been applied to the inguinal 
region before.  
Baseline values recorded in the supine position (approximately 5-10 mmHg) were stable over 
several minutes in either supine or seated position and were nearly always positive. This may 
be related to the use of a simple needle rather than a slit-catheter. For example, Moed et al. 
(1993) reported that the simple needle gave a consistently higher pressure by 18 mmHg in the 
antero-lateral compartment of the dog hind-limb than a slit catheter or side-ported needle. 
There is approximately 18 mmHg difference between the resting pressures obtained in this 
study and the -6mmHg described in Guyton’s method, suggesting a similar effect. Although 
in absolute terms these values may be over-stated, their consistency over time, demonstrated 
by a coefficient of variation of 6.5% on supine pressures and 11.1% on seated pressures 
during 5 repeated trials for normal weight subjects lends credibility to their use for 
demonstrating relative changes on change in posture.  
A significant change of approximately 8 mmHg that stabilised within 1 min of moving from 
supine to sitting was observed but only in the obese subjects. There were no pressure 
differences between the BMI groups when supine, but the changes in pressure on sitting were 
significantly correlated with BMI and the measures of subcutaneous abdominal fat 
contributing to seated ‘overhang’ (SAD, SA/SP, ultrasound thickness) but not % truncal fat 
which includes visceral fat. It appears that a SAD of > 22 cm or a SA/SP of 0.5, the minimum 
values for the obese group, are required before raised inguinal tissue pressure on sitting is 
evident. Despite this relationship, there was only a weak positive but non significant 
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correlation between the increase in pressure when seated and the increase in size of the FV. 
This was contrary to expectation and suggests other factors may be involved.  
The needle for measuring pressure was carefully placed in the femoral triangle next to the FV 
under ultrasound guidance. This does not, however, enable determination of intra-abdominal 
pressures which are more commonly measured using a bladder catheter (Malbrain, 2004). The 
hypothesis that abdominal adiposity causes a raise in intra-abdominal pressure was put 
forward by Sugerman et al. (1997) and Cobb et al. (2005) and Arfvidsson et al. (2005) showed 
that morbidly obese patients with elevated intra-abdominal pressure also had raised ileo-
femoral pressures. There is no information on whether inguinal tissue pressure matches intra-
abdominal pressure. However, consistent with the present study, intra-abdominal pressures 
have been reported to be positive and higher in obese (8-14 mmHg) than normal weight 
individual (5-7 mmHg) and to be increased on moving from supine to a head-elevated 
position (Cheatham et al. 2009). It is likely, therefore, that the obese subjects in the current 
work experienced raised intra-abdominal as well as inguinal pressure, which may have 
contributed to the larger vein size.  
 
4.5.2 Femoral Vein Flow 
What is the likely impact of abdominal adiposity and raised inguinal tissue pressure on 
venous outflow from the lower limbs? To investigate potential impedance, FV flow was 
derived from flow velocity and vein diameter supine and seated, and during calf compression. 
Supine femoral velocities were lower (7.5 cm/s) than those reported by others - 13 cm/s in 
healthy men and women (Fromy et al. 1997), 14.6 cm/s in females (Fronek et al. 2001), 37.3 
cm/s in healthy supine men and women of all ages (Ashby et al. 1995). This may be due to 
differences in the manner in which the readings were taken. The present study recorded 
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average velocity over 15 cardiac cycles determined by ECG and derived from the internal 
software of the Envisor ultrasound machine. Fromy et al. (1997), on the other hand, took 
average peak velocity only during an 8 second period while other papers do not give details of 
measurement period. It is important to collect data over a sufficient time period to take 
account of cardiac rhythm since Abu-Yousef et al. (1997) showed variation in femoral 
velocity of -1.8 to 12 cm/s between diastolic and systolic phases. Also respiration changes 
femoral velocity with a 53% increase during deep regular breathing (Kwon et al. 2003) and 
variations in the proportion of flow occurring during inspiration from 65% to -11% depending 
on the type of respiration (Miller et al. 2005). Calculated femoral volume flow values (152-
212ml/min) were also considerably lower than published in the data e.g. 864ml/min (Fromy et 
al. 1997), 800 ml/min (Miller et al. 2005) but the latter were measured at the common FV, not 
in the femoral triangle as in the present study. However, on the basis that arterial inflow and 
venous outflow to the leg should be comparable, the current vein flows are in keeping with 
superficial femoral artery flow measured by Thijssen et al. (2008) as 184ml/min in healthy 
young men.  
It was found that there was no significant change in volume flow in the FV when moving 
from the supine to seated position because vein diameter had increased and velocity 
decreased. All three BMI groups showed the same effects. There was also no correlation with 
abdominal adiposity measures or inguinal tissue pressure and it therefore appears that, despite 
fat ‘overhang’ and raised inguinal tissue pressure, there was no evidence of impedance to leg 
venous outflow. However, this was achieved through greater distension of the FV in the obese 
than overweight than normal weight groups which implies greater pressure to distend because 
of abdominal fat, consistent with the findings of Van Rij et al. (2008) of higher leg vein 
pressures with obesity in seated patients with venous disease. A larger vein size as a result of 
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adaptation over time to higher pressures coupled with similar volume flows as in normal sized 
veins leads to a greater venous reservoir in the limbs which may itself cause problems by 
allowing stagnation and stasis..  
An additional test of potential femoral flow was made by recording peak flow velocity during 
calf compression with a cuff inflated briefly to 80mmHg. Peak velocities when supine (~ 120 
cm/s) were similar to those found by Delis et al. 2000 when they applied clinical compression 
devices to the lower leg (120cm/s). They increased significantly on sitting in all BMI groups 
to a similar extent, and as with resting femoral flow, there was no relationship to abdominal 
adiposity, inguinal tissue pressure or leg size.  
Supine position equates to an underfilled venous system as resistance to outflow is reduced 
(removal of hydrostatic pressure). The veins at this point have the ability to absorb sharp rises 
in venous pressure or flow by distension. The ability to distend means that mechanical force 
given by the cuff to generate the peak flow is not only being seen in increased flow of blood 
but also in the venous distension. In the seated position the veins are filled. The amount of 
distensibility in the veins is now reduced. When mechanical force is applied this will be 
converted more into flow than into venous distensibility. An increase in flow was noted on 
moving from supine and seated in the peak flow and this may reflect this description.  
 
4.5.3 Lower Limb Tissue Durometry  
Increased pressure in the groin may not be sufficient to have an increased effect over and 
above that of intra-abdominal pressure on venous flow but may be sufficient to disrupt the 
flow of lymphatic fluid from the limb (Guyton et al. 1971). Intra-abdominal hypertension has 
indeed been associated with impedance to lymph flow in intensive care patients on positive 
pressure ventilation. (Malbrain et al. 2007). With impedance of lymphatic outflow, the limb 
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would be in a persistent state of lymphatic congestion akin to lymphoedema. This would have 
the long term consequences to the tissues of the complications seen in lymphatic disease 
(eczema, haemosiderin deposit, lipodermatosclerosis and ulceration). Durometry as an 
assessment tool is in its infancy and has initially been used by Falanga et al. (1993) and 
Romanelli et al. (1995) to evaluate skin hardness in systemic sclerosis and venous disease. 
Both studies showed a high correlation between disease severity and tissue hardness and have 
recommended its use for assessment of these conditions. Impedance to lymphatic outflow 
from abdominal adiposity may cause an increase in tissue turgor leading to increased 
durometry readings 
It was found that calf, but not thigh, skin increased significantly in hardness after relatively 
short periods of moving to the seated position, and that the change was greatest in the obese 
group, although not this significant against the other BMI groups. Changes in skin hardness 
were unrelated to subcutaneous tissue depth and therefore represent true changes in the 
properties of the tissue underneath the durometry probe. Standing alone has been 
demonstrated to increase lower limb tissue hardness in healthy individuals and increasing 
BMI was correlated with this through weight (Wall et al. 2010). In seated subjects in the 
present study the increase in hardness only in the calf may in part be due to the tightness of 
the lower limb skin. The calf readings were higher than at the thigh when supine, and a small 
volume increase into the calf which has less capacity to expand would be expected to be 
transferred more quickly to the skin than the same increase in the thigh which may have a 
greater capacity to absorb volume increase. It may also be that the time allowed for changes to 
occur was too short and with longer durations, thigh hardness may also have increased.  
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4.6 BLOOD FLOW AND FILTRATION 
 
4.6.1 Blood Flow 
Although the main focus of this work was the venous circulation, limb blood flow was also 
estimated because of its potential influence upon venous filling characteristics in the calf. 
Resting calf blood flow by strain gauge plethysmography was positively correlated with BMI 
and abdominal obesity. Data comparing basal limb blood flow in obese and lean subjects are 
contradictory, with reports of no difference in young (femoral flow, Limberg et al. 2010), 
middle-aged (calf SGP, Vollenweider et al. 1994) or elderly obese individuals (calf SGP, 
Acree et al. 2007). On the other hand, Ribeiro et al. (2001) found lower basal forearm blood 
flow by SGP in middle-aged females associated with higher levels of muscle sympathetic 
nerve activity, but others found it to be higher in heavier individuals (Stepniakowski & Egan, 
1995) or not different (Vollenweider et al 1994).  
Some of this variation may be due to the fact that SGP measures flow from skin and 
subcutaneous fat as well as skeletal muscle. Estimates of blood flow by xenon clearance to 
forearm skin (9.1 ml/min/100g) and adipose tissue (3.8 ml/min/100g) were higher than for 
skeletal muscle (1.6 ml/min/100g), (Elia & Kurpad, 1993) and a greater proportion of the 
former two tissues in the limb will give rise to higher plethysmographic flow. This is 
supported by correlation found between calf blood flow and total but not lean calf cross 
sectional area.  
Furthermore, in obesity these anatomical differences may be confounded by alterations in 
vascular tone and reactivity because of systemic and hormonal changes. Hypertension, which 
is associated with reduced limb blood flow, is unlikely to be involved as the subject cohort 
were normotensive. Oestrogen is a vasodilator that has been shown to increase forearm blood 
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flow (Volteranni et al. 1995). Peripheral conversion of oestrogen has been demonstrated to be 
higher in the presence of a raised BMI (Quinkler et al. 2004) and long term exposure to HRT 
in post menopausal females has been shown by Vehkavaara et al. (2000) to increase blood 
flow over non-users. Although oestrogen levels at the time of study did not correlate with calf 
blood flow, life time exposure to higher levels of oestrogen may account for the higher 
readings of calf blood flow. However, there was no association with OCP use or pregnancy 
data. 
Another potential vasodilator is insulin and its presence at increased levels might explain an 
increase in flow (Birkeland et al. 1995). Blood insulin was found to be higher with increasing 
BMI and associated with a rising but normal glucose level across the groups. The HOMA2 
index for the obese population put them within the published levels for Insulin Resistance 
(IR) as defined in a normal population by Geloneze et al. (2009). Insulin infusion increases 
leg blood flow (Birkeland et al. 1995) and Vollenweider et al. (1994) showed that chronic 
long term high levels of insulin are just as effective at producing increased calf blood flow 
and decreased calf resistance as pulses of insulin. A raised blood glucose level has been noted 
to have the same dilator effect by Straznicky et al. (2009). In the presence of IR (calculated 
from insulin and glucose) they also demonstrated a greater blood flow at rest than in insulin-
sensitive volunteers, associated with decreased glucose uptake into skeletal muscle (Laakso et 
al. 1990).  Irving et al. (2001) showed higher fasting plasma glucose was associated with 
lower capillary density but increased capillary blood velocity in the skin. If these three 
observations are taken together, a situation where increased inflow to the tissues is matched 
by lower peripheral limb resistance, shown in obesity Messerli et al. (1981), due to chronic 
exposure to insulin manifesting as a reduced transit time through the capillary bed can be 
envisaged. The correlation between HOMA2 index and basal calf blood flow is consistent 
 169
with this scenario. Vehkavaara et al. (2000) studied interactions between insulin and 
oestrogen, both known to increase blood flow (de Jongh et al. 2004), but concluded that they 
are not additive.  
 
4.6.2 Capillary Filtration 
Estimation of capillary filtration coefficient (Kf) with the multi-step pressure protocol devised 
by Gamble 2002162 enable derivation of not only Kf but also Pvi, the isovolumetric pressure 
in the microcirculation at which fluid filtration occurs, and Pvest, the pressure in the venous 
system at rest. The results obtained for Kf in the normal weight group were in keeping with 
those previously published by Gamble et al. (1998, 2002 ) 0.0030 ml/100ml/min/mmHg) and 
Lindenberger et al. (2007) (0.0045 ml/100ml/min/mmHg) even these studies were performed 
on younger study populations. There was a decrease in Kf with increasing BMI, and a similar 
inverse correlation with measures of abdominal obesity. Considering the finding that the 
obese volunteers had a greater blood flow than the normal and overweight group, how is it 
that the Kf of the obese group is lower? 
L’Hermitte et al. (2003) looked at the effect of adiposity on the capillary filtration of albumin 
and lower limb lymphatic function. Obese volunteers had an expanded circulating volume 
(reinforced by Messerli et al. 1981) with greater extra-cellular fluid volume. This may suggest 
that the limbs are “loaded” with excess volume before measurements commenced and that the 
results reflect limited additional fluid movement into an already full leg. However, the study 
data does not support this as inguinal tissue pressure and tissue durometry – an indicator of 
tissue turgor due to fluid accumulation - did not correlate at rest with any indices of 
abdominal composition.  
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Lindenberger et al. (2007) noted that there was higher Kf in females than males which raises 
the possibility that sex hormones are involved. Although not significant, there was a positive 
correlation between oestrogen levels and Kf in the present study, although oestrogen was not 
related to BMI. Turzyniecka et al. (2009) assessed calf capillary filtration in the same way as 
in the present study in an obese non-diabetic older population and noted a decreased Kf with 
increasing insulin resistance and abdominal adiposity. These authors suggested that there is 
capillary rarefaction occurring in this situation, providing less surface area for fluid exchange 
to occur. Having demonstrated IR in the study obese individuals, it is possible that they are 
demonstrating early changes in their microcirculation. A similar structural microvascular 
deficit has also been suggested by Noon et al. (1997) in young men predisposed to 
hypertension which the obese group, although normotensive, are at risk of developing.  
Another explanation for the decrease in capillary filtration seen in the obese group in the face 
of higher calf blood flow relates to the role of insulin in control of blood flow through limb 
skeletal muscle. Rattigan et al. (2006) propose that muscle capillaries are laid out in two 
parallel circuits, one which supplies nutrients to the muscle when required (nutritive), and 
another that bypasses the muscle capillary bed (non-nutritive) and that insulin, as a 
vasodilator, plays a key role in directing flow preferentially through skeletal muscle. In IR 
states, however, this does not occur and flow bypasses the capillary bed so that less capillary 
surface area will be exposed for fluid filtration to occur across. It must be emphasized at this 
point that the concept of parallel capillary pathways and insulin-mediated capillary 
recruitment has been challenged by others in the field of muscle microcirculation (Poole et al 
2008). 
A raised isovolumetric venous pressure, Pvi, has been associated with conditions of 
inflammation and leucocyte adhesion in the microcirculation (Anim-Nyame et al. 2003) but 
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the study did not demonstrate any difference in the Pvi of the BMI groups. It is interesting to 
note that inflammatory changes including leucocyte adhesion are evident in veins chronically 
exposed to pressure (Bergan et al. 2006) and hence implicated in the pathogenesis of venous 
disease (Somers & Knaapen, 2006, Lim & Davies, 2009). The absence of an obesity-related 
increase in Pvi derived from whole calf plethysmography is consistent with the lack of effect 
of body size or abdominal adiposity on calf venous capacitance. The contrast between this and 
the changes seen in the large leg veins with obesity highlights the discrepancy between what 
is happening to the small venules and venous microcirculation as opposed to the large vessels. 
It may be the case that smaller veins do not yet display alterations that are evident in the large 
vessels. 
Supine venous pressure at calf level, Pvest, showed a slight but not significant correlation 
with BMI but a stronger positive relationship with abdominal fat measures (SAD p=0.06, 
ultrasound abdominal thickness p=0.07). In agreement with the study hypothesis, this is 
indicative of a degree of venous hypertension that would be expected to increase when sitting 
or standing. and could be a contributor to the changes seen in   
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4.7 PREGANANCY AND WEIGHT HISTORY 
 
This area of the study was dependent on the self-reporting of the study volunteers. It is 
probably safe to assume that the volunteers were aware of the number of full term pregnancies 
they had undergone and that this is an accurate result. Historical BMI is more open to 
retrospective interpretation by the volunteers. The study could not demonstrate any 
correlations between the parameters of venous function measured and the number of 
pregnancies or the historical BMI. No correlation was demonstrated between BMI or 
historical BMI and the number of pregnancies.  
The literature reports that those females whom have had pregnancies increase their weight and 
this maybe a confounding factor in large population based studies i.e. Jukkola et al. (2006). 
This may have also had an effect in this study but numbers were insufficient to demonstrate 
this. 
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4.8 LIMITATIONS OF THE STUDY 
 
4.8.1 Study Design 
The aim of the study was to examine the effect of obesity on venous function in a healthy 
population. It would also have been possible to compare the relationship of obesity to vein 
function in subjects with and without established venous disease. However, examination of 
venous parameters in subjects prior to development of pathological changes rather than 
comparison of normal and diseased veins was felt to be appropriate for several reasons. A 
varicose vein wall is different from the wall in non-diseased vein due to imbalance in the 
structural proteins (Sansilvestri-Morel et al. 2001) and also the structure and number of 
smooth muscle cells (Venturi et al. 1996). This alters the mechanical properties of the vein as 
described by Travers et al. (1996) and reinforced by Krasiński et al. (2010). Studying the vein 
when it is diseased would complicate the assessment of venous functioning as it is not able to 
react to the stresses of filling as normal veins do (van Rij et al. 2008) and it is difficult to 
quantify the degree to which the vein has been affected. Furthermore, as described in the 
Introduction section, work has demonstrated that the vein is not uniform in its disease 
(Labropoulos et al. 1999, Abu-Own et al. 1994) and therefore, during imaging, it would be 
difficult to ascertain if the assessment was of diseased or normal vein segment.    
 
4.8.2 Recruitment and Small Sample Size 
The power calculations initially used for the establishment of the number of volunteers in this 
study were designed to detect a difference in the femoral vein flow velocity following 
postural movements. No data was available for the analysis of venous compliance using 
ultrasound measurement and hence power calculations were not based on these measures. The 
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recruiting difficulties in this study are dealt with in the Discussion section and the low number 
of volunteers that this yielded made interpreting the results achieved much more difficult. 
Following discussion with Dr Peter Nightingale regarding data interpretation all data were 
analysed with non-parametric testing, which did not require assumption of normal 
distribution. Correlational analysis was used for the majority of data interpretation as the 
small numbers in each group meant that multivariate regression analysis was not possible. 
The author hopes that the data presented can highlight for the reader the correlations 
demonstrated in the population. The small numbers in each BMI group did allow for 
assessment between the BMI groups but the standard deviation in each group was larger due 
to small sample sizes, increasing the likelihood of a Type II error. Larger numbers would be 
required to determine significant differences in the groups. 
 
4.8.3 Gender Considerations 
The mode of advertisement used for the study meant that the majority of volunteers were 
female.  Small numbers of males were recruited but were insufficient for analysis. This means 
that the author has not been able to produce baseline data for the male population or make any 
comment on the functioning of male lower limb veins through this study. Although no 
confounding effects of female hormones on venous haemodymanics were seen in the female 
study population, the complex interactions of oestrogen and progesterone with veins may 
mean that the genders display differing effects in venous function through their exposure to 
obesity. 
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4.8.4 New Technology 
The assessment of any new investigative techniques requires two criteria to be satisfied. Is the 
test acceptable to the volunteersa and is the test accurate in individual assessment and 
reproducible across an investigated population?  Several of the measures in the study e.g. 
femoral vein cross sectional area, height, weight etc. were not repeated during the test 
sessions because their validity has been established in previous studies and hence the time 
commitment of each volunteer could be kept to a minimum. One omission for the study was 
the establishment of the reproducibility of venous occlusion plethysmography in this subject 
cohort. Occlusion plethysmography as a technique is well established but in the study The 
technical challenges of simultaneous venous imaging and whole limb readings are described 
elsewhere in the discussion but a failure of this study is that these measures were not able to 
be repeated and therefore the variability of this test could not be confirmed. The inguinal 
tissue pressure measures were only performed at one meeting as the test was invasive. The 
repeatability of this test was described in the Results section and had a coefficient of variation 
of 6.5% when supine and 11.1% when seated. This was a measure of the whole group 
readings and suggests that the test could be used in the future for investigation of the tissue 
pressure. The possible limitations of this technique are presented in the Discussion section.  
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CHAPTER 5: 
GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES 
This thesis set out to investigate whether being overweight or obese in middle age is 
associated with deleterious changes in leg vein properties even before venous disease can be 
diagnosed. Abdominal adiposity was considered as a key factor likely to be imposing 
mechanical hindrance to venous outflow from the legs and / or increased venous pressure. 
This study has suggested that in an obese population with no clinical venous disease there is 
demonstrable enlargement in the size of lower limb veins in the deep and superficial systems 
accompanied by a loss of venous compliance. These changes were linked with the presence of 
greater levels of abdominal fat both subcutaneous and visceral, which correlated with raised 
inguinal tissue pressure especially in the sitting position. The most likely scenario is one 
whereby venous hypertension is induced by central obesity over and above the normal 
hydrostatic forces due to gravity and weight, and this is illustrated in Figure 5.1 below. Even 
though inguinal compression of the femoral vein alone using the fingers is capable of 
increasing femoral vein size (Kim et al. 2008) by a similar degree as seen with obesity in the 
present study, it is likely that higher intra-abdominal pressure due to visceral fat also plays a 
role in accounting for femoral vein distension when seated. It was surprising in some respects 
that weight history, which documented loosely the duration of obesity, was not related to vein 
distension even though the average weight gain for the group since the age of 20 years was 
approximately 20 kg. Nor was the number of pregnancies a significant factor even though this 
has been suggested to impose abdominal pressure and pelvic venous congestion.  
In terms of obstruction to venous outflow, no difference was observed between normal weight 
and obese individuals in femoral volume flow irrespective of posture, but this was 
accommodated by the bigger size of the vein in obesity. Whether there are changes in the 
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femoral vein wall composition as a result of obesity-induced distension remains to be 
determined. The novel finding of lower compliance of the GSV with increasing BMI in a non-
disease state implies that structural changes to the vein wall may already be underway. This 
could only be confirmed by direct histological examination of vein tissue, which is not ethical 
in healthy subjects. Krasiński et al. (2010) have demonstrated differing tensile strengths 
between GSV in health and disease and compared it to healthy FV harvested at post-traumatic 
amputation. Such an approach allied to obesity measures may provided further evidence of a 
systemic structural deficiency as described by Sansilvestri-Morel et al. (2007). 
It was interesting to note that a tendency for raised venous pressure in the calf – albeit 
estimated indirectly – was not associated with a higher isovolumetric pressure, which would 
have indicated an inflammatory state. Given that venous disease is clearly linked with an 
inflammatory cascade affecting the valves and vein wall (Bergan et al. 2008), it may be that 
this will ensue at a later time point. There is no way of knowing from this study whether the 
venous changes associated with obesity would have progressed to overt venous disease in 
time. This could only be ascertained from a longterm cohort study over the next 10-20 years. 
This would likely require a large multicentre population based approach. Of consideration but 
not within the scope of this study is the pro-inflammatory condition present in morbid obesity 
and metabolic syndrome and whether this may play a role in the venous parameters studied. 
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 Figure 5.1 Diagram of the forces applied to the vein in the study volunteers where there was 
no demonstrable clinical venous reflux or disease. 
 
Despite correlational analysis, it remains impossible to establish definitive cause and effect 
between being overweight, having abdominal obesity and changes in venous properties from 
the small population studied. There are various animal models that could be used to shed light 
on this, such as surgical venous ligation techniques to induce hypertension (Bergan et al. 2008 
193) or the approach used by Monos et al. (1995) where rat hindlimb venous pressure was 
chronically elevated by maintaining animals in a head-up posture leading to saphenous vein 
enlargement. To date, none of these have been applied to obese animal strains to investigate 
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interactions with body size and adiposity. From the human perspective, the study would have 
been strengthened by intravenous pressure monitoring in different postures, but this invasive 
approach was not felt to be warranted in healthy individuals. Future scope for assessment of 
femoral venous haemodynamics without intervention will be possible. Deformation analysis 
using ultrasound to calculate intravenous pressure and 3-D ultrasound allowing for venous 
flow analysis could both be of benefit. This may give a better understanding of the flow 
dynamics in the vein and may be used to produce models of venous blood flow. This could 
help in the development of reconstructive deep venous disease such as the use of in-stent 
venous valve devices. (Geselschap et al 2006) 
A surprising aspect of the findings was that there appeared to be no relationship between vein 
properties and oestrogen or progesterone levels despite a considerable body of evidence 
showing both arterio- and veno-dilator effects of these hormones. This may simply be a 
reflection of the fact that menstrual phase was tightly controlled and that OCP use was well 
monitored, albeit by self-report. Although it would involve confounding effects of age, a more 
stringent examination of the association between endogenous or exogenous oestrogen and 
vein characteristics in a ‘free from venous disease’ post-menopausal sample of women with 
and without hormone replacement therapy might help to resolve this issue. Previous evidence 
has shown an improvement in venous function when exogenous oestrogen has been 
administered to post menopausal woman Ciardullo et al. (2000). 
The metabolic syndrome of insulin resistance is well known for its link to obesity but no 
connection was found between glucose / insulin levels and vein properties other than higher 
resting calf blood flow. Insulin has been shown to reduce venous constrictor tone, an effect 
attenuated by obesity (Feldman et al. 1995). Indeed, there are many other vasoactive 
substances that can modify venomotor tone (see Appendix A) and it may be that an impaired 
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ability of veins to counter distending pressure by myogenic constriction or changes in vein 
response to venodilators / constrictors – catecholamines, endothelin, endothelial-dependent 
factors etc. – plays a role in the development of wider vessels and loss of compliance. Such 
effects would have to be vein-specific to account for the differential adaptation of the 
saphenous versus popliteal vein. It is clear that different leg veins react in different ways. For 
instance, the popliteal vein has been shown not to be responsive to sympathetic neural 
activation with a cold pressor test (Young et al 2008) whereas the whole limb and the GSV 
vein demonstrate increased venous tone (Philips, 2010). Therefore the degree of adrenergic 
innervation of the popliteal vein may be different from the small deep veins / the superficial 
venous system. It can be seen from figures 3.19, 3.20 and 3.21 that there is a marked 
difference between the compliance of individual veins and the whole limb/calf. In the freely-
moving human, interactions between pressure effects within the superficial and deep systems 
and factors that influence venous tone are inevitably complex (Ludbrook, 1962, Ludbrook et 
al. 1964) and full understanding of how this fails in venous disease must await future 
investigation.  
Not only were there disparate changes to large vein properties within the superficial and deep 
systems but venous capacity and compliance based on calf plethysmography showed no 
overall effects from obesity. It becomes clear from this study and published literature that 
when examining lower limb venous function the method of experimental approach is 
fundamentally important. Lower limb plethysmography has long been used as a surrogate for 
venous function based on venous vascular volume but this technique has recently been 
challenged by Young et al. (2008) when they demonstrated a difference in the compliance of 
the popliteal vein from that of whole limb. With whole limb plethysmography, volume 
changes during filling include not only expansion of deep veins (Buckey et al. 1988) but also 
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a significant contribution from small venous vessels (Cirovic et al. 2006) as well as soft tissue 
compliance, hysteresis and ‘creep’. It is therefore less easy to ascribe changes to one or other 
of these components definitively. The use of ultrasound for assessment of lower limb venous 
parameters offers direct vision of the venous vessels for measurement of capacity and 
compliance (De Groot et al. 2005, Young et al. 2008) but is, of course, limited to veins of a 
certain size compatible with the resolution of the imaging. Increasing accuracy of cross 
sectional and in-line ultrasound investigation into venous parameters of the limb suggests the 
modality of choice for the future and researchers should not rely on whole limb 
plethysmography as a surrogate marker.  
The study did not demonstrate any clear association between venous function in obesity and 
signs of skin changes although in disease, the pathway from venous hypertension through 
microvessel inflammation, oedema, skin hardening and impaired oxygen delivery to 
ulceration is well documented. However, the reduced capillary filtration in the face of raised 
arterial inflow in the calf suggests that microvascular disturbances have occurred that presage 
deleterious nutritive perfusion. This may well also involve skeletal muscle, which is the major 
contributor to calf cross-sectional area encompassed by a strain gauge. In advanced venous 
disease, calf muscle shows changes indicative of a failure of the adequate delivery of nutrients 
to the tissues and / or failure of the tissue to clear waste and breakdown products. For 
example, Qiao et al. (2005) noted pathological changes in the gastrocnemius muscle of 
varicose vein patients, correlated with ambulatory venous hypertension. Disruption of 
nutritive perfusion in either tissue is therefore a consequence of obesity to be aware of. 
A caveat to all the findings of the present study is that the data are derived from a relatively 
small number of subjects. Despite substantial efforts on the part of the author in the 
recruitment for this study over a 16 months period, the number of female volunteers remained 
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only 26. Due to some difficulties in scheduling testing sessions and occasional failures in 
certain measurement procedures, a complete set of data was not obtained from each subject, 
as indicated by the smaller n number shown against values in the Results section. This led to 
the data being treated as non-parametric for analytic purposes. The power to determine the 
difference between the groups is reduced due to the low numbers and the correlation is less 
robust when relying on these small numbers to demonstrate relationships between the 
variables. Despite the small numbers, it has been shown in the Discussion section that the data 
acquired are in line with previously published studies. This study therefore provides baseline 
data on a small population sample from which larger cohort studies could be designed.  
Since commencement of the thesis papers by Willenberg et al. (2010, 2011) have been 
published studying the effect of obesity on venous flow either in an obese population free 
from venous disease or simulated obesity with abdominal cuffs. The data displayed in these 
papers correlate closely on the measures with the findings of this thesis on the size of the 
femoral vein and reduction in venous velocity. Willendberg et al. surmised from their data 
that obesity was creating mechanical impedance to lower limb venous flow and suggested this 
may give rise to an increase risk of chronic venous disease.  
Venous disease remains one of the major health care costs. 2% of the NHS budget is spent on 
venous ulceration and as this study is suggesting, the venous disease is going to increase in 
prevalence due to obesity then this cost would be expected to rise. The question of future 
research then turns to see if the situation can be recovered by a change in body habitus. This 
was noted by Sugerman (et al 2001) who showed healing of lower limb ulceration and 
resolution of venous/congestive ulceration post weight reduction sugery. A study designed to 
examine the metabolic and venous parameters pre and post gastric bypass/banding may help 
to go someway to demonstrate if the situation of loss of venous compliance examined in this 
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thesis could be reversed. Allied to this would be an understanding of the changes in the skin 
and muscular vasculature to help aid explanation of chronic changes induced by venous stasis. 
Ultimately tissue sampling of venous wall may be required to gain full understanding of the 
pathophysiological changes induced by obesity in the healthy individual. This could have 
major  implications for future health prevention and care. If the financial burden of venous 
disease could be reduced through weight reduction then it makes a powerful arguement for 
more aggressive interventions in controlling obesity at an earlier stage, looking to reduce 
future health burden. 
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APPENDICES 
Appendix A: Vasoactive Substances 
Multiple pharmacological agents are known to affect the venous system. Listed in the 
appendix below are the substances and there known to have an effect (Aellig, 1994). 
Pharmacological 
Group 
Effect on the Venous System 
α1-α2 Adrenoreceptor 
Agonists 
Cause venoconstriction at 1000 times the concentration required to 
cause an alteration in the systolic blood pressure. Evidence that both 
receptors are present in the venous system but adrenaline appears to 
have greatest effect suggesting α1 predominates. 
5-HT-Receptors 
Agonists 
Shown to cause venoconstriction and potentiate the effects of 
adrenoreceptor agonists. 
Ergot Compounds 
Has a venoconstrictive effect that can be shown to remain present and 
even increase post infusion for up to 30 minutes. This was suggested 
to represent a deeper receptor compartment delaying maximal 
response activated by diffusion. 
Angiotensin 1,2 and 
ACE Inhibitors 
Angiotensin 1 and 2 produces dose dependent response in 
administration into peripheral hand vein of venoconstriction. There is 
evidence that conversion from less potent angiotensin 1 to 2 also 
occurs in venous segments which shows the presence of ACE in the 
endothelium of peripheral venous tissue. 
Endothelin A venoconstrictor which acts via calcium channel activation. 
Effects of 
Prostaglandins 
Can be shown that different compounds effect the artrerial and 
venous systems differently A1, A2, E1 and E2 were shown to produce 
a venodilatation in preconstricted veins. B1 and F2α  produce 
venoconstriction likely to be due to stimulation of Thromboxane A2. 
β-Adrenoreceptor 
Agonists 
Reports suggest that this class of drugs cause venodilatation when 
infused into superficial arm veins. This can be inhibited by β-
adrenoreceptor blockers. Venous distensibility can be shown to 
reduce in patients who have taken propanolol for 2 weeks. This is 
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reversible. 
Muscarinic Receptor 
Agonists 
At low doses they cause venodilitation in pre constricted veins due to 
release of Nitrous oxide (Endothelium Derived Relaxing Factor, 
EDRF). At higher doses they cause venoconstriction thought to be 
due to release of noradrenaline controlled by muscarinic receptors. 
Nitrates 
Best known and most widely used venodilators. Shown to cause 
venodilitation in the hand vein pre-constricted with noradrenaline. 
Action is via the release of Nitric Oxide (EDRF). 
Calcium Channel 
Antagonist 
Shown to cause venodilitation in preconstricted hand vein. With a 
greater effect on post-junctional extrasynaptic α2-adrenoreceptors 
than in post-synaptic α1-adrenoreceptors. Very little report of clinical 
orthostatic intolerance suggesting that calcium channel antagonists 
have little effect on the neuronal control of venous tone which may be 
higher in hypertensive patients. 
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Appendix B: Screening Visit 
SCREENING VISIT ASSESSMENT SHEET 
Date: ____________________ 
 
Name: ____________________ 
 
Date of Birth ____________________ 
 
Study No: ____________________ 
 
GP Practice: ____________________ 
 ____________________ 
 ____________________ 
 ____________________ 
 ____________________ 
 
Dominant Leg ____________________ 
 
Height ____________________ 
Weight ____________________ 
 
LMP in females ____________________ 
 
Could the subject be pregnant    YES / NO 
 
Past Medical History 
 
 
ABPI   L_____________ TBPI L___________ 
 R_____________    R___________ 
 
 
Exclusion Criteria: 
 Yes No 
DVT   
Post thrombotic syndrome   
Post menopausal   
Type 1 Diabetes Mellitus   
Pregnancy   
Peripheral arterial Disease   
Heart Failure   
Exercise limiting Arthritis   
Lymphoedema   
Liver Failure   
Clinical use of Steroids   
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USS duplex of leg: _________________________________ 
 
Acceptable for study: YES / NO 
 
If yes give patient info leaflet, questionnaires and arrange for next visit: 
Next visit set at _____________________ at the ___________________ 
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Appendix C: Weight Recall 
Below is a copy of the weight recall questionnaire used in the study to ascertain the 
volunteers’ weight throughout their adult life. A mean of the results returned was used with 
the volunteers’ present height to calculate the historical BMI. 
WEIGHT QUESTIONNAIRE 
Age ______ Weight __________ Height__________ BMI________ 
 
 Weight at 20 __________ 
 Weight at 25 __________ 
 Weight at 30 __________ 
 Weight at 35 __________ 
 Weight at 40 __________ 
 Weight at 45 __________ 
 Weight at 50 __________ 
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Appendix D: Gynaecology History 
GYNAECOLOGY QUESTIONNAIRE 
• Age of first Period _________ 
• Date of last period (first day) __________ 
• Do you have regular periods? YES / NO 
• Do you suffer from premenstrual symptoms such as bloating or cramping abdominal 
pain? YES / NO 
_____________________________________________________________________
_________________________ 
 
 
• Is there a chance you maybe pregnant? (there is a small risk with the radiation from 
the DEXA scan)  YES / NO 
• Have you ever used the oral contraceptive pill?  YES / NO 
 
If yes for how long in total throughout your life time? (it does not have to have been 
continuous)  ___________________________ 
If yes which different makes of pill have you used and for how long each one? 
________________________________________________________________________
________________________________________________________________________
________________________ 
• Have you ever had a full term pregnancy? YES / NO 
 
If Yes:  How many full term deliveries? __________ 
What age/s were you when your child/dren were born? 
____________________________________________ 
 
• Have you had any premature children? YES / NO 
If Yes: How many premature deliveries? _____________________ 
 How many weeks were the deliveries? _________________ 
 What age/s were you when your child/dren were born? 
 _________________________________________________ 
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 • Have you ever had any failed pregnancies? YES / NO 
 
If Yes: How many failed pregnancies? _______________________ 
How many weeks was / were your pregnancy/ies? 
_________________________________________________ 
What ages were you at the start of these pregnancies? 
_________________________________________________ 
 
• Have you ever breastfed your child/dren? YES / NO 
 
If Yes For how long in total? ________________________ 
• Have you ever had any gynaecological surgery? YES / NO 
 
If yes What operation/s was performed? ______________ 
 __________________________________________ 
 How long ago was this done? __________________ 
 
• Have you had ever had any menopausal symptoms (such as hot flushes or period 
irregularity)? YES / NO  
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Appendix E: Stanford Seven Day Activity Recall Questionnaire 
The Stanford Seven Day Recall Questionnaire is a validated questionnaire for assessment of 
daily activity (Washburn et al 2003 163) The volunteers are required to recall and record  the 
different levels of physical activity they undertake over how long each  day for a continuous 7 
day period and this data is used to calculate the energy expenditure per day. 
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Appendix F: Patient information leaflet 
The effects of OBesity on Venous Impedance and Outflow 
measured by UltraSound 
“OBVIOUS STUDY” 
Participants Information Leaflet 
Research Study 
We would like to invite you to take part in a research study examining how the blood 
flow in our legs is affected by our differing body shapes. Before you decide, it is important for 
you to understand why the research is being undertaken and what it will involve. Please take 
the time to read the following information carefully. Feel free to ask questions if there is 
anything that is not clear or if you would like more information.  
Thank you for reading this information sheet.  
What is the purpose of the research? 
Problems with the veins that drain the blood from our legs affect about 1% of people. 
They can lead to varicose veins, eczema and eventually ulcers. If we want to prevent this 
happening and develop treatments, we need to understand how blood moves out of the legs. 
We think that being overweight or using oral contraceptives may change the way the veins do 
this, especially when we are sitting. 
Why am I right for the study? 
  We would like to study men and women, who may or may not have used oral 
contraceptives in the past, of all different body shapes and sizes.  If you have volunteered and 
been chosen for the study it is because you have no other medical problems which would 
interfere with our investigation and, based on a leg ultrasound scan, you have a normal venous 
system draining your legs. 
Do I have to take part? 
 It is up to you to decide whether or not to take part. If you do decide to take part you 
will be given this sheet to keep for reference and asked to sign a consent form. If you do 
decide to take part, you are free to withdraw at any time and without giving a reason. This 
decision will not in any way affect any present or future care. 
What will happen to me if I take part? 
Having volunteered you will be asked to attend an assessment at the Vascular 
Outpatients, Selly Oak Hospital, where we will ask questions about your general health and 
carry out an ultrasound scan of the veins of your legs. We will then be able to inform you if 
you are suitable for the study. 
The next visit is arranged to take place at the Wellcome Clinical Research Facility at the 
Queen Elizabeth Hospital, Edgbaston, Birmingham where you will sign the consent form to 
enter the study. We will then: 
1. check your pulse and blood pressure 
2. inspect your legs for any signs of problems with your veins 
3. measure blood pressure in your legs 
4. measure your waist, hip, wrist and ankle circumference 
5. measure your leg length and stomach depth, lying and sitting 
You will be asked to fill out questionnaires on your weight since you were age 20, your daily 
physical activity and, if you are female, a history of contraceptive use and pregnancies up 
until the present time and your present position in the menstrual cycle (to help determine the 
date of your next visit). We will then: 
 193
6. ask you to lie down and then sit up while we measure how long it takes your leg to 
refill with blood. This involves three cuffs and a painless sensor placed around your 
leg and the cuffs inflated for short periods at low pressure 
7. ask you to lie down and sit up whilst a painless probe is placed on your leg to measure 
its firmness. 
8. ask you to lie down and have a small injection in your groin with a needle to numb the 
skin. A needle will then be placed in the tissue below the skin to measure the pressure 
and you will be asked to sit up to see if the pressure goes up or down.  
9. ask you to undergo a DEXA scan. This is a very low intensity X-ray which measures 
the composition of the different materials of your body (muscle, bone and fat). 
 
A final visit will be arranged at the School of Sport and Exercise Sciences, University of 
Birmingham, Edgbaston, Birmingham where we will: 
1. take 15 ml of blood (less than an egg cup) 
2. measure the depth of tissue around your arms, trunk and legs with an ultrasound 
probe and calipers. 
3. carry out an ultrasound scan of your leg veins to examine the flow of blood and 
how they fill up after emptying (by being raised up). This uses cuffs that inflate 
and deflate around the leg. The pressure used is less than taking normal blood 
pressure in the arm. 
 
What do I have to do? 
 Transportation will be arranged to and from all visits. In total, the study will take 8 
hours of your time. All visits will be set in and around your schedule to cause minimal 
disruption to you. The night before and the morning of your visits we will ask you to control 
the amount you drink and ask you to not eat and avoid caffeinated drinks. 
What are the benefits? 
 Although the study may be of no personal benefit for you, we hope to gain a greater 
understanding of the problems associated with leg veins and how they occur. 
What are the risks? 
 Blood taking can result in bruising of the arm. A needle placed in the groin may have 
the same effect and runs a very small risk of bleeding that might require prolonged pressure to 
stop. There is also a very small risk of infection with both procedures. The dose from a 
DEXA scan is equal to one normal days background radiation dose (less than half a standard 
chest X-ray in casualty). 
What if something goes wrong? 
 If you are harmed by taking part in this research project, there are no special 
compensation arrangements. If you wish to complain or have been in anyway harmed by any 
action taken during the study, the normal National Health Service complaints procedure will 
be available to you. Information will be supplied as required.  
What will happen to the information gathered? 
 All the gathered information in the study is strictly confidential. No identifiable 
information will be given out. The data once analysed will be publish in medical journals or 
presented at medical meetings, again with no personal identifiers. All information will be 
stored behind hospital password-protected computer systems. 
Who is organising the study? 
 The research is being arranged jointly between the University Hospital Birmingham 
Vascular Department and the University of Birmingham School of Sport and Exercise 
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Sciences. There is no official financial sponsor for the project, funding coming jointly from 
the above organisations.  
Who has reviewed the study? 
 The study has been reviewed and Approved by the Dudley and Wolverhampton 
Research Ethics committee. 
Contact for further information: 
Mr Michael Wall Telephone  
(Lead researcher) Fax  
 Mobile  
 
Mr Malcolm Simms Telephone   
(Vascular Surgeon and Chief Investigator) 
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Appendix G: Test Session 1: University of Birmingham School of 
Sport and Exercise Science  
The effects of OBesity on Venous Impedance and Outflow measured by UltraSound 
“OBVIOUS STUDY” 
 
PROTOCOL SHEET  Date: ……………………………………………. 
 
Subject information:  ID ……………………………   
 Gender:  M  /   F 
    Date of birth: ……………………………………………..  
(Age        yrs) 
    Dominant leg       L    /   R 
 
Anthropometry 
Height (cm) ……………………………………… Weight 
(kg)……………………………….. 
Waist circumference (cm) ……………………… Hip circumference (cm)………………… 
Wrist circumference (L / R cm) ………………… Ankle circumference (L / R cm) 
………………… 
Thigh circumference (L / R cm) ……………….. Calf circumference (L / R  cm) 
…………………… 
 
[Mark positions on skin of:  lower leg 15 cm above medial  malleolus 
    Thigh 15 cm above femoral condyle 
    Abdomen 3 cm below umbilicus] 
 
CEAP Clinical classification of chronic lower extremity venous disease (Porter & Moneta 
1995) 
Clinical signs  Class  Tick appropriate 
class 
No visible or palpable signs of venous disease 0  
Teleangiectases, reticular veins, malleolar flare 1  
Varicose veins 2  
Edema without skin changes  3  
Skin changes ascribed to venous disease 
(pigmentation, venous eczema, 
lipodermatosclerosis) 
4  
Skin changes (as defined above) in conjunction 
with healed ulceration 
5  
Skin changes (as defined above) in conjunction 
with active ulceration 
6  
 
 
Sagittal abdominal diameter 
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Subject to lie flat on couch and rest. Place caliper under back, ask subject to breathe out 
slowly and make measurement 
SAD (cm)…………….. 
Wall-Simms index 
Subject to sit upright with legs outstretched. Measure distance from sacrum to superior border 
of patella. Measure distance from sacrum to final point of contact between abdomen and 
thigh. 
Sacrum – patella (cm) ………. Sacrum – abdomen (cm)  ………. 
Durometry  
Record 2 measures of skin hardness at sites 1, 2 & 3 above. 
 Reading 1 Reading 2 Mean
Abdomen    
Thigh left    
Thigh Right    
Calf Left    
Calf Right    
    
Ultrasound 
Measure depth of subcutaneous tissue at sites 1, 2 and 3 above. Use vein setup 
 Reading 1 Reading 2 Mean
Abdomen    
Thigh left    
Thigh Right    
Calf Left    
Calf Right    
 
Harpenden calipers 
Measure depth of subcutaneous tissue at sites 1, 2 and 3 above. 
 Reading 1 Reading 2 Mean
Abdomen    
Thigh left    
Thigh Right    
Calf Left    
Calf Right    
 
Ultrasound flow velocities 
Fit regular arm-sized Hokansen© cuff around lower leg (R or L, dominant). Set up cuff 
inflator to 80 mmHg. 
Attach ECG electrodes to subject. 
 
Use [Mike] venous DUS setup (LE vein + Adaptive Doppler + autotrace + average over 15 
cycles). 
Locate femoral vein in colour Doppler. Switch to Pulse Wave and set up for recording 
velocity. Switch to spectral mode. Press measure to obtain autotrace (blue / black outlines) or 
use Waveform softkey on/off (left hand under screen). Check scale for velocity (usually less 
than 100 cm/s). 
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Ask subject to breath quietly and regularly. Allow to record 15 cycles and freeze image as 
soon as velocity data is displayed.  Repeat. 
SUPINE resting venous flow velocities: 
1. Mean velocity (cm/s)…………   TAVM (cm/s) ……..  S velocity (cm/s) ……….  D 
velocity (cm/s) ……… 
2. Mean velocity (cm/s)…………   TAVM (cm/s) ……..  S velocity (cm/s) ……….  D 
velocity (cm/s) ……… 
 
After short rest period, inflate cuff around calf to 80 mmHg for 4 secs. Upon release note peak 
velocity. Repeat. 
SUPINE Peak venous flow velocities: 
1. Peak (cm/s) ………… 
2. Peak (cm/s) ………… 
3. Peak (cm.s) ………… 
 
Repeat all measures in sitting position. 
SITTING resting venous flow velocities: 
1. Mean velocity (cm/s)…………   TAVM (cm/s) ……..  S velocity (cm/s) ……….  D 
velocity (cm/s) ……… 
2. Mean velocity (cm/s)…………   TAVM (cm/s) ……..  S velocity (cm/s) ……….  D 
velocity (cm/s) ……… 
 
After short rest period, inflate cuff around calf to 80 mmHg for 4 secs. Upon release note peak 
velocity. Repeat. 
SITTING Peak venous flow velocities: 
1. Peak (cm/s) ………… 
2. Peak (cm/s) ………… 
3. Peak (cm.s) ………… 
 
Resting calf blood flows 
Remove calf cuff. Place 2 Hokansen thigh cuffs around L and R thighs. Measure calf 
circumference and select strain gauge 2 cm smaller. Fit gauges to both calves. Fit small 
Hokansen cuffs around ankles. Set cuff inflator to 50 mmHg. 
Set up Chart / Powerlab© to record volumes. Set up Portapres© to record finger blood 
pressure (and heart rate) and display on Chart. 
Inflate ankle cuffs manually to systolic BP + 50 mmHg 
Inflate thigh cuffs to 50 mmHg for 8-10 sec. Record calf volume increase. Repeat twice more. 
Venous distension 
Remove thigh cuff from dominant leg and replace with cuff from DRT4. Leave other thigh 
cuff on. Attach LDF probe from DRT4 to non-dominant leg close to strain gauge. Check 
recording via DRT4© onto PC using Moor software©. Subject to position feet on bench and 
secure using bean bag pad. Check BP recording OK from Portapres©. If necessary, use 
heating blanket.  
Re-locate femoral vein with DUS and image in longitudinal section. Set up VIA to track 
diameter. Set up Chart and DRT4 to measure volume. Check PORH setup on DRT4 to be 50 
mmHg for 300 sec. 
Control distension 
When ready, press start on DRT4 to give 20 sec countdown to cuff inflation. 
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At start of cuff inflation / distension, press start on clock. 
At 2 min 40 sec, inflate Hokansen 50 mmHg for 8-10 sec to get blood flow from non-
dominant leg 
At 2 min 55 sec, countdown to START OF INTERVENTION PERIOD. 
At 3 min 40 sec, inflate Hokansen 50 mmHg for 8-10 sec to get blood flow from non-
dominant leg 
At 3 min 55 sec, countdown to END OF INTERVENTION PERIOD. 
At 5 min, cuff will deflate automatically. Keep imaging until full deflation (30 sec). 
CPT distension 
When ready, press start on DRT4 to give 20 sec countdown to cuff inflation. 
At start of cuff inflation / distension, press start on clock. 
At 2 min 40 sec, inflate Hokansen 50 mmHg for 8-10 sec to get blood flow from non-
dominant leg. 
At 2 min 55 sec, countdown to START OF INTERVENTION PERIOD. 
SUBJECT TO PLACE HAND UP TO WRIST IN ICE WATER. 
At 3 min 40 sec, inflate Hokansen 50 mmHg for 8-10 sec to get blood flow from non-
dominant leg. 
At 3 min 55 sec, countdown to END OF INTERVENTION PERIOD. 
SUBJECT TO REMOVE HAND FROM ICE WATER. 
At 5 min, cuff will deflate automatically. Keep imaging until full deflation (30 sec). 
Stop and save DRT4 and all Chart recordings.  
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Appendix H: Test Session 2: Wellcome Research Facility 
University Hospitals Birmingham 
The effects of OBesity on Venous Impedance and Outflow measured by UltraSound 
“OBVIOUS STUDY” 
 
Admission onto Wellcome trust system and DEXA Scanning 
Set up pressure transducer and draw up lignocaine and saline flush 
Name: ____________________________ 
Next of Kin ____________________________ 
 ____________________________ 
  
Date of Examination: ____________________________ 
DOB: ____________________________ 
 
Check Consent into study: _______ Allergies ________________ 
Check in Female the LMP: _______ Check Pregnancy status: _______ 
Collect Questionnaires: _______ 
Lie down on bed 
Oxygen Saturations: ____________ 
Blood Pressure: ____________ 
MAP:  ____________ 
Pulse:  ____________ 
BP Left arm        
BP Right arm  
BP Left Leg  
BP Right Leg  
TP Left Leg  
TP Right leg  
 
ABPI: ____________  TBPI: ____________ 
 Circumference in cm 
Wrist  
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Waist  
Hip  
Ankle  
 
Wall-Brown-Simms ratio:  ______________ 
 Tissue hardness
Position Left Right 
Thigh 15 cm from medial femoral condyle   
Calf 15 cm from medial malleolus   
Abdomen 3 cm below umbilicus  
 
Introduce lignocaine 
Introduce pressure transducer into groin under ultrasound guidance. 
Flush line 
Start Stop Watch Cycle 1 Cycle 2 Cycle 3 Cycle 4 
Record resting 
pressure at 1 min 
    
Record resting 
pressure at 2 min 
    
     
Sit patient up to 
90 degrees 
    
Pressure at 1 
minute 
    
Pressure at 2 
minutes 
    
Pressure at 3 
minutes 
    
Pressure at 4 
minutes 
    
Pressure at 5 
minutes 
    
   
Tissue Hardness 
After first Cycle  
Left Right 
Thigh   
Calf   
 
Remove transducer and apply pressure to the wound: 
Venous refill time: 
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Dominant Limb ____________ 
Take Bloods: 
Completion of examination session date _______________ 
Lead investigator: ___________________________ 
Research nurse: ___________________________ 
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Appendix I: Kolmogorov-Smirnov Test for Normality of Data. 
Observe and calculated data were analysed using a Kolmogorov-Smirnov to establish if the 
variables that were to be future analysed were normally distributed. The results are displayed 
below. The majority of the data was normally distributed. 
Vascular Parameters 
Variable Kolmogorov-Smirnov test p=0.05 Normal Distribution
   
Mean Arterial Pressure 0.975 Yes 
Ankle Brachial pressure index 0.646 Yes 
Dominant limb arterial blood flow 0.305 Yes 
Venous Refill time 0.012 No 
 
Body composition 
Variable Kolmogorov Smirnov test p=0.05 
Normal 
Distribution 
   
Age 0.625 Yes 
Height 0.974 Yes 
Weight 0.746 Yes 
BMI 0.698 Yes 
Age Adjusted BMI 0.032 No 
   
Left Wrist 0.008 No 
Right Wrist 0.180 Yes 
Left Ankle 0.653 Yes 
Right Ankle 0.323 Yes 
Left Thigh 0.008 No 
Right Thigh 0.487 Yes 
Left Calf 0.742 Yes 
Right Calf 0.946 Yes 
   
SA/SP index 0.789 Yes 
Sagittal Abdominal Diameter 0.312 Yes 
% Truncal Fat as determined by 
DEXA 1.000 Yes 
Waist-Hip ratio 0.962 Yes 
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Variable Kolmogorov Smirnov test p=0.05 
Normal 
Distribution 
Ultrasound Anterior Abdominal 
Wall subcutaneous tissue 
thickness 
0.739 Yes 
Ultrasound Thigh subcutaneous 
tissue thickness 0.833 Yes 
Ultrasound Calf subcutaneous 
tissue thickness 1.000 Yes 
Caliper Anterior Abdominal Wall 
subcutaneous tissue thickness 0.999 Yes 
Caliper Thigh subcutaneous tissue 
thickness 0.643 Yes 
Caliper Calf subcutaneous tissue 
thickness 0.752 Yes 
   
Dominant Calf Cross sectional 
area 0.868 Yes 
Dominant Calf Radius 0.974 Yes 
Dominant Calf lean Cross 
Sectional area 0.100 Yes 
Dominant Calf lean Cross 
sectional area as a percentage of 
whole calf 
0.043 No 
   
Oestrogen levels 0.076 No 
7 day Activity Questionnaire 0.993 Yes 
Age at Menarch 0.212 Yes 
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Inguinal tissue pressure and femoral vein flow. 
Variable Kolmogorov Smirnov test p=0.05 
Normal 
Distribution 
   
Difference in Inguinal Tissue Pressure from 
Supine to Seated 0.844 Yes 
   
Supine femoral vein diameter 0.853 Yes 
Supine femoral vein radius 0.767 Yes 
Supine femoral vein Cross Sectional Area 0.493 Yes 
Supine resting mean femoral flow velocity per 
second 0.622 Yes 
Supine resting time average velocity mean 
femoral flow velocity per second 0.766 Yes 
Supine resting systolic femoral flow velocity 
per second 0.572 Yes 
Supine resting diastolic femoral flow velocity 
per second 0.762 Yes 
Supine peak femoral vein velocity per second 0.810 Yes 
Supine resting mean femoral flow velocity per 
min 0.420 Yes 
Supine peak femoral flow velocity per min 0.952 Yes 
   
Seated femoral vein diameter 0.468 Yes 
Seated femoral vein radius 0.460 Yes 
Seated femoral vein Cross Sectional Area 0.292 Yes 
Seated resting mean femoral flow velocity per 
second 0.346 Yes 
Seated resting time average velocity mean 
femoral flow velocity per second 0.606 Yes 
Seated resting systolic femoral flow velocity 
per second 0.696 Yes 
Seated resting diastolic femoral flow velocity 
per second 0.177 Yes 
Seated peak femoral vein velocity per second 0.988 Yes 
Seated resting mean femoral flow velocity per 
min 0.017 No 
Seated peak femoral flow velocity per min 0.706 Yes 
   
Change in femoral vein Cross sectional area 
supine to seated 0.979 Yes 
Percentage change in the mean femoral vein 
flow from supine to seated 0.268 Yes 
Percentage change in the mean femoral vein 
flow from supine to seated 0.633 Yes 
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Durometry 
Variable Kolmogorov Smirnov test p=0.05 Normal Distribution
   
Durometry Thigh 0.763 Yes 
Durometry Calf 0.925 Yes 
Difference in Thigh Durometry supine 
to seated 0.426 Yes 
Difference in Calf Durometry supine to 
seated 0.839 Yes 
 
Lower leg venous properties (whole limb capacity, capillary filtration, vein size) 
Variable Kolmogorov Smirnov test p=0.05 
Normal 
Distribution 
   
Venous Capacitance at 120 seconds 0.693 Yes 
Max Venous Capacitance  after 300 seconds 0.914 Yes 
Filtration determined from Chart analysis 0.939 Yes 
Filtration determined from filtrass analysis 0.812 Yes 
PVi 0.467 Yes 
PV 0.993 Yes 
Popliteal Vein Maximum Diameter 0.958 Yes 
Popliteal vein Maximum Cross Sectional Area 0.830 Yes 
Great Saphenous Vein Maximum Diameter 0.421 Yes 
Great Saphenous Vein Maximum CSA  0.313 Yes 
 
Lower leg venous compliance 
Variable Kolmogorov Smirnov test p=0.05 
Normal 
Distribution 
   
Whole Limb Compliance 0.149 Yes 
Popliteal Vein Compliance 0.537 Yes 
Great Saphenous Vein Compliance 0.895 Yes 
 
Fasting Blood Glucose, Insulin and HOMA2 index 
Variable Kolmogorov Smirnov test p=0.05 
Normal 
Distribution 
   
Glucose mmol/l  0.830 Yes 
Insulin μUI/ml 0.093 Yes 
HOMA2 Index 0.238 Yes 
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